Clinical	PMC3820476	0	8	O	-1	-1	0
Epidemiology	PMC3820476	9	21	O	-1	-1	0


	PMC3820476	21	23	O	-1	-1	0

Dovepress	PMC3820476	23	32	O	-1	-1	0
open	PMC3820476	33	37	O	-1	-1	0
access	PMC3820476	38	44	O	-1	-1	0
to	PMC3820476	45	47	O	-1	-1	0
scientific	PMC3820476	48	58	O	-1	-1	0
and	PMC3820476	59	62	O	-1	-1	0
medical	PMC3820476	63	70	O	-1	-1	0
research	PMC3820476	71	79	O	-1	-1	0


	PMC3820476	79	81	O	-1	-1	0

O	PMC3820476	81	82	O	-1	-1	0
r	PMC3820476	83	84	O	-1	-1	0

i	PMC3820476	85	86	O	-1	-1	0
g	PMC3820476	87	88	O	-1	-1	0

i	PMC3820476	89	90	O	-1	-1	0
nal	PMC3820476	91	94	O	-1	-1	0
R	PMC3820476	95	96	O	-1	-1	0
esearch	PMC3820476	97	104	O	-1	-1	0


	PMC3820476	104	106	O	-1	-1	0

Open	PMC3820476	106	110	O	-1	-1	0
Access	PMC3820476	111	117	O	-1	-1	0
Full	PMC3820476	118	122	O	-1	-1	0
Text	PMC3820476	123	127	O	-1	-1	0
Article	PMC3820476	128	135	O	-1	-1	0


	PMC3820476	135	137	O	-1	-1	0
Comorbidity	PMC3820476	137	148	O	-1	-1	0
and	PMC3820476	149	152	O	-1	-1	0
survival	PMC3820476	153	161	O	-1	-1	0
of	PMC3820476	162	164	O	-1	-1	0
Danish	PMC3820476	165	171	O	-1	-1	0
breast	PMC3820476	172	178	O	-1	-1	0
cancer	PMC3820476	179	185	O	-1	-1	0

patients	PMC3820476	186	194	O	-1	-1	0
from	PMC3820476	195	199	O	-1	-1	0
2000–2011	PMC3820476	200	209	O	-1	-1	0
:	PMC3820476	209	210	O	-1	-1	0

a	PMC3820476	211	212	O	-1	-1	0
population	PMC3820476	213	223	O	-1	-1	0
-	PMC3820476	223	224	O	-1	-1	0
based	PMC3820476	224	229	O	-1	-1	0
cohort	PMC3820476	230	236	O	-1	-1	0
study	PMC3820476	237	242	O	-1	-1	0

This	PMC3820476	243	247	O	-1	-1	0
article	PMC3820476	248	255	O	-1	-1	0
was	PMC3820476	256	259	O	-1	-1	0
published	PMC3820476	260	269	O	-1	-1	0
in	PMC3820476	270	272	O	-1	-1	0
the	PMC3820476	273	276	O	-1	-1	0
following	PMC3820476	277	286	O	-1	-1	0
Dove	PMC3820476	287	291	O	-1	-1	0
Press	PMC3820476	292	297	O	-1	-1	0
journal	PMC3820476	298	305	O	-1	-1	0
:	PMC3820476	305	306	O	-1	-1	0
Clinical	PMC3820476	307	315	O	-1	-1	0
Epidemiology	PMC3820476	316	328	O	-1	-1	0
1	PMC3820476	329	330	O	-1	-1	0
November	PMC3820476	331	339	O	-1	-1	0
2013	PMC3820476	340	344	O	-1	-1	0

Number	PMC3820476	345	351	O	-1	-1	0
of	PMC3820476	352	354	O	-1	-1	0
times	PMC3820476	355	360	O	-1	-1	0
this	PMC3820476	361	365	O	-1	-1	0
article	PMC3820476	366	373	O	-1	-1	0
has	PMC3820476	374	377	O	-1	-1	0
been	PMC3820476	378	382	O	-1	-1	0
viewed	PMC3820476	383	389	O	-1	-1	0


	PMC3820476	389	391	O	-1	-1	0
Anne	PMC3820476	391	395	O	-1	-1	0
Gulbech	PMC3820476	396	403	O	-1	-1	0

Ording	PMC3820476	404	410	O	-1	-1	0
1	PMC3820476	411	412	O	-1	-1	0

Deirdre	PMC3820476	413	420	O	-1	-1	0
P	PMC3820476	421	422	O	-1	-1	0
Cronin	PMC3820476	423	429	O	-1	-1	0
-	PMC3820476	429	430	O	-1	-1	0
Fenton	PMC3820476	430	436	O	-1	-1	0
1	PMC3820476	437	438	O	-1	-1	0

Jacob	PMC3820476	439	444	O	-1	-1	0
Bonde	PMC3820476	445	450	O	-1	-1	0
Jacobsen	PMC3820476	451	459	O	-1	-1	0
1	PMC3820476	460	461	O	-1	-1	0

Mette	PMC3820476	462	467	O	-1	-1	0
Nørgaard	PMC3820476	468	476	O	-1	-1	0
1	PMC3820476	477	478	O	-1	-1	0

Reimar	PMC3820476	479	485	O	-1	-1	0
Wernich	PMC3820476	486	493	O	-1	-1	0
Thomsen	PMC3820476	494	501	O	-1	-1	0
1	PMC3820476	502	503	O	-1	-1	0

Peer	PMC3820476	504	508	O	-1	-1	0
Christiansen	PMC3820476	509	521	O	-1	-1	0
2	PMC3820476	522	523	O	-1	-1	0

Mette	PMC3820476	524	529	O	-1	-1	0
Søgaard	PMC3820476	530	537	O	-1	-1	0
1	PMC3820476	538	539	O	-1	-1	0
Department	PMC3820476	540	550	O	-1	-1	0
of	PMC3820476	551	553	O	-1	-1	0
Clinical	PMC3820476	554	562	O	-1	-1	0

Epidemiology	PMC3820476	563	575	O	-1	-1	0
,	PMC3820476	575	576	O	-1	-1	0
2	PMC3820476	577	578	O	-1	-1	0
Breast	PMC3820476	579	585	O	-1	-1	0
and	PMC3820476	586	589	O	-1	-1	0
Endocrine	PMC3820476	590	599	O	-1	-1	0
Section	PMC3820476	600	607	O	-1	-1	0
,	PMC3820476	607	608	O	-1	-1	0
Department	PMC3820476	609	619	O	-1	-1	0
of	PMC3820476	620	622	O	-1	-1	0
Surgery	PMC3820476	623	630	O	-1	-1	0
P	PMC3820476	631	632	O	-1	-1	0
,	PMC3820476	632	633	O	-1	-1	0

Aarhus	PMC3820476	634	640	O	-1	-1	0
University	PMC3820476	641	651	O	-1	-1	0
Hospital	PMC3820476	652	660	O	-1	-1	0
,	PMC3820476	660	661	O	-1	-1	0
Aarhus	PMC3820476	662	668	O	-1	-1	0
,	PMC3820476	668	669	O	-1	-1	0

Denmark	PMC3820476	670	677	O	-1	-1	0

1	PMC3820476	678	679	O	-1	-1	0


	PMC3820476	679	681	O	-1	-1	0

Objective	PMC3820476	681	690	O	-1	-1	0

:	PMC3820476	690	691	O	-1	-1	0
Previous	PMC3820476	692	700	O	-1	-1	0
studies	PMC3820476	701	708	O	-1	-1	0
have	PMC3820476	709	713	O	-1	-1	0
suggested	PMC3820476	714	723	O	-1	-1	0
that	PMC3820476	724	728	O	-1	-1	0
breast	PMC3820476	729	735	O	-1	-1	0
cancer	PMC3820476	736	742	O	-1	-1	0
survival	PMC3820476	743	751	O	-1	-1	0
in	PMC3820476	752	754	O	-1	-1	0
Denmark	PMC3820476	755	762	B-Location	-1	-1	0
has	PMC3820476	763	766	O	-1	-1	0
improved	PMC3820476	767	775	O	-1	-1	0
,	PMC3820476	775	776	O	-1	-1	0
primarily	PMC3820476	777	786	O	-1	-1	0
in	PMC3820476	787	789	O	-1	-1	0
cancer	PMC3820476	790	796	O	-1	-1	0
patients	PMC3820476	797	805	O	-1	-1	0
without	PMC3820476	806	813	O	-1	-1	0
comorbidity	PMC3820476	814	825	O	-1	-1	0
.	PMC3820476	825	826	O	-1	-1	0

We	PMC3820476	827	829	O	-1	-1	0
therefore	PMC3820476	830	839	O	-1	-1	0
conducted	PMC3820476	840	849	O	-1	-1	0
a	PMC3820476	850	851	O	-1	-1	0
­population	PMC3820476	852	863	O	-1	-1	0
-	PMC3820476	863	864	O	-1	-1	0
based	PMC3820476	864	869	O	-1	-1	0
cohort	PMC3820476	870	876	O	-1	-1	0
study	PMC3820476	877	882	O	-1	-1	0
to	PMC3820476	883	885	O	-1	-1	0
examine	PMC3820476	886	893	O	-1	-1	0
recent	PMC3820476	894	900	O	-1	-1	0
temporal	PMC3820476	901	909	O	-1	-1	0
changes	PMC3820476	910	917	O	-1	-1	0
in	PMC3820476	918	920	O	-1	-1	0
survival	PMC3820476	921	929	O	-1	-1	0
and	PMC3820476	930	933	O	-1	-1	0
mortality	PMC3820476	934	943	O	-1	-1	0
among	PMC3820476	944	949	O	-1	-1	0
breast	PMC3820476	950	956	O	-1	-1	0
cancer	PMC3820476	957	963	O	-1	-1	0
patients	PMC3820476	964	972	O	-1	-1	0
with	PMC3820476	973	977	O	-1	-1	0
different	PMC3820476	978	987	O	-1	-1	0
extents	PMC3820476	988	995	O	-1	-1	0
of	PMC3820476	996	998	O	-1	-1	0
comorbidity	PMC3820476	999	1010	O	-1	-1	0
.	PMC3820476	1010	1011	O	-1	-1	0

Methods	PMC3820476	1012	1019	O	-1	-1	0
:	PMC3820476	1019	1020	O	-1	-1	0

We	PMC3820476	1021	1023	O	-1	-1	0
used	PMC3820476	1024	1028	O	-1	-1	0
population	PMC3820476	1029	1039	O	-1	-1	0
-	PMC3820476	1039	1040	O	-1	-1	0
based	PMC3820476	1040	1045	O	-1	-1	0
medical	PMC3820476	1046	1053	O	-1	-1	0
and	PMC3820476	1054	1057	O	-1	-1	0
administrative	PMC3820476	1058	1072	O	-1	-1	0
registries	PMC3820476	1073	1083	O	-1	-1	0
to	PMC3820476	1084	1086	O	-1	-1	0
identify	PMC3820476	1087	1095	O	-1	-1	0
breast	PMC3820476	1096	1102	O	-1	-1	0
cancer	PMC3820476	1103	1109	O	-1	-1	0
patients	PMC3820476	1110	1118	O	-1	-1	0
diagnosed	PMC3820476	1119	1128	O	-1	-1	0
between	PMC3820476	1129	1136	O	-1	-1	0
2000	PMC3820476	1137	1141	O	-1	-1	0
and	PMC3820476	1142	1145	O	-1	-1	0
2011	PMC3820476	1146	1150	O	-1	-1	0
in	PMC3820476	1151	1153	O	-1	-1	0
the	PMC3820476	1154	1157	O	-1	-1	0
Central	PMC3820476	1158	1165	B-Location	-1	-1	0
Denmark	PMC3820476	1166	1173	I-Location	-1	-1	0
Region	PMC3820476	1174	1180	I-Location	-1	-1	0
.	PMC3820476	1180	1181	O	-1	-1	0

We	PMC3820476	1182	1184	O	-1	-1	0
defined	PMC3820476	1185	1192	O	-1	-1	0
comorbid	PMC3820476	1193	1201	O	-1	-1	0
diseases	PMC3820476	1202	1210	O	-1	-1	0
according	PMC3820476	1211	1220	O	-1	-1	0
to	PMC3820476	1221	1223	O	-1	-1	0
the	PMC3820476	1224	1227	O	-1	-1	0
Charlson	PMC3820476	1228	1236	O	-1	-1	0
Comorbidity	PMC3820476	1237	1248	O	-1	-1	0
Index	PMC3820476	1249	1254	O	-1	-1	0
(	PMC3820476	1255	1256	O	-1	-1	0
CCI	PMC3820476	1256	1259	O	-1	-1	0
)	PMC3820476	1259	1260	O	-1	-1	0
,	PMC3820476	1260	1261	O	-1	-1	0
including	PMC3820476	1262	1271	O	-1	-1	0
a	PMC3820476	1272	1273	O	-1	-1	0
history	PMC3820476	1274	1281	O	-1	-1	0
of	PMC3820476	1282	1284	O	-1	-1	0
hospitalization	PMC3820476	1285	1300	O	-1	-1	0
for	PMC3820476	1301	1304	O	-1	-1	0
comorbid	PMC3820476	1305	1313	O	-1	-1	0
disease	PMC3820476	1314	1321	O	-1	-1	0
up	PMC3820476	1322	1324	O	-1	-1	0
to	PMC3820476	1325	1327	O	-1	-1	0
10	PMC3820476	1328	1330	O	-1	-1	0
years	PMC3820476	1331	1336	O	-1	-1	0
before	PMC3820476	1337	1343	O	-1	-1	0
breast	PMC3820476	1344	1350	O	-1	-1	0
cancer	PMC3820476	1351	1357	O	-1	-1	0
diagnosis	PMC3820476	1358	1367	O	-1	-1	0
.	PMC3820476	1367	1368	O	-1	-1	0

We	PMC3820476	1369	1371	O	-1	-1	0
studied	PMC3820476	1372	1379	O	-1	-1	0
the	PMC3820476	1380	1383	O	-1	-1	0
impact	PMC3820476	1384	1390	O	-1	-1	0
of	PMC3820476	1391	1393	O	-1	-1	0
comorbidities	PMC3820476	1394	1407	O	-1	-1	0
on	PMC3820476	1408	1410	O	-1	-1	0
overall	PMC3820476	1411	1418	O	-1	-1	0
1-	PMC3820476	1419	1421	O	-1	-1	0
and	PMC3820476	1422	1425	O	-1	-1	0
5-year	PMC3820476	1426	1432	O	-1	-1	0
survival	PMC3820476	1433	1441	O	-1	-1	0
in	PMC3820476	1442	1444	O	-1	-1	0
different	PMC3820476	1445	1454	O	-1	-1	0
calendar	PMC3820476	1455	1463	O	-1	-1	0
time	PMC3820476	1464	1468	O	-1	-1	0
periods	PMC3820476	1469	1476	O	-1	-1	0
,	PMC3820476	1476	1477	O	-1	-1	0
using	PMC3820476	1478	1483	O	-1	-1	0
a	PMC3820476	1484	1485	O	-1	-1	0
hybrid	PMC3820476	1486	1492	O	-1	-1	0
analysis	PMC3820476	1493	1501	O	-1	-1	0
for	PMC3820476	1502	1505	O	-1	-1	0
survival	PMC3820476	1506	1514	O	-1	-1	0
prediction	PMC3820476	1515	1525	O	-1	-1	0
in	PMC3820476	1526	1528	O	-1	-1	0
the	PMC3820476	1529	1532	O	-1	-1	0
most	PMC3820476	1533	1537	O	-1	-1	0
recent	PMC3820476	1538	1544	O	-1	-1	0
calendar	PMC3820476	1545	1553	O	-1	-1	0
periods	PMC3820476	1554	1561	O	-1	-1	0
.	PMC3820476	1561	1562	O	-1	-1	0

Results	PMC3820476	1563	1570	O	-1	-1	0
:	PMC3820476	1570	1571	O	-1	-1	0
We	PMC3820476	1572	1574	O	-1	-1	0
included	PMC3820476	1575	1583	O	-1	-1	0
9,329	PMC3820476	1584	1589	O	-1	-1	0
breast	PMC3820476	1590	1596	O	-1	-1	0
cancer	PMC3820476	1597	1603	O	-1	-1	0
patients	PMC3820476	1604	1612	O	-1	-1	0
.	PMC3820476	1612	1613	O	-1	-1	0

The	PMC3820476	1614	1617	O	-1	-1	0
proportion	PMC3820476	1618	1628	O	-1	-1	0
of	PMC3820476	1629	1631	O	-1	-1	0
patients	PMC3820476	1632	1640	O	-1	-1	0
within	PMC3820476	1641	1647	O	-1	-1	0
different	PMC3820476	1648	1657	O	-1	-1	0
comorbidity	PMC3820476	1658	1669	O	-1	-1	0
categories	PMC3820476	1670	1680	O	-1	-1	0
remained	PMC3820476	1681	1689	O	-1	-1	0
stable	PMC3820476	1690	1696	O	-1	-1	0
from	PMC3820476	1697	1701	O	-1	-1	0
2000	PMC3820476	1702	1706	O	-1	-1	0
to	PMC3820476	1707	1709	O	-1	-1	0
2011	PMC3820476	1710	1714	O	-1	-1	0
.	PMC3820476	1714	1715	O	-1	-1	0

One	PMC3820476	1716	1719	O	-1	-1	0
-	PMC3820476	1719	1720	O	-1	-1	0
year	PMC3820476	1720	1724	O	-1	-1	0
survival	PMC3820476	1725	1733	O	-1	-1	0
improved	PMC3820476	1734	1742	O	-1	-1	0
from	PMC3820476	1743	1747	O	-1	-1	0
91	PMC3820476	1748	1750	O	-1	-1	0
%	PMC3820476	1750	1751	O	-1	-1	0
in	PMC3820476	1752	1754	O	-1	-1	0
2000–2002	PMC3820476	1755	1764	O	-1	-1	0
to	PMC3820476	1765	1767	O	-1	-1	0
95	PMC3820476	1768	1770	O	-1	-1	0
%	PMC3820476	1770	1771	O	-1	-1	0
in	PMC3820476	1772	1774	O	-1	-1	0
2009–2011	PMC3820476	1775	1784	O	-1	-1	0
,	PMC3820476	1784	1785	O	-1	-1	0
while	PMC3820476	1786	1791	O	-1	-1	0
5-year	PMC3820476	1792	1798	O	-1	-1	0
survival	PMC3820476	1799	1807	O	-1	-1	0
improved	PMC3820476	1808	1816	O	-1	-1	0
from	PMC3820476	1817	1821	O	-1	-1	0
72	PMC3820476	1822	1824	O	-1	-1	0
%	PMC3820476	1824	1825	O	-1	-1	0
to	PMC3820476	1826	1828	O	-1	-1	0
a	PMC3820476	1829	1830	O	-1	-1	0
predicted	PMC3820476	1831	1840	O	-1	-1	0
78	PMC3820476	1841	1843	O	-1	-1	0
%	PMC3820476	1843	1844	O	-1	-1	0
.	PMC3820476	1844	1845	O	-1	-1	0

During	PMC3820476	1846	1852	O	-1	-1	0
the	PMC3820476	1853	1856	O	-1	-1	0
entire	PMC3820476	1857	1863	O	-1	-1	0
study	PMC3820476	1864	1869	O	-1	-1	0
period	PMC3820476	1870	1876	O	-1	-1	0
,	PMC3820476	1876	1877	O	-1	-1	0
comorbidity	PMC3820476	1878	1889	O	-1	-1	0
was	PMC3820476	1890	1893	O	-1	-1	0
a	PMC3820476	1894	1895	O	-1	-1	0
strong	PMC3820476	1896	1902	O	-1	-1	0
predictor	PMC3820476	1903	1912	O	-1	-1	0
of	PMC3820476	1913	1915	O	-1	-1	0
the	PMC3820476	1916	1919	O	-1	-1	0
survival	PMC3820476	1920	1928	O	-1	-1	0
of	PMC3820476	1929	1931	O	-1	-1	0
breast	PMC3820476	1932	1938	O	-1	-1	0
cancer	PMC3820476	1939	1945	O	-1	-1	0
patients	PMC3820476	1946	1954	O	-1	-1	0
.	PMC3820476	1954	1955	O	-1	-1	0

However	PMC3820476	1956	1963	O	-1	-1	0
,	PMC3820476	1963	1964	O	-1	-1	0
we	PMC3820476	1965	1967	O	-1	-1	0
observed	PMC3820476	1968	1976	O	-1	-1	0
improvements	PMC3820476	1977	1989	O	-1	-1	0
over	PMC3820476	1990	1994	O	-1	-1	0
time	PMC3820476	1995	1999	O	-1	-1	0
in	PMC3820476	2000	2002	O	-1	-1	0
1-	PMC3820476	2003	2005	O	-1	-1	0

and	PMC3820476	2006	2009	O	-1	-1	0

5-year	PMC3820476	2010	2016	O	-1	-1	0
survival	PMC3820476	2017	2025	O	-1	-1	0
for	PMC3820476	2026	2029	O	-1	-1	0
all	PMC3820476	2030	2033	O	-1	-1	0
comorbidity	PMC3820476	2034	2045	O	-1	-1	0
groups	PMC3820476	2046	2052	O	-1	-1	0
.	PMC3820476	2052	2053	O	-1	-1	0

During	PMC3820476	2054	2060	O	-1	-1	0
the	PMC3820476	2061	2064	O	-1	-1	0
12-year	PMC3820476	2065	2072	O	-1	-1	0
study	PMC3820476	2073	2078	O	-1	-1	0
period	PMC3820476	2079	2085	O	-1	-1	0
,	PMC3820476	2085	2086	O	-1	-1	0
the	PMC3820476	2087	2090	O	-1	-1	0
estimated	PMC3820476	2091	2100	O	-1	-1	0
5-year	PMC3820476	2101	2107	O	-1	-1	0
survival	PMC3820476	2108	2116	O	-1	-1	0
for	PMC3820476	2117	2120	O	-1	-1	0
patients	PMC3820476	2121	2129	O	-1	-1	0
with	PMC3820476	2130	2134	O	-1	-1	0
a	PMC3820476	2135	2136	O	-1	-1	0
high	PMC3820476	2137	2141	O	-1	-1	0
comorbidity	PMC3820476	2142	2153	O	-1	-1	0
disease	PMC3820476	2154	2161	O	-1	-1	0
burden	PMC3820476	2162	2168	O	-1	-1	0
(	PMC3820476	2169	2170	O	-1	-1	0
CCI	PMC3820476	2170	2173	O	-1	-1	0
score	PMC3820476	2174	2179	O	-1	-1	0
$	PMC3820476	2180	2181	O	-1	-1	0
3	PMC3820476	2181	2182	O	-1	-1	0
)	PMC3820476	2182	2183	O	-1	-1	0
increased	PMC3820476	2184	2193	O	-1	-1	0
from	PMC3820476	2194	2198	O	-1	-1	0
25	PMC3820476	2199	2201	O	-1	-1	0
%	PMC3820476	2201	2202	O	-1	-1	0
to	PMC3820476	2203	2205	O	-1	-1	0
a	PMC3820476	2206	2207	O	-1	-1	0
predicted	PMC3820476	2208	2217	O	-1	-1	0
50	PMC3820476	2218	2220	O	-1	-1	0
%	PMC3820476	2220	2221	O	-1	-1	0
,	PMC3820476	2221	2222	O	-1	-1	0
and	PMC3820476	2223	2226	O	-1	-1	0
their	PMC3820476	2227	2232	O	-1	-1	0
5-year	PMC3820476	2233	2239	O	-1	-1	0
age	PMC3820476	2240	2243	O	-1	-1	0
-	PMC3820476	2243	2244	O	-1	-1	0
adjusted	PMC3820476	2244	2252	O	-1	-1	0
mortality	PMC3820476	2253	2262	O	-1	-1	0
hazard	PMC3820476	2263	2269	O	-1	-1	0
ratio	PMC3820476	2270	2275	O	-1	-1	0
(	PMC3820476	2276	2277	O	-1	-1	0
HR	PMC3820476	2277	2279	O	-1	-1	0
)	PMC3820476	2279	2280	O	-1	-1	0
fell	PMC3820476	2281	2285	O	-1	-1	0
from	PMC3820476	2286	2290	O	-1	-1	0
4.0	PMC3820476	2291	2294	O	-1	-1	0
(	PMC3820476	2295	2296	O	-1	-1	0
95	PMC3820476	2296	2298	O	-1	-1	0
%	PMC3820476	2298	2299	O	-1	-1	0
confidence	PMC3820476	2300	2310	O	-1	-1	0
interval	PMC3820476	2311	2319	O	-1	-1	0
[	PMC3820476	2320	2321	O	-1	-1	0
CI	PMC3820476	2321	2323	O	-1	-1	0
]	PMC3820476	2323	2324	O	-1	-1	0
:	PMC3820476	2324	2325	O	-1	-1	0
3.0	PMC3820476	2326	2329	O	-1	-1	0
,	PMC3820476	2329	2330	O	-1	-1	0
5.4	PMC3820476	2331	2334	O	-1	-1	0
)	PMC3820476	2334	2335	O	-1	-1	0
to	PMC3820476	2336	2338	O	-1	-1	0
2.7	PMC3820476	2339	2342	O	-1	-1	0
(	PMC3820476	2343	2344	O	-1	-1	0
95	PMC3820476	2344	2346	O	-1	-1	0
%	PMC3820476	2346	2347	O	-1	-1	0
CI	PMC3820476	2348	2350	O	-1	-1	0
:	PMC3820476	2350	2351	O	-1	-1	0
2.0	PMC3820476	2352	2355	O	-1	-1	0
,	PMC3820476	2355	2356	O	-1	-1	0
3.6	PMC3820476	2357	2360	O	-1	-1	0
)	PMC3820476	2360	2361	O	-1	-1	0
,	PMC3820476	2361	2362	O	-1	-1	0
respectively	PMC3820476	2363	2375	O	-1	-1	0
,	PMC3820476	2375	2376	O	-1	-1	0
compared	PMC3820476	2377	2385	O	-1	-1	0
with	PMC3820476	2386	2390	O	-1	-1	0
patients	PMC3820476	2391	2399	O	-1	-1	0
with	PMC3820476	2400	2404	O	-1	-1	0
no	PMC3820476	2405	2407	O	-1	-1	0
comorbid	PMC3820476	2408	2416	O	-1	-1	0
disease	PMC3820476	2417	2424	O	-1	-1	0
.	PMC3820476	2424	2425	O	-1	-1	0

Conclusion	PMC3820476	2426	2436	O	-1	-1	0
:	PMC3820476	2436	2437	O	-1	-1	0

Survival	PMC3820476	2438	2446	O	-1	-1	0
of	PMC3820476	2447	2449	O	-1	-1	0
breast	PMC3820476	2450	2456	O	-1	-1	0
cancer	PMC3820476	2457	2463	O	-1	-1	0
patients	PMC3820476	2464	2472	O	-1	-1	0
diagnosed	PMC3820476	2473	2482	O	-1	-1	0
in	PMC3820476	2483	2485	O	-1	-1	0
the	PMC3820476	2486	2489	O	-1	-1	0
Central	PMC3820476	2490	2497	B-Location	-1	-1	0
Denmark	PMC3820476	2498	2505	I-Location	-1	-1	0
Region	PMC3820476	2506	2512	I-Location	-1	-1	0
improved	PMC3820476	2513	2521	O	-1	-1	0
from	PMC3820476	2522	2526	O	-1	-1	0
2000	PMC3820476	2527	2531	O	-1	-1	0
to	PMC3820476	2532	2534	O	-1	-1	0
2011	PMC3820476	2535	2539	O	-1	-1	0
,	PMC3820476	2539	2540	O	-1	-1	0
regardless	PMC3820476	2541	2551	O	-1	-1	0
of	PMC3820476	2552	2554	O	-1	-1	0
the	PMC3820476	2555	2558	O	-1	-1	0
extent	PMC3820476	2559	2565	O	-1	-1	0
of	PMC3820476	2566	2568	O	-1	-1	0
comorbid	PMC3820476	2569	2577	O	-1	-1	0
disease	PMC3820476	2578	2585	O	-1	-1	0
.	PMC3820476	2585	2586	O	-1	-1	0

Keywords	PMC3820476	2587	2595	O	-1	-1	0
:	PMC3820476	2595	2596	O	-1	-1	0

breast	PMC3820476	2597	2603	O	-1	-1	0
neoplasm	PMC3820476	2604	2612	O	-1	-1	0
,	PMC3820476	2612	2613	O	-1	-1	0
survival	PMC3820476	2614	2622	O	-1	-1	0
,	PMC3820476	2622	2623	O	-1	-1	0
mortality	PMC3820476	2624	2633	O	-1	-1	0
,	PMC3820476	2633	2634	O	-1	-1	0
comorbidity	PMC3820476	2635	2646	O	-1	-1	0
,	PMC3820476	2646	2647	O	-1	-1	0
prognosis	PMC3820476	2648	2657	O	-1	-1	0


	PMC3820476	2657	2659	O	-1	-1	0

Introduction	PMC3820476	2659	2671	O	-1	-1	0


	PMC3820476	2671	2673	O	-1	-1	0

Correspondence	PMC3820476	2673	2687	O	-1	-1	0
:	PMC3820476	2687	2688	O	-1	-1	0

Anne	PMC3820476	2689	2693	O	-1	-1	0
G	PMC3820476	2694	2695	O	-1	-1	0
Ording	PMC3820476	2696	2702	O	-1	-1	0
Department	PMC3820476	2703	2713	O	-1	-1	0
of	PMC3820476	2714	2716	O	-1	-1	0
Clinical	PMC3820476	2717	2725	O	-1	-1	0
Epidemiology	PMC3820476	2726	2738	O	-1	-1	0
,	PMC3820476	2738	2739	O	-1	-1	0
Aarhus	PMC3820476	2740	2746	O	-1	-1	0
University	PMC3820476	2747	2757	O	-1	-1	0
Hospital	PMC3820476	2758	2766	O	-1	-1	0
,	PMC3820476	2766	2767	O	-1	-1	0

Olof	PMC3820476	2768	2772	O	-1	-1	0
Palmes	PMC3820476	2773	2779	O	-1	-1	0
Allé	PMC3820476	2780	2784	O	-1	-1	0
43	PMC3820476	2785	2787	O	-1	-1	0
-	PMC3820476	2787	2788	O	-1	-1	0
45	PMC3820476	2788	2790	O	-1	-1	0
,	PMC3820476	2790	2791	O	-1	-1	0
8200	PMC3820476	2792	2796	O	-1	-1	0

Aarhus	PMC3820476	2797	2803	O	-1	-1	0
N	PMC3820476	2804	2805	O	-1	-1	0
,	PMC3820476	2805	2806	O	-1	-1	0
Denmark	PMC3820476	2807	2814	O	-1	-1	0

Tel	PMC3820476	2815	2818	O	-1	-1	0
+45	PMC3820476	2819	2822	O	-1	-1	0
87	PMC3820476	2823	2825	O	-1	-1	0
16	PMC3820476	2826	2828	O	-1	-1	0
80	PMC3820476	2829	2831	O	-1	-1	0
63	PMC3820476	2832	2834	O	-1	-1	0

Fax	PMC3820476	2835	2838	O	-1	-1	0
+45	PMC3820476	2839	2842	O	-1	-1	0
87	PMC3820476	2843	2845	O	-1	-1	0
16	PMC3820476	2846	2848	O	-1	-1	0
72	PMC3820476	2849	2851	O	-1	-1	0
15	PMC3820476	2852	2854	O	-1	-1	0

Email	PMC3820476	2855	2860	O	-1	-1	0

ao@dce.au.dk	PMC3820476	2861	2873	O	-1	-1	0


	PMC3820476	2873	2875	O	-1	-1	0

submit	PMC3820476	2875	2881	O	-1	-1	0
your	PMC3820476	2882	2886	O	-1	-1	0
manuscript	PMC3820476	2887	2897	O	-1	-1	0

|	PMC3820476	2898	2899	O	-1	-1	0

www.dovepress.com	PMC3820476	2900	2917	O	-1	-1	0


	PMC3820476	2917	2919	O	-1	-1	0

Dovepress	PMC3820476	2919	2928	O	-1	-1	0

http://dx.doi.org/10.2147/CLEP.S47152	PMC3820476	2929	2966	O	-1	-1	0


	PMC3820476	2966	2968	O	-1	-1	0

Denmark	PMC3820476	2968	2975	B-Location	-1	-1	0
currently	PMC3820476	2976	2985	O	-1	-1	0
has	PMC3820476	2986	2989	O	-1	-1	0
the	PMC3820476	2990	2993	O	-1	-1	0
second	PMC3820476	2994	3000	O	-1	-1	0
-	PMC3820476	3000	3001	O	-1	-1	0
highest	PMC3820476	3001	3008	O	-1	-1	0
breast	PMC3820476	3009	3015	O	-1	-1	0
cancer	PMC3820476	3016	3022	O	-1	-1	0
incidence	PMC3820476	3023	3032	O	-1	-1	0
and	PMC3820476	3033	3036	O	-1	-1	0
the	PMC3820476	3037	3040	O	-1	-1	0
highest	PMC3820476	3041	3048	O	-1	-1	0
mortality	PMC3820476	3049	3058	O	-1	-1	0
from	PMC3820476	3059	3063	O	-1	-1	0
breast	PMC3820476	3064	3070	O	-1	-1	0
cancer	PMC3820476	3071	3077	O	-1	-1	0
in	PMC3820476	3078	3080	O	-1	-1	0
Europe.1	PMC3820476	3081	3089	B-Location	-1	-1	0
Breast	PMC3820476	3090	3096	O	-1	-1	0
cancer	PMC3820476	3097	3103	O	-1	-1	0
risk	PMC3820476	3104	3108	O	-1	-1	0
increases	PMC3820476	3109	3118	O	-1	-1	0
with	PMC3820476	3119	3123	O	-1	-1	0
age	PMC3820476	3124	3127	O	-1	-1	0
,	PMC3820476	3127	3128	O	-1	-1	0
so	PMC3820476	3129	3131	O	-1	-1	0

breast	PMC3820476	3132	3138	O	-1	-1	0
cancer	PMC3820476	3139	3145	O	-1	-1	0
patients	PMC3820476	3146	3154	O	-1	-1	0
often	PMC3820476	3155	3160	O	-1	-1	0
have	PMC3820476	3161	3165	O	-1	-1	0
comorbid	PMC3820476	3166	3174	O	-1	-1	0
disease	PMC3820476	3175	3182	O	-1	-1	0
at	PMC3820476	3183	3185	O	-1	-1	0
the	PMC3820476	3186	3189	O	-1	-1	0
time	PMC3820476	3190	3194	O	-1	-1	0
of	PMC3820476	3195	3197	O	-1	-1	0
their	PMC3820476	3198	3203	O	-1	-1	0
breast	PMC3820476	3204	3210	O	-1	-1	0
cancer	PMC3820476	3211	3217	O	-1	-1	0

diagnosis.2–4	PMC3820476	3218	3231	O	-1	-1	0

In	PMC3820476	3232	3234	O	-1	-1	0
Denmark	PMC3820476	3235	3242	B-Location	-1	-1	0
,	PMC3820476	3242	3243	O	-1	-1	0
this	PMC3820476	3244	3248	O	-1	-1	0
amounts	PMC3820476	3249	3256	O	-1	-1	0
to	PMC3820476	3257	3259	O	-1	-1	0
about	PMC3820476	3260	3265	O	-1	-1	0
20	PMC3820476	3266	3268	O	-1	-1	0
%	PMC3820476	3268	3269	O	-1	-1	0
of	PMC3820476	3270	3272	O	-1	-1	0
all	PMC3820476	3273	3276	O	-1	-1	0
breast	PMC3820476	3277	3283	O	-1	-1	0
cancer	PMC3820476	3284	3290	O	-1	-1	0

patients.5	PMC3820476	3291	3301	O	-1	-1	0

Several	PMC3820476	3302	3309	O	-1	-1	0
studies	PMC3820476	3310	3317	O	-1	-1	0
have	PMC3820476	3318	3322	O	-1	-1	0
documented	PMC3820476	3323	3333	O	-1	-1	0
that	PMC3820476	3334	3338	O	-1	-1	0
comorbid	PMC3820476	3339	3347	O	-1	-1	0
diseases	PMC3820476	3348	3356	O	-1	-1	0
negatively	PMC3820476	3357	3367	O	-1	-1	0
affect	PMC3820476	3368	3374	O	-1	-1	0
survival	PMC3820476	3375	3383	O	-1	-1	0
after	PMC3820476	3384	3389	O	-1	-1	0
breast	PMC3820476	3390	3396	O	-1	-1	0
cancer.6,7	PMC3820476	3397	3407	O	-1	-1	0
Mortality	PMC3820476	3408	3417	O	-1	-1	0
in	PMC3820476	3418	3420	O	-1	-1	0
these	PMC3820476	3421	3426	O	-1	-1	0
patients	PMC3820476	3427	3435	O	-1	-1	0
may	PMC3820476	3436	3439	O	-1	-1	0
often	PMC3820476	3440	3445	O	-1	-1	0
be	PMC3820476	3446	3448	O	-1	-1	0
related	PMC3820476	3449	3456	O	-1	-1	0
to	PMC3820476	3457	3459	O	-1	-1	0
the	PMC3820476	3460	3463	O	-1	-1	0
comorbidities	PMC3820476	3464	3477	O	-1	-1	0
rather	PMC3820476	3478	3484	O	-1	-1	0
than	PMC3820476	3485	3489	O	-1	-1	0
to	PMC3820476	3490	3492	O	-1	-1	0
the	PMC3820476	3493	3496	O	-1	-1	0
breast	PMC3820476	3497	3503	O	-1	-1	0
cancer,8,9	PMC3820476	3504	3514	O	-1	-1	0
in	PMC3820476	3515	3517	O	-1	-1	0
particular	PMC3820476	3518	3528	O	-1	-1	0
among	PMC3820476	3529	3534	O	-1	-1	0
patients	PMC3820476	3535	3543	O	-1	-1	0
with	PMC3820476	3544	3548	O	-1	-1	0
extensive	PMC3820476	3549	3558	O	-1	-1	0
comorbidity.10–12	PMC3820476	3559	3576	O	-1	-1	0

Survival	PMC3820476	3577	3585	O	-1	-1	0
after	PMC3820476	3586	3591	O	-1	-1	0
breast	PMC3820476	3592	3598	O	-1	-1	0
cancer	PMC3820476	3599	3605	O	-1	-1	0
has	PMC3820476	3606	3609	O	-1	-1	0
improved	PMC3820476	3610	3618	O	-1	-1	0
in	PMC3820476	3619	3621	O	-1	-1	0
Denmark13	PMC3820476	3622	3631	B-Location	-1	-1	0
but	PMC3820476	3632	3635	O	-1	-1	0
,	PMC3820476	3635	3636	O	-1	-1	0
according	PMC3820476	3637	3646	O	-1	-1	0
to	PMC3820476	3647	3649	O	-1	-1	0
a	PMC3820476	3650	3651	O	-1	-1	0
recent	PMC3820476	3652	3658	O	-1	-1	0
Danish	PMC3820476	3659	3665	O	-1	-1	0
population	PMC3820476	3666	3676	O	-1	-1	0
-	PMC3820476	3676	3677	O	-1	-1	0
based	PMC3820476	3677	3682	O	-1	-1	0
study	PMC3820476	3683	3688	O	-1	-1	0
,	PMC3820476	3688	3689	O	-1	-1	0
the	PMC3820476	3690	3693	O	-1	-1	0
5-year	PMC3820476	3694	3700	O	-1	-1	0
survival	PMC3820476	3701	3709	O	-1	-1	0
of	PMC3820476	3710	3712	O	-1	-1	0
breast	PMC3820476	3713	3719	O	-1	-1	0
cancer	PMC3820476	3720	3726	O	-1	-1	0
patients	PMC3820476	3727	3735	O	-1	-1	0


	PMC3820476	3735	3737	O	-1	-1	0

Clinical	PMC3820476	3737	3745	O	-1	-1	0
Epidemiology	PMC3820476	3746	3758	O	-1	-1	0
2013:5	PMC3820476	3759	3765	O	-1	-1	0

(	PMC3820476	3766	3767	O	-1	-1	0
Suppl	PMC3820476	3767	3772	O	-1	-1	0
1	PMC3820476	3773	3774	O	-1	-1	0
)	PMC3820476	3774	3775	O	-1	-1	0

39–46	PMC3820476	3776	3781	O	-1	-1	0

©	PMC3820476	3782	3783	O	-1	-1	0
2013	PMC3820476	3784	3788	O	-1	-1	0

Ording	PMC3820476	3789	3795	O	-1	-1	0
et	PMC3820476	3796	3798	O	-1	-1	0
al	PMC3820476	3799	3801	O	-1	-1	0
,	PMC3820476	3801	3802	O	-1	-1	0
publisher	PMC3820476	3803	3812	O	-1	-1	0
and	PMC3820476	3813	3816	O	-1	-1	0

licensee	PMC3820476	3817	3825	O	-1	-1	0
Dove	PMC3820476	3826	3830	O	-1	-1	0
Medical	PMC3820476	3831	3838	O	-1	-1	0
Press	PMC3820476	3839	3844	O	-1	-1	0
Ltd.	PMC3820476	3845	3849	O	-1	-1	0
This	PMC3820476	3850	3854	O	-1	-1	0
is	PMC3820476	3855	3857	O	-1	-1	0
an	PMC3820476	3858	3860	O	-1	-1	0
Open	PMC3820476	3861	3865	O	-1	-1	0
Access	PMC3820476	3866	3872	O	-1	-1	0
article	PMC3820476	3873	3880	O	-1	-1	0
which	PMC3820476	3881	3886	O	-1	-1	0
permits	PMC3820476	3887	3894	O	-1	-1	0
unrestricted	PMC3820476	3895	3907	O	-1	-1	0
noncommercial	PMC3820476	3908	3921	O	-1	-1	0
use	PMC3820476	3922	3925	O	-1	-1	0
,	PMC3820476	3925	3926	O	-1	-1	0
provided	PMC3820476	3927	3935	O	-1	-1	0
the	PMC3820476	3936	3939	O	-1	-1	0
original	PMC3820476	3940	3948	O	-1	-1	0
work	PMC3820476	3949	3953	O	-1	-1	0
is	PMC3820476	3954	3956	O	-1	-1	0
properly	PMC3820476	3957	3965	O	-1	-1	0
cited	PMC3820476	3966	3971	O	-1	-1	0
.	PMC3820476	3971	3972	O	-1	-1	0


	PMC3820476	3972	3974	O	-1	-1	0

39	PMC3820476	3974	3976	O	-1	-1	0


	PMC3820476	3976	3978	O	-1	-1	0

Dovepress	PMC3820476	3978	3987	O	-1	-1	0


	PMC3820476	3987	3989	O	-1	-1	0

Ording	PMC3820476	3989	3995	O	-1	-1	0
et	PMC3820476	3996	3998	O	-1	-1	0
al	PMC3820476	3999	4001	O	-1	-1	0


	PMC3820476	4001	4003	O	-1	-1	0
with	PMC3820476	4003	4007	O	-1	-1	0
a	PMC3820476	4008	4009	O	-1	-1	0
Charlson	PMC3820476	4010	4018	O	-1	-1	0
Comorbidity	PMC3820476	4019	4030	O	-1	-1	0
Index	PMC3820476	4031	4036	O	-1	-1	0
(	PMC3820476	4037	4038	O	-1	-1	0
CCI	PMC3820476	4038	4041	O	-1	-1	0
)	PMC3820476	4041	4042	O	-1	-1	0
score	PMC3820476	4043	4048	O	-1	-1	0
of	PMC3820476	4049	4051	O	-1	-1	0
$	PMC3820476	4052	4053	O	-1	-1	0
3	PMC3820476	4053	4054	O	-1	-1	0
has	PMC3820476	4055	4058	O	-1	-1	0
only	PMC3820476	4059	4063	O	-1	-1	0
increased	PMC3820476	4064	4073	O	-1	-1	0
from	PMC3820476	4074	4078	O	-1	-1	0
42.0	PMC3820476	4079	4083	O	-1	-1	0
%	PMC3820476	4083	4084	O	-1	-1	0
in	PMC3820476	4085	4087	O	-1	-1	0
1990–1994	PMC3820476	4088	4097	O	-1	-1	0
to	PMC3820476	4098	4100	O	-1	-1	0
43.5	PMC3820476	4101	4105	O	-1	-1	0
%	PMC3820476	4105	4106	O	-1	-1	0
in	PMC3820476	4107	4109	O	-1	-1	0
2000–2004.14	PMC3820476	4110	4122	O	-1	-1	0

Another	PMC3820476	4123	4130	O	-1	-1	0
previous	PMC3820476	4131	4139	O	-1	-1	0
Danish	PMC3820476	4140	4146	O	-1	-1	0
population	PMC3820476	4147	4157	O	-1	-1	0
-	PMC3820476	4157	4158	O	-1	-1	0
based	PMC3820476	4158	4163	O	-1	-1	0
study	PMC3820476	4164	4169	O	-1	-1	0
reported	PMC3820476	4170	4178	O	-1	-1	0
slightly	PMC3820476	4179	4187	O	-1	-1	0
poorer	PMC3820476	4188	4194	O	-1	-1	0
survival	PMC3820476	4195	4203	O	-1	-1	0
over	PMC3820476	4204	4208	O	-1	-1	0
time	PMC3820476	4209	4213	O	-1	-1	0
among	PMC3820476	4214	4219	O	-1	-1	0
breast	PMC3820476	4220	4226	O	-1	-1	0
cancer	PMC3820476	4227	4233	O	-1	-1	0
patients	PMC3820476	4234	4242	O	-1	-1	0
with	PMC3820476	4243	4247	O	-1	-1	0
severe	PMC3820476	4248	4254	O	-1	-1	0
comorbidity	PMC3820476	4255	4266	O	-1	-1	0
between	PMC3820476	4267	4274	O	-1	-1	0
1995	PMC3820476	4275	4279	O	-1	-1	0
and	PMC3820476	4280	4283	O	-1	-1	0
2005.5	PMC3820476	4284	4290	O	-1	-1	0

The	PMC3820476	4291	4294	O	-1	-1	0
aim	PMC3820476	4295	4298	O	-1	-1	0
of	PMC3820476	4299	4301	O	-1	-1	0
this	PMC3820476	4302	4306	O	-1	-1	0
paper	PMC3820476	4307	4312	O	-1	-1	0
was	PMC3820476	4313	4316	O	-1	-1	0
to	PMC3820476	4317	4319	O	-1	-1	0
study	PMC3820476	4320	4325	O	-1	-1	0
temporal	PMC3820476	4326	4334	O	-1	-1	0
changes	PMC3820476	4335	4342	O	-1	-1	0
in	PMC3820476	4343	4345	O	-1	-1	0
mortality	PMC3820476	4346	4355	O	-1	-1	0
in	PMC3820476	4356	4358	O	-1	-1	0
a	PMC3820476	4359	4360	O	-1	-1	0
cohort	PMC3820476	4361	4367	O	-1	-1	0
of	PMC3820476	4368	4370	O	-1	-1	0
breast	PMC3820476	4371	4377	O	-1	-1	0
cancer	PMC3820476	4378	4384	O	-1	-1	0
patients	PMC3820476	4385	4393	O	-1	-1	0
diagnosed	PMC3820476	4394	4403	O	-1	-1	0
between	PMC3820476	4404	4411	O	-1	-1	0
2000	PMC3820476	4412	4416	O	-1	-1	0
and	PMC3820476	4417	4420	O	-1	-1	0
2011	PMC3820476	4421	4425	O	-1	-1	0
by	PMC3820476	4426	4428	O	-1	-1	0
extent	PMC3820476	4429	4435	O	-1	-1	0
of	PMC3820476	4436	4438	O	-1	-1	0
comorbid	PMC3820476	4439	4447	O	-1	-1	0
diseases	PMC3820476	4448	4456	O	-1	-1	0
,	PMC3820476	4456	4457	O	-1	-1	0
as	PMC3820476	4458	4460	O	-1	-1	0
defined	PMC3820476	4461	4468	O	-1	-1	0
by	PMC3820476	4469	4471	O	-1	-1	0
the	PMC3820476	4472	4475	O	-1	-1	0
CCI.15	PMC3820476	4476	4482	O	-1	-1	0


	PMC3820476	4482	4484	O	-1	-1	0
dementia	PMC3820476	4484	4492	O	-1	-1	0
;	PMC3820476	4492	4493	O	-1	-1	0
connective	PMC3820476	4494	4504	O	-1	-1	0
tissue	PMC3820476	4505	4511	O	-1	-1	0
disease	PMC3820476	4512	4519	O	-1	-1	0
;	PMC3820476	4519	4520	O	-1	-1	0
ulcer	PMC3820476	4521	4526	O	-1	-1	0
disease	PMC3820476	4527	4534	O	-1	-1	0
;	PMC3820476	4534	4535	O	-1	-1	0
­diabetes	PMC3820476	4536	4545	O	-1	-1	0
;	PMC3820476	4545	4546	O	-1	-1	0
renal	PMC3820476	4547	4552	O	-1	-1	0
disease	PMC3820476	4553	4560	O	-1	-1	0
;	PMC3820476	4560	4561	O	-1	-1	0
cancer	PMC3820476	4562	4568	O	-1	-1	0
;	PMC3820476	4568	4569	O	-1	-1	0
and	PMC3820476	4570	4573	O	-1	-1	0
HIV	PMC3820476	4574	4577	O	-1	-1	0
/	PMC3820476	4577	4578	O	-1	-1	0
AIDS	PMC3820476	4578	4582	O	-1	-1	0
.	PMC3820476	4582	4583	O	-1	-1	0

Breast	PMC3820476	4584	4590	O	-1	-1	0
cancer	PMC3820476	4591	4597	O	-1	-1	0
diagnoses	PMC3820476	4598	4607	O	-1	-1	0
were	PMC3820476	4608	4612	O	-1	-1	0
excluded	PMC3820476	4613	4621	O	-1	-1	0
when	PMC3820476	4622	4626	O	-1	-1	0
we	PMC3820476	4627	4629	O	-1	-1	0
computed	PMC3820476	4630	4638	O	-1	-1	0
the	PMC3820476	4639	4642	O	-1	-1	0
CCI	PMC3820476	4643	4646	O	-1	-1	0
score	PMC3820476	4647	4652	O	-1	-1	0
.	PMC3820476	4652	4653	O	-1	-1	0

Furthermore	PMC3820476	4654	4665	O	-1	-1	0
,	PMC3820476	4665	4666	O	-1	-1	0
cancer	PMC3820476	4667	4673	O	-1	-1	0
diagnoses	PMC3820476	4674	4683	O	-1	-1	0
within	PMC3820476	4684	4690	O	-1	-1	0
60	PMC3820476	4691	4693	O	-1	-1	0
days	PMC3820476	4694	4698	O	-1	-1	0
before	PMC3820476	4699	4705	O	-1	-1	0
the	PMC3820476	4706	4709	O	-1	-1	0
breast	PMC3820476	4710	4716	O	-1	-1	0
cancer	PMC3820476	4717	4723	O	-1	-1	0
diagnosis	PMC3820476	4724	4733	O	-1	-1	0
were	PMC3820476	4734	4738	O	-1	-1	0
excluded	PMC3820476	4739	4747	O	-1	-1	0
from	PMC3820476	4748	4752	O	-1	-1	0
the	PMC3820476	4753	4756	O	-1	-1	0
calculations	PMC3820476	4757	4769	O	-1	-1	0
,	PMC3820476	4769	4770	O	-1	-1	0
in	PMC3820476	4771	4773	O	-1	-1	0
order	PMC3820476	4774	4779	O	-1	-1	0
to	PMC3820476	4780	4782	O	-1	-1	0
eliminate	PMC3820476	4783	4792	O	-1	-1	0
possible	PMC3820476	4793	4801	O	-1	-1	0
nonspecific	PMC3820476	4802	4813	O	-1	-1	0
cancer	PMC3820476	4814	4820	O	-1	-1	0
diagnoses	PMC3820476	4821	4830	O	-1	-1	0
related	PMC3820476	4831	4838	O	-1	-1	0
to	PMC3820476	4839	4841	O	-1	-1	0
the	PMC3820476	4842	4845	O	-1	-1	0
breast	PMC3820476	4846	4852	O	-1	-1	0
cancer	PMC3820476	4853	4859	O	-1	-1	0
diagnosis	PMC3820476	4860	4869	O	-1	-1	0
.	PMC3820476	4869	4870	O	-1	-1	0

We	PMC3820476	4871	4873	O	-1	-1	0
­categorized	PMC3820476	4874	4886	O	-1	-1	0
comorbidities	PMC3820476	4887	4900	O	-1	-1	0
as	PMC3820476	4901	4903	O	-1	-1	0
none	PMC3820476	4904	4908	O	-1	-1	0
(	PMC3820476	4909	4910	O	-1	-1	0
CCI	PMC3820476	4910	4913	O	-1	-1	0
score	PMC3820476	4914	4919	O	-1	-1	0
=	PMC3820476	4920	4921	O	-1	-1	0
0	PMC3820476	4922	4923	O	-1	-1	0
)	PMC3820476	4923	4924	O	-1	-1	0
,	PMC3820476	4924	4925	O	-1	-1	0
medium	PMC3820476	4926	4932	O	-1	-1	0

(	PMC3820476	4933	4934	O	-1	-1	0
CCI	PMC3820476	4934	4937	O	-1	-1	0
score	PMC3820476	4938	4943	O	-1	-1	0
=	PMC3820476	4944	4945	O	-1	-1	0

1–2	PMC3820476	4946	4949	O	-1	-1	0
)	PMC3820476	4949	4950	O	-1	-1	0
,	PMC3820476	4950	4951	O	-1	-1	0
or	PMC3820476	4952	4954	O	-1	-1	0
high	PMC3820476	4955	4959	O	-1	-1	0

(	PMC3820476	4960	4961	O	-1	-1	0
CCI	PMC3820476	4961	4964	O	-1	-1	0
score	PMC3820476	4965	4970	O	-1	-1	0
$	PMC3820476	4971	4972	O	-1	-1	0
3	PMC3820476	4972	4973	O	-1	-1	0
)	PMC3820476	4973	4974	O	-1	-1	0
.	PMC3820476	4974	4975	O	-1	-1	0


	PMC3820476	4975	4977	O	-1	-1	0

Materials	PMC3820476	4977	4986	O	-1	-1	0
and	PMC3820476	4987	4990	O	-1	-1	0
methods	PMC3820476	4991	4998	O	-1	-1	0

Study	PMC3820476	4999	5004	O	-1	-1	0
population	PMC3820476	5005	5015	O	-1	-1	0


	PMC3820476	5015	5017	O	-1	-1	0

Vital	PMC3820476	5017	5022	O	-1	-1	0
status	PMC3820476	5023	5029	O	-1	-1	0


	PMC3820476	5029	5031	O	-1	-1	0

This	PMC3820476	5031	5035	O	-1	-1	0
population	PMC3820476	5036	5046	O	-1	-1	0
-	PMC3820476	5046	5047	O	-1	-1	0
based	PMC3820476	5047	5052	O	-1	-1	0
cohort	PMC3820476	5053	5059	O	-1	-1	0
study	PMC3820476	5060	5065	O	-1	-1	0
was	PMC3820476	5066	5069	O	-1	-1	0
based	PMC3820476	5070	5075	O	-1	-1	0
in	PMC3820476	5076	5078	O	-1	-1	0
the	PMC3820476	5079	5082	O	-1	-1	0
­Central	PMC3820476	5083	5091	O	-1	-1	0
Denmark	PMC3820476	5092	5099	B-Location	-1	-1	0
Region	PMC3820476	5100	5106	I-Location	-1	-1	0
,	PMC3820476	5106	5107	O	-1	-1	0
which	PMC3820476	5108	5113	O	-1	-1	0
has	PMC3820476	5114	5117	O	-1	-1	0
approximately	PMC3820476	5118	5131	O	-1	-1	0
1.2	PMC3820476	5132	5135	O	-1	-1	0
million	PMC3820476	5136	5143	O	-1	-1	0
inhabitants	PMC3820476	5144	5155	O	-1	-1	0
.	PMC3820476	5155	5156	O	-1	-1	0

The	PMC3820476	5157	5160	O	-1	-1	0
Danish	PMC3820476	5161	5167	O	-1	-1	0
National	PMC3820476	5168	5176	O	-1	-1	0
Health	PMC3820476	5177	5183	O	-1	-1	0
service	PMC3820476	5184	5191	O	-1	-1	0
provides	PMC3820476	5192	5200	O	-1	-1	0
universal	PMC3820476	5201	5210	O	-1	-1	0
,	PMC3820476	5210	5211	O	-1	-1	0
tax	PMC3820476	5212	5215	O	-1	-1	0
-	PMC3820476	5215	5216	O	-1	-1	0
supported	PMC3820476	5216	5225	O	-1	-1	0
health	PMC3820476	5226	5232	O	-1	-1	0
care	PMC3820476	5233	5237	O	-1	-1	0
,	PMC3820476	5237	5238	O	-1	-1	0
guaranteeing	PMC3820476	5239	5251	O	-1	-1	0
unfettered	PMC3820476	5252	5262	O	-1	-1	0
access	PMC3820476	5263	5269	O	-1	-1	0
to	PMC3820476	5270	5272	O	-1	-1	0
all	PMC3820476	5273	5276	O	-1	-1	0
general	PMC3820476	5277	5284	O	-1	-1	0
practitioners	PMC3820476	5285	5298	O	-1	-1	0
and	PMC3820476	5299	5302	O	-1	-1	0
hospitals	PMC3820476	5303	5312	O	-1	-1	0
.	PMC3820476	5312	5313	O	-1	-1	0

Accurate	PMC3820476	5314	5322	O	-1	-1	0
and	PMC3820476	5323	5326	O	-1	-1	0
unambiguous	PMC3820476	5327	5338	O	-1	-1	0
linkage	PMC3820476	5339	5346	O	-1	-1	0
of	PMC3820476	5347	5349	O	-1	-1	0
all	PMC3820476	5350	5353	O	-1	-1	0
registries	PMC3820476	5354	5364	O	-1	-1	0
at	PMC3820476	5365	5367	O	-1	-1	0
the	PMC3820476	5368	5371	O	-1	-1	0
individual	PMC3820476	5372	5382	O	-1	-1	0
level	PMC3820476	5383	5388	O	-1	-1	0
is	PMC3820476	5389	5391	O	-1	-1	0
possible	PMC3820476	5392	5400	O	-1	-1	0
in	PMC3820476	5401	5403	O	-1	-1	0
Denmark	PMC3820476	5404	5411	B-Location	-1	-1	0
by	PMC3820476	5412	5414	O	-1	-1	0
means	PMC3820476	5415	5420	O	-1	-1	0
of	PMC3820476	5421	5423	O	-1	-1	0
the	PMC3820476	5424	5427	O	-1	-1	0
unique	PMC3820476	5428	5434	O	-1	-1	0
civil	PMC3820476	5435	5440	O	-1	-1	0
personal	PMC3820476	5441	5449	O	-1	-1	0
registration	PMC3820476	5450	5462	O	-1	-1	0
(	PMC3820476	5463	5464	O	-1	-1	0
CPR	PMC3820476	5464	5467	O	-1	-1	0
)	PMC3820476	5467	5468	O	-1	-1	0
number	PMC3820476	5469	5475	O	-1	-1	0
assigned	PMC3820476	5476	5484	O	-1	-1	0
to	PMC3820476	5485	5487	O	-1	-1	0
each	PMC3820476	5488	5492	O	-1	-1	0
Danish	PMC3820476	5493	5499	O	-1	-1	0
inhabitant	PMC3820476	5500	5510	O	-1	-1	0
at	PMC3820476	5511	5513	O	-1	-1	0
birth	PMC3820476	5514	5519	O	-1	-1	0
or	PMC3820476	5520	5522	O	-1	-1	0
immigration.16	PMC3820476	5523	5537	O	-1	-1	0


	PMC3820476	5537	5539	O	-1	-1	0

Identification	PMC3820476	5539	5553	O	-1	-1	0
of	PMC3820476	5554	5556	O	-1	-1	0
patients	PMC3820476	5557	5565	O	-1	-1	0
with	PMC3820476	5566	5570	O	-1	-1	0
breast	PMC3820476	5571	5577	O	-1	-1	0
cancer	PMC3820476	5578	5584	O	-1	-1	0

The	PMC3820476	5585	5588	O	-1	-1	0
Danish	PMC3820476	5589	5595	O	-1	-1	0
National	PMC3820476	5596	5604	O	-1	-1	0
Registry	PMC3820476	5605	5613	O	-1	-1	0
of	PMC3820476	5614	5616	O	-1	-1	0
Patients	PMC3820476	5617	5625	O	-1	-1	0
(	PMC3820476	5626	5627	O	-1	-1	0
NRP	PMC3820476	5627	5630	O	-1	-1	0
)	PMC3820476	5630	5631	O	-1	-1	0
contains	PMC3820476	5632	5640	O	-1	-1	0
information	PMC3820476	5641	5652	O	-1	-1	0
on	PMC3820476	5653	5655	O	-1	-1	0
all	PMC3820476	5656	5659	O	-1	-1	0
discharges	PMC3820476	5660	5670	O	-1	-1	0
from	PMC3820476	5671	5675	O	-1	-1	0
nonpsychiatric	PMC3820476	5676	5690	O	-1	-1	0
hospitals	PMC3820476	5691	5700	O	-1	-1	0
in	PMC3820476	5701	5703	O	-1	-1	0
Denmark	PMC3820476	5704	5711	B-Location	-1	-1	0
since	PMC3820476	5712	5717	O	-1	-1	0
1977	PMC3820476	5718	5722	O	-1	-1	0
and	PMC3820476	5723	5726	O	-1	-1	0
from	PMC3820476	5727	5731	O	-1	-1	0
emergency	PMC3820476	5732	5741	O	-1	-1	0
room	PMC3820476	5742	5746	O	-1	-1	0
and	PMC3820476	5747	5750	O	-1	-1	0
outpatient	PMC3820476	5751	5761	O	-1	-1	0
visits	PMC3820476	5762	5768	O	-1	-1	0
at	PMC3820476	5769	5771	O	-1	-1	0
hospitals	PMC3820476	5772	5781	O	-1	-1	0
since	PMC3820476	5782	5787	O	-1	-1	0
1995.17	PMC3820476	5788	5795	O	-1	-1	0

Each	PMC3820476	5796	5800	O	-1	-1	0
hospital	PMC3820476	5801	5809	O	-1	-1	0
discharge	PMC3820476	5810	5819	O	-1	-1	0
or	PMC3820476	5820	5822	O	-1	-1	0
outpatient	PMC3820476	5823	5833	O	-1	-1	0
visit	PMC3820476	5834	5839	O	-1	-1	0
is	PMC3820476	5840	5842	O	-1	-1	0
recorded	PMC3820476	5843	5851	O	-1	-1	0
in	PMC3820476	5852	5854	O	-1	-1	0
the	PMC3820476	5855	5858	O	-1	-1	0
registry	PMC3820476	5859	5867	O	-1	-1	0
with	PMC3820476	5868	5872	O	-1	-1	0
one	PMC3820476	5873	5876	O	-1	-1	0
primary	PMC3820476	5877	5884	O	-1	-1	0
diagnosis	PMC3820476	5885	5894	O	-1	-1	0
and	PMC3820476	5895	5898	O	-1	-1	0
one	PMC3820476	5899	5902	O	-1	-1	0
or	PMC3820476	5903	5905	O	-1	-1	0
more	PMC3820476	5906	5910	O	-1	-1	0
secondary	PMC3820476	5911	5920	O	-1	-1	0
diagnoses	PMC3820476	5921	5930	O	-1	-1	0
classified	PMC3820476	5931	5941	O	-1	-1	0
according	PMC3820476	5942	5951	O	-1	-1	0
to	PMC3820476	5952	5954	O	-1	-1	0
the	PMC3820476	5955	5958	O	-1	-1	0
International	PMC3820476	5959	5972	O	-1	-1	0
Classification	PMC3820476	5973	5987	O	-1	-1	0
of	PMC3820476	5988	5990	O	-1	-1	0
Diseases	PMC3820476	5991	5999	O	-1	-1	0
,	PMC3820476	5999	6000	O	-1	-1	0
8th	PMC3820476	6001	6004	O	-1	-1	0
edition	PMC3820476	6005	6012	O	-1	-1	0
(	PMC3820476	6013	6014	O	-1	-1	0
ICD-8	PMC3820476	6014	6019	O	-1	-1	0
)	PMC3820476	6019	6020	O	-1	-1	0
until	PMC3820476	6021	6026	O	-1	-1	0
the	PMC3820476	6027	6030	O	-1	-1	0
end	PMC3820476	6031	6034	O	-1	-1	0
of	PMC3820476	6035	6037	O	-1	-1	0
1993	PMC3820476	6038	6042	O	-1	-1	0
,	PMC3820476	6042	6043	O	-1	-1	0
and	PMC3820476	6044	6047	O	-1	-1	0
ICD-10	PMC3820476	6048	6054	O	-1	-1	0
thereafter	PMC3820476	6055	6065	O	-1	-1	0
.	PMC3820476	6065	6066	O	-1	-1	0

Using	PMC3820476	6067	6072	O	-1	-1	0
the	PMC3820476	6073	6076	O	-1	-1	0
NRP	PMC3820476	6077	6080	O	-1	-1	0
,	PMC3820476	6080	6081	O	-1	-1	0
we	PMC3820476	6082	6084	O	-1	-1	0
identified	PMC3820476	6085	6095	O	-1	-1	0
all	PMC3820476	6096	6099	O	-1	-1	0
female	PMC3820476	6100	6106	O	-1	-1	0
patients	PMC3820476	6107	6115	O	-1	-1	0
with	PMC3820476	6116	6120	O	-1	-1	0
an	PMC3820476	6121	6123	O	-1	-1	0
invasive	PMC3820476	6124	6132	O	-1	-1	0
breast	PMC3820476	6133	6139	O	-1	-1	0
cancer	PMC3820476	6140	6146	O	-1	-1	0
diagnosis	PMC3820476	6147	6156	O	-1	-1	0
(	PMC3820476	6157	6158	O	-1	-1	0
ICD-10	PMC3820476	6158	6164	O	-1	-1	0
code	PMC3820476	6165	6169	O	-1	-1	0
C50	PMC3820476	6170	6173	O	-1	-1	0
)	PMC3820476	6173	6174	O	-1	-1	0
from	PMC3820476	6175	6179	O	-1	-1	0
January	PMC3820476	6180	6187	O	-1	-1	0
1	PMC3820476	6188	6189	O	-1	-1	0
,	PMC3820476	6189	6190	O	-1	-1	0
2000	PMC3820476	6191	6195	O	-1	-1	0
to	PMC3820476	6196	6198	O	-1	-1	0
December	PMC3820476	6199	6207	O	-1	-1	0
31	PMC3820476	6208	6210	O	-1	-1	0
,	PMC3820476	6210	6211	O	-1	-1	0
2011	PMC3820476	6212	6216	O	-1	-1	0
.	PMC3820476	6216	6217	O	-1	-1	0

Patients	PMC3820476	6218	6226	O	-1	-1	0
with	PMC3820476	6227	6231	O	-1	-1	0
breast	PMC3820476	6232	6238	O	-1	-1	0
cancer	PMC3820476	6239	6245	O	-1	-1	0
diagnosed	PMC3820476	6246	6255	O	-1	-1	0
between	PMC3820476	6256	6263	O	-1	-1	0
1977	PMC3820476	6264	6268	O	-1	-1	0
and	PMC3820476	6269	6272	O	-1	-1	0
1999	PMC3820476	6273	6277	O	-1	-1	0
were	PMC3820476	6278	6282	O	-1	-1	0
excluded	PMC3820476	6283	6291	O	-1	-1	0
.	PMC3820476	6291	6292	O	-1	-1	0


	PMC3820476	6292	6294	O	-1	-1	0

Comorbid	PMC3820476	6294	6302	O	-1	-1	0
diseases	PMC3820476	6303	6311	O	-1	-1	0
at	PMC3820476	6312	6314	O	-1	-1	0
breast	PMC3820476	6315	6321	O	-1	-1	0

cancer	PMC3820476	6322	6328	O	-1	-1	0
diagnosis	PMC3820476	6329	6338	O	-1	-1	0

To	PMC3820476	6339	6341	O	-1	-1	0
assess	PMC3820476	6342	6348	O	-1	-1	0
patient	PMC3820476	6349	6356	O	-1	-1	0
comorbidity	PMC3820476	6357	6368	O	-1	-1	0
,	PMC3820476	6368	6369	O	-1	-1	0
the	PMC3820476	6370	6373	O	-1	-1	0
CCI	PMC3820476	6374	6377	O	-1	-1	0
score	PMC3820476	6378	6383	O	-1	-1	0
was	PMC3820476	6384	6387	O	-1	-1	0
computed	PMC3820476	6388	6396	O	-1	-1	0
at	PMC3820476	6397	6399	O	-1	-1	0
date	PMC3820476	6400	6404	O	-1	-1	0
of	PMC3820476	6405	6407	O	-1	-1	0
breast	PMC3820476	6408	6414	O	-1	-1	0
cancer	PMC3820476	6415	6421	O	-1	-1	0
diagnosis	PMC3820476	6422	6431	O	-1	-1	0
for	PMC3820476	6432	6435	O	-1	-1	0
each	PMC3820476	6436	6440	O	-1	-1	0
patient	PMC3820476	6441	6448	O	-1	-1	0
based	PMC3820476	6449	6454	O	-1	-1	0
on	PMC3820476	6455	6457	O	-1	-1	0
NRP	PMC3820476	6458	6461	O	-1	-1	0

records	PMC3820476	6462	6469	O	-1	-1	0
up	PMC3820476	6470	6472	O	-1	-1	0
to	PMC3820476	6473	6475	O	-1	-1	0
10	PMC3820476	6476	6478	O	-1	-1	0
years	PMC3820476	6479	6484	O	-1	-1	0
preceding	PMC3820476	6485	6494	O	-1	-1	0
the	PMC3820476	6495	6498	O	-1	-1	0
date	PMC3820476	6499	6503	O	-1	-1	0
of	PMC3820476	6504	6506	O	-1	-1	0
the	PMC3820476	6507	6510	O	-1	-1	0
breast	PMC3820476	6511	6517	O	-1	-1	0
cancer	PMC3820476	6518	6524	O	-1	-1	0
diagnosis	PMC3820476	6525	6534	O	-1	-1	0

(	PMC3820476	6535	6536	O	-1	-1	0
Table	PMC3820476	6536	6541	O	-1	-1	0
S1).15	PMC3820476	6542	6548	O	-1	-1	0
The	PMC3820476	6549	6552	O	-1	-1	0
CCI	PMC3820476	6553	6556	O	-1	-1	0
has	PMC3820476	6557	6560	O	-1	-1	0
been	PMC3820476	6561	6565	O	-1	-1	0
adapted	PMC3820476	6566	6573	O	-1	-1	0
and	PMC3820476	6574	6577	O	-1	-1	0
validated	PMC3820476	6578	6587	O	-1	-1	0
for	PMC3820476	6588	6591	O	-1	-1	0
use	PMC3820476	6592	6595	O	-1	-1	0
with	PMC3820476	6596	6600	O	-1	-1	0
hospital	PMC3820476	6601	6609	O	-1	-1	0
discharge	PMC3820476	6610	6619	O	-1	-1	0
data	PMC3820476	6620	6624	O	-1	-1	0
for	PMC3820476	6625	6628	O	-1	-1	0
the	PMC3820476	6629	6632	O	-1	-1	0
prediction	PMC3820476	6633	6643	O	-1	-1	0
of	PMC3820476	6644	6646	O	-1	-1	0
short-	PMC3820476	6647	6653	O	-1	-1	0
and	PMC3820476	6654	6657	O	-1	-1	0
long	PMC3820476	6658	6662	O	-1	-1	0
-	PMC3820476	6662	6663	O	-1	-1	0
term	PMC3820476	6663	6667	O	-1	-1	0
mortality.15,18	PMC3820476	6668	6683	O	-1	-1	0

The	PMC3820476	6684	6687	O	-1	-1	0
following	PMC3820476	6688	6697	O	-1	-1	0
disease	PMC3820476	6698	6705	O	-1	-1	0
categories	PMC3820476	6706	6716	O	-1	-1	0
are	PMC3820476	6717	6720	O	-1	-1	0
included	PMC3820476	6721	6729	O	-1	-1	0
:	PMC3820476	6729	6730	O	-1	-1	0

liver	PMC3820476	6731	6736	O	-1	-1	0
diseases	PMC3820476	6737	6745	O	-1	-1	0
;	PMC3820476	6745	6746	O	-1	-1	0
myocardial	PMC3820476	6747	6757	O	-1	-1	0
infarction	PMC3820476	6758	6768	O	-1	-1	0
;	PMC3820476	6768	6769	O	-1	-1	0
congestive	PMC3820476	6770	6780	O	-1	-1	0
heart	PMC3820476	6781	6786	O	-1	-1	0
failure	PMC3820476	6787	6794	O	-1	-1	0
;	PMC3820476	6794	6795	O	-1	-1	0
peripheral	PMC3820476	6796	6806	O	-1	-1	0
vascular	PMC3820476	6807	6815	O	-1	-1	0
disease	PMC3820476	6816	6823	O	-1	-1	0
;	PMC3820476	6823	6824	O	-1	-1	0
chronic	PMC3820476	6825	6832	O	-1	-1	0
pulmonary	PMC3820476	6833	6842	O	-1	-1	0
disease	PMC3820476	6843	6850	O	-1	-1	0
;	PMC3820476	6850	6851	O	-1	-1	0
cerebrovascular	PMC3820476	6852	6867	O	-1	-1	0
disease	PMC3820476	6868	6875	O	-1	-1	0
;	PMC3820476	6875	6876	O	-1	-1	0
hemiplegia	PMC3820476	6877	6887	O	-1	-1	0
;	PMC3820476	6887	6888	O	-1	-1	0


	PMC3820476	6888	6890	O	-1	-1	0
40	PMC3820476	6890	6892	O	-1	-1	0


	PMC3820476	6892	6894	O	-1	-1	0
submit	PMC3820476	6894	6900	O	-1	-1	0
your	PMC3820476	6901	6905	O	-1	-1	0
manuscript	PMC3820476	6906	6916	O	-1	-1	0
|	PMC3820476	6917	6918	O	-1	-1	0

www.dovepress.com	PMC3820476	6919	6936	O	-1	-1	0


	PMC3820476	6936	6938	O	-1	-1	0

Dovepress	PMC3820476	6938	6947	O	-1	-1	0


	PMC3820476	6947	6949	O	-1	-1	0

Members	PMC3820476	6949	6956	O	-1	-1	0
of	PMC3820476	6957	6959	O	-1	-1	0
the	PMC3820476	6960	6963	O	-1	-1	0
study	PMC3820476	6964	6969	O	-1	-1	0
cohort	PMC3820476	6970	6976	O	-1	-1	0
were	PMC3820476	6977	6981	O	-1	-1	0
linked	PMC3820476	6982	6988	O	-1	-1	0
via	PMC3820476	6989	6992	O	-1	-1	0
their	PMC3820476	6993	6998	O	-1	-1	0
CPR	PMC3820476	6999	7002	O	-1	-1	0
number	PMC3820476	7003	7009	O	-1	-1	0
to	PMC3820476	7010	7012	O	-1	-1	0
the	PMC3820476	7013	7016	O	-1	-1	0
Danish	PMC3820476	7017	7023	O	-1	-1	0
Civil	PMC3820476	7024	7029	O	-1	-1	0
Registration	PMC3820476	7030	7042	O	-1	-1	0
System	PMC3820476	7043	7049	O	-1	-1	0
to	PMC3820476	7050	7052	O	-1	-1	0
obtain	PMC3820476	7053	7059	O	-1	-1	0
information	PMC3820476	7060	7071	O	-1	-1	0
on	PMC3820476	7072	7074	O	-1	-1	0
vital	PMC3820476	7075	7080	O	-1	-1	0
status.16	PMC3820476	7081	7090	O	-1	-1	0

This	PMC3820476	7091	7095	O	-1	-1	0
registry	PMC3820476	7096	7104	O	-1	-1	0
has	PMC3820476	7105	7108	O	-1	-1	0
recorded	PMC3820476	7109	7117	O	-1	-1	0
all	PMC3820476	7118	7121	O	-1	-1	0
changes	PMC3820476	7122	7129	O	-1	-1	0
in	PMC3820476	7130	7132	O	-1	-1	0
vital	PMC3820476	7133	7138	O	-1	-1	0
status	PMC3820476	7139	7145	O	-1	-1	0
and	PMC3820476	7146	7149	O	-1	-1	0
migration	PMC3820476	7150	7159	O	-1	-1	0
for	PMC3820476	7160	7163	O	-1	-1	0
the	PMC3820476	7164	7167	O	-1	-1	0
entire	PMC3820476	7168	7174	O	-1	-1	0
Danish	PMC3820476	7175	7181	O	-1	-1	0
population	PMC3820476	7182	7192	O	-1	-1	0
since	PMC3820476	7193	7198	O	-1	-1	0
1968	PMC3820476	7199	7203	O	-1	-1	0
,	PMC3820476	7203	7204	O	-1	-1	0
with	PMC3820476	7205	7209	O	-1	-1	0
daily	PMC3820476	7210	7215	O	-1	-1	0
electronic	PMC3820476	7216	7226	O	-1	-1	0
updates	PMC3820476	7227	7234	O	-1	-1	0
.	PMC3820476	7234	7235	O	-1	-1	0

The	PMC3820476	7236	7239	O	-1	-1	0
outcome	PMC3820476	7240	7247	O	-1	-1	0
was	PMC3820476	7248	7251	O	-1	-1	0
overall	PMC3820476	7252	7259	O	-1	-1	0
mortality	PMC3820476	7260	7269	O	-1	-1	0
defined	PMC3820476	7270	7277	O	-1	-1	0
as	PMC3820476	7278	7280	O	-1	-1	0
death	PMC3820476	7281	7286	O	-1	-1	0
from	PMC3820476	7287	7291	O	-1	-1	0
any	PMC3820476	7292	7295	O	-1	-1	0
cause	PMC3820476	7296	7301	O	-1	-1	0
.	PMC3820476	7301	7302	O	-1	-1	0

Follow	PMC3820476	7303	7309	O	-1	-1	0
-	PMC3820476	7309	7310	O	-1	-1	0
up	PMC3820476	7310	7312	O	-1	-1	0
was	PMC3820476	7313	7316	O	-1	-1	0
through	PMC3820476	7317	7324	O	-1	-1	0
patient	PMC3820476	7325	7332	O	-1	-1	0
date	PMC3820476	7333	7337	O	-1	-1	0
of	PMC3820476	7338	7340	O	-1	-1	0
death	PMC3820476	7341	7346	O	-1	-1	0
,	PMC3820476	7346	7347	O	-1	-1	0
emigration	PMC3820476	7348	7358	O	-1	-1	0
,	PMC3820476	7358	7359	O	-1	-1	0
or	PMC3820476	7360	7362	O	-1	-1	0
December	PMC3820476	7363	7371	O	-1	-1	0
31	PMC3820476	7372	7374	O	-1	-1	0
,	PMC3820476	7374	7375	O	-1	-1	0
2011	PMC3820476	7376	7380	O	-1	-1	0
,	PMC3820476	7380	7381	O	-1	-1	0
whichever	PMC3820476	7382	7391	O	-1	-1	0
occurred	PMC3820476	7392	7400	O	-1	-1	0
first	PMC3820476	7401	7406	O	-1	-1	0
.	PMC3820476	7406	7407	O	-1	-1	0


	PMC3820476	7407	7409	O	-1	-1	0

Statistical	PMC3820476	7409	7420	O	-1	-1	0
analysis	PMC3820476	7421	7429	O	-1	-1	0

The	PMC3820476	7430	7433	O	-1	-1	0
prevalence	PMC3820476	7434	7444	O	-1	-1	0
of	PMC3820476	7445	7447	O	-1	-1	0
comorbidity	PMC3820476	7448	7459	O	-1	-1	0
was	PMC3820476	7460	7463	O	-1	-1	0
computed	PMC3820476	7464	7472	O	-1	-1	0
in	PMC3820476	7473	7475	O	-1	-1	0
study	PMC3820476	7476	7481	O	-1	-1	0
patients	PMC3820476	7482	7490	O	-1	-1	0
during	PMC3820476	7491	7497	O	-1	-1	0
four	PMC3820476	7498	7502	O	-1	-1	0
3-year	PMC3820476	7503	7509	O	-1	-1	0
calendar	PMC3820476	7510	7518	O	-1	-1	0
time	PMC3820476	7519	7523	O	-1	-1	0
periods	PMC3820476	7524	7531	O	-1	-1	0
(	PMC3820476	7532	7533	O	-1	-1	0
2000–2002	PMC3820476	7533	7542	O	-1	-1	0
,	PMC3820476	7542	7543	O	-1	-1	0
2003–2005	PMC3820476	7544	7553	O	-1	-1	0
,	PMC3820476	7553	7554	O	-1	-1	0
2006–2008	PMC3820476	7555	7564	O	-1	-1	0
,	PMC3820476	7564	7565	O	-1	-1	0
and	PMC3820476	7566	7569	O	-1	-1	0
2009–2011	PMC3820476	7570	7579	O	-1	-1	0
)	PMC3820476	7579	7580	O	-1	-1	0
.	PMC3820476	7580	7581	O	-1	-1	0

For	PMC3820476	7582	7585	O	-1	-1	0
each	PMC3820476	7586	7590	O	-1	-1	0
comorbidity	PMC3820476	7591	7602	O	-1	-1	0
category	PMC3820476	7603	7611	O	-1	-1	0
,	PMC3820476	7611	7612	O	-1	-1	0
we	PMC3820476	7613	7615	O	-1	-1	0
constructed	PMC3820476	7616	7627	O	-1	-1	0
Kaplan	PMC3820476	7628	7634	O	-1	-1	0
–	PMC3820476	7634	7635	O	-1	-1	0
Meier	PMC3820476	7635	7640	O	-1	-1	0
survival	PMC3820476	7641	7649	O	-1	-1	0

curves	PMC3820476	7650	7656	O	-1	-1	0
for	PMC3820476	7657	7660	O	-1	-1	0
the	PMC3820476	7661	7664	O	-1	-1	0
different	PMC3820476	7665	7674	O	-1	-1	0
calendar	PMC3820476	7675	7683	O	-1	-1	0
time	PMC3820476	7684	7688	O	-1	-1	0
periods	PMC3820476	7689	7696	O	-1	-1	0
.	PMC3820476	7696	7697	O	-1	-1	0

Next	PMC3820476	7698	7702	O	-1	-1	0
,	PMC3820476	7702	7703	O	-1	-1	0
we	PMC3820476	7704	7706	O	-1	-1	0
used	PMC3820476	7707	7711	O	-1	-1	0
Cox	PMC3820476	7712	7715	O	-1	-1	0
proportional	PMC3820476	7716	7728	O	-1	-1	0
hazards	PMC3820476	7729	7736	O	-1	-1	0
regression	PMC3820476	7737	7747	O	-1	-1	0
to	PMC3820476	7748	7750	O	-1	-1	0
compute	PMC3820476	7751	7758	O	-1	-1	0
1-	PMC3820476	7759	7761	O	-1	-1	0
and	PMC3820476	7762	7765	O	-1	-1	0
5-year	PMC3820476	7766	7772	O	-1	-1	0
crude	PMC3820476	7773	7778	O	-1	-1	0
and	PMC3820476	7779	7782	O	-1	-1	0
age	PMC3820476	7783	7786	O	-1	-1	0
-	PMC3820476	7786	7787	O	-1	-1	0
adjusted	PMC3820476	7787	7795	O	-1	-1	0
hazard	PMC3820476	7796	7802	O	-1	-1	0
ratios	PMC3820476	7803	7809	O	-1	-1	0
as	PMC3820476	7810	7812	O	-1	-1	0
a	PMC3820476	7813	7814	O	-1	-1	0
measure	PMC3820476	7815	7822	O	-1	-1	0
of	PMC3820476	7823	7825	O	-1	-1	0
relative	PMC3820476	7826	7834	O	-1	-1	0
overall	PMC3820476	7835	7842	O	-1	-1	0
mortality	PMC3820476	7843	7852	O	-1	-1	0
to	PMC3820476	7853	7855	O	-1	-1	0
assess	PMC3820476	7856	7862	O	-1	-1	0
the	PMC3820476	7863	7866	O	-1	-1	0
association	PMC3820476	7867	7878	O	-1	-1	0
of	PMC3820476	7879	7881	O	-1	-1	0
comorbidity	PMC3820476	7882	7893	O	-1	-1	0
with	PMC3820476	7894	7898	O	-1	-1	0
mortality	PMC3820476	7899	7908	O	-1	-1	0
using	PMC3820476	7909	7914	O	-1	-1	0
a	PMC3820476	7915	7916	O	-1	-1	0
CCI	PMC3820476	7917	7920	O	-1	-1	0
score	PMC3820476	7921	7926	O	-1	-1	0
=	PMC3820476	7927	7928	O	-1	-1	0
0	PMC3820476	7929	7930	O	-1	-1	0

as	PMC3820476	7931	7933	O	-1	-1	0
the	PMC3820476	7934	7937	O	-1	-1	0
reference	PMC3820476	7938	7947	O	-1	-1	0
category	PMC3820476	7948	7956	O	-1	-1	0
in	PMC3820476	7957	7959	O	-1	-1	0
each	PMC3820476	7960	7964	O	-1	-1	0
calendar	PMC3820476	7965	7973	O	-1	-1	0
time	PMC3820476	7974	7978	O	-1	-1	0
period	PMC3820476	7979	7985	O	-1	-1	0
.	PMC3820476	7985	7986	O	-1	-1	0

In	PMC3820476	7987	7989	O	-1	-1	0
the	PMC3820476	7990	7993	O	-1	-1	0
latter	PMC3820476	7994	8000	O	-1	-1	0
periods	PMC3820476	8001	8008	O	-1	-1	0
,	PMC3820476	8008	8009	O	-1	-1	0
we	PMC3820476	8010	8012	O	-1	-1	0
predicted	PMC3820476	8013	8022	O	-1	-1	0
1-	PMC3820476	8023	8025	O	-1	-1	0
and	PMC3820476	8026	8029	O	-1	-1	0
5-year	PMC3820476	8030	8036	O	-1	-1	0
survival	PMC3820476	8037	8045	O	-1	-1	0
using	PMC3820476	8046	8051	O	-1	-1	0
a	PMC3820476	8052	8053	O	-1	-1	0
hybrid	PMC3820476	8054	8060	O	-1	-1	0
analysis	PMC3820476	8061	8069	O	-1	-1	0
in	PMC3820476	8070	8072	O	-1	-1	0
which	PMC3820476	8073	8078	O	-1	-1	0
survival	PMC3820476	8079	8087	O	-1	-1	0
was	PMC3820476	8088	8091	O	-1	-1	0
estimated	PMC3820476	8092	8101	O	-1	-1	0
using	PMC3820476	8102	8107	O	-1	-1	0
the	PMC3820476	8108	8111	O	-1	-1	0
survival	PMC3820476	8112	8120	O	-1	-1	0
experience	PMC3820476	8121	8131	O	-1	-1	0
of	PMC3820476	8132	8134	O	-1	-1	0
patients	PMC3820476	8135	8143	O	-1	-1	0
in	PMC3820476	8144	8146	O	-1	-1	0
the	PMC3820476	8147	8150	O	-1	-1	0
previous	PMC3820476	8151	8159	O	-1	-1	0
calendar	PMC3820476	8160	8168	O	-1	-1	0
time	PMC3820476	8169	8173	O	-1	-1	0

periods.19	PMC3820476	8174	8184	O	-1	-1	0

Breast	PMC3820476	8185	8191	O	-1	-1	0
cancer	PMC3820476	8192	8198	O	-1	-1	0
stage	PMC3820476	8199	8204	O	-1	-1	0
and	PMC3820476	8205	8208	O	-1	-1	0
grade	PMC3820476	8209	8214	O	-1	-1	0
were	PMC3820476	8215	8219	O	-1	-1	0
considered	PMC3820476	8220	8230	O	-1	-1	0
to	PMC3820476	8231	8233	O	-1	-1	0
be	PMC3820476	8234	8236	O	-1	-1	0
causal	PMC3820476	8237	8243	O	-1	-1	0

intermediates	PMC3820476	8244	8257	O	-1	-1	0
in	PMC3820476	8258	8260	O	-1	-1	0
the	PMC3820476	8261	8264	O	-1	-1	0
association	PMC3820476	8265	8276	O	-1	-1	0
between	PMC3820476	8277	8284	O	-1	-1	0
comorbidity	PMC3820476	8285	8296	O	-1	-1	0
and	PMC3820476	8297	8300	O	-1	-1	0
mortality	PMC3820476	8301	8310	O	-1	-1	0
,	PMC3820476	8310	8311	O	-1	-1	0
thus	PMC3820476	8312	8316	O	-1	-1	0
not	PMC3820476	8317	8320	O	-1	-1	0
included	PMC3820476	8321	8329	O	-1	-1	0
in	PMC3820476	8330	8332	O	-1	-1	0
the	PMC3820476	8333	8336	O	-1	-1	0
analyses	PMC3820476	8337	8345	O	-1	-1	0
.	PMC3820476	8345	8346	O	-1	-1	0

The	PMC3820476	8347	8350	O	-1	-1	0
proportional	PMC3820476	8351	8363	O	-1	-1	0
hazards	PMC3820476	8364	8371	O	-1	-1	0
assumption	PMC3820476	8372	8382	O	-1	-1	0
was	PMC3820476	8383	8386	O	-1	-1	0
assessed	PMC3820476	8387	8395	O	-1	-1	0
graphically	PMC3820476	8396	8407	O	-1	-1	0
and	PMC3820476	8408	8411	O	-1	-1	0
found	PMC3820476	8412	8417	O	-1	-1	0
to	PMC3820476	8418	8420	O	-1	-1	0
be	PMC3820476	8421	8423	O	-1	-1	0
appropriate	PMC3820476	8424	8435	O	-1	-1	0
.	PMC3820476	8435	8436	O	-1	-1	0

All	PMC3820476	8437	8440	O	-1	-1	0
analyses	PMC3820476	8441	8449	O	-1	-1	0
were	PMC3820476	8450	8454	O	-1	-1	0
performed	PMC3820476	8455	8464	O	-1	-1	0
using	PMC3820476	8465	8470	O	-1	-1	0
SAS	PMC3820476	8471	8474	O	-1	-1	0
software	PMC3820476	8475	8483	O	-1	-1	0
(	PMC3820476	8484	8485	O	-1	-1	0
v	PMC3820476	8485	8486	O	-1	-1	0
9.2	PMC3820476	8487	8490	O	-1	-1	0
;	PMC3820476	8490	8491	O	-1	-1	0
SAS	PMC3820476	8492	8495	O	-1	-1	0
Institute	PMC3820476	8496	8505	O	-1	-1	0
Inc	PMC3820476	8506	8509	O	-1	-1	0
,	PMC3820476	8509	8510	O	-1	-1	0
Cary	PMC3820476	8511	8515	B-Location	-1	-1	0
,	PMC3820476	8515	8516	O	-1	-1	0
NC	PMC3820476	8517	8519	B-Location	-1	-1	0
,	PMC3820476	8519	8520	O	-1	-1	0
USA	PMC3820476	8521	8524	B-Location	-1	-1	0
)	PMC3820476	8524	8525	O	-1	-1	0
.	PMC3820476	8525	8526	O	-1	-1	0

The	PMC3820476	8527	8530	O	-1	-1	0
Danish	PMC3820476	8531	8537	O	-1	-1	0
Data	PMC3820476	8538	8542	O	-1	-1	0
Protection	PMC3820476	8543	8553	O	-1	-1	0
Agency	PMC3820476	8554	8560	O	-1	-1	0
approved	PMC3820476	8561	8569	O	-1	-1	0
the	PMC3820476	8570	8573	O	-1	-1	0
study	PMC3820476	8574	8579	O	-1	-1	0
(	PMC3820476	8580	8581	O	-1	-1	0
record	PMC3820476	8581	8587	O	-1	-1	0
number	PMC3820476	8588	8594	O	-1	-1	0
2009	PMC3820476	8595	8599	O	-1	-1	0
-	PMC3820476	8599	8600	O	-1	-1	0
41	PMC3820476	8600	8602	O	-1	-1	0
-	PMC3820476	8602	8603	O	-1	-1	0
3866	PMC3820476	8603	8607	O	-1	-1	0
)	PMC3820476	8607	8608	O	-1	-1	0
.	PMC3820476	8608	8609	O	-1	-1	0


	PMC3820476	8609	8611	O	-1	-1	0

Results	PMC3820476	8611	8618	O	-1	-1	0

The	PMC3820476	8619	8622	O	-1	-1	0
study	PMC3820476	8623	8628	O	-1	-1	0
included	PMC3820476	8629	8637	O	-1	-1	0
9,329	PMC3820476	8638	8643	O	-1	-1	0
women	PMC3820476	8644	8649	O	-1	-1	0
diagnosed	PMC3820476	8650	8659	O	-1	-1	0
with	PMC3820476	8660	8664	O	-1	-1	0
breast	PMC3820476	8665	8671	O	-1	-1	0
cancer	PMC3820476	8672	8678	O	-1	-1	0
between	PMC3820476	8679	8686	O	-1	-1	0
2000	PMC3820476	8687	8691	O	-1	-1	0
and	PMC3820476	8692	8695	O	-1	-1	0
2011	PMC3820476	8696	8700	O	-1	-1	0
.	PMC3820476	8700	8701	O	-1	-1	0

As	PMC3820476	8702	8704	O	-1	-1	0
shown	PMC3820476	8705	8710	O	-1	-1	0
in	PMC3820476	8711	8713	O	-1	-1	0
Tables	PMC3820476	8714	8720	O	-1	-1	0
1	PMC3820476	8721	8722	O	-1	-1	0
and	PMC3820476	8723	8726	O	-1	-1	0
S2	PMC3820476	8727	8729	O	-1	-1	0
,	PMC3820476	8729	8730	O	-1	-1	0
the	PMC3820476	8731	8734	O	-1	-1	0
proportion	PMC3820476	8735	8745	O	-1	-1	0
of	PMC3820476	8746	8748	O	-1	-1	0
patients	PMC3820476	8749	8757	O	-1	-1	0
across	PMC3820476	8758	8764	O	-1	-1	0
different	PMC3820476	8765	8774	O	-1	-1	0
CCI	PMC3820476	8775	8778	O	-1	-1	0
score	PMC3820476	8779	8784	O	-1	-1	0
categories	PMC3820476	8785	8795	O	-1	-1	0
and	PMC3820476	8796	8799	O	-1	-1	0
individual	PMC3820476	8800	8810	O	-1	-1	0
comorbid	PMC3820476	8811	8819	O	-1	-1	0
diseases	PMC3820476	8820	8828	O	-1	-1	0
was	PMC3820476	8829	8832	O	-1	-1	0
relatively	PMC3820476	8833	8843	O	-1	-1	0


	PMC3820476	8843	8845	O	-1	-1	0
Clinical	PMC3820476	8845	8853	O	-1	-1	0
Epidemiology	PMC3820476	8854	8866	O	-1	-1	0
2013:5	PMC3820476	8867	8873	O	-1	-1	0

(	PMC3820476	8874	8875	O	-1	-1	0
Suppl	PMC3820476	8875	8880	O	-1	-1	0
1	PMC3820476	8881	8882	O	-1	-1	0
)	PMC3820476	8882	8883	O	-1	-1	0


	PMC3820476	8883	8885	O	-1	-1	0

Dovepress	PMC3820476	8885	8894	O	-1	-1	0


	PMC3820476	8894	8896	O	-1	-1	0
Comorbidity	PMC3820476	8896	8907	O	-1	-1	0
and	PMC3820476	8908	8911	O	-1	-1	0
survival	PMC3820476	8912	8920	O	-1	-1	0
of	PMC3820476	8921	8923	O	-1	-1	0
Danish	PMC3820476	8924	8930	O	-1	-1	0
breast	PMC3820476	8931	8937	O	-1	-1	0
cancer	PMC3820476	8938	8944	O	-1	-1	0
patients	PMC3820476	8945	8953	O	-1	-1	0


	PMC3820476	8953	8955	O	-1	-1	0
Table	PMC3820476	8955	8960	O	-1	-1	0
1	PMC3820476	8961	8962	O	-1	-1	0
Distribution	PMC3820476	8963	8975	O	-1	-1	0
of	PMC3820476	8976	8978	O	-1	-1	0
breast	PMC3820476	8979	8985	O	-1	-1	0
cancer	PMC3820476	8986	8992	O	-1	-1	0
patients	PMC3820476	8993	9001	O	-1	-1	0
diagnosed	PMC3820476	9002	9011	O	-1	-1	0
between	PMC3820476	9012	9019	O	-1	-1	0
2000	PMC3820476	9020	9024	O	-1	-1	0
and	PMC3820476	9025	9028	O	-1	-1	0
2011	PMC3820476	9029	9033	O	-1	-1	0
by	PMC3820476	9034	9036	O	-1	-1	0
CCI	PMC3820476	9037	9040	O	-1	-1	0
score	PMC3820476	9041	9046	O	-1	-1	0
in	PMC3820476	9047	9049	O	-1	-1	0
four	PMC3820476	9050	9054	O	-1	-1	0
calendar	PMC3820476	9055	9063	O	-1	-1	0
time	PMC3820476	9064	9068	O	-1	-1	0
periods	PMC3820476	9069	9076	O	-1	-1	0

2000–2002	PMC3820476	9077	9086	O	-1	-1	0


	PMC3820476	9086	9088	O	-1	-1	0

2003–2005	PMC3820476	9088	9097	O	-1	-1	0


	PMC3820476	9097	9099	O	-1	-1	0

Patients	PMC3820476	9099	9107	O	-1	-1	0
,	PMC3820476	9107	9108	O	-1	-1	0
n	PMC3820476	9109	9110	O	-1	-1	0
(	PMC3820476	9111	9112	O	-1	-1	0
%	PMC3820476	9112	9113	O	-1	-1	0
)	PMC3820476	9113	9114	O	-1	-1	0

1,980	PMC3820476	9115	9120	O	-1	-1	0
(	PMC3820476	9121	9122	O	-1	-1	0
21	PMC3820476	9122	9124	O	-1	-1	0
)	PMC3820476	9124	9125	O	-1	-1	0
1,994	PMC3820476	9126	9131	O	-1	-1	0
(	PMC3820476	9132	9133	O	-1	-1	0
21	PMC3820476	9133	9135	O	-1	-1	0
)	PMC3820476	9135	9136	O	-1	-1	0
Median	PMC3820476	9137	9143	O	-1	-1	0
age	PMC3820476	9144	9147	O	-1	-1	0
62	PMC3820476	9148	9150	O	-1	-1	0
(	PMC3820476	9151	9152	O	-1	-1	0
53	PMC3820476	9152	9154	O	-1	-1	0
,	PMC3820476	9154	9155	O	-1	-1	0
74	PMC3820476	9156	9158	O	-1	-1	0
)	PMC3820476	9158	9159	O	-1	-1	0

61	PMC3820476	9160	9162	O	-1	-1	0
(	PMC3820476	9163	9164	O	-1	-1	0
52	PMC3820476	9164	9166	O	-1	-1	0
,	PMC3820476	9166	9167	O	-1	-1	0
72	PMC3820476	9168	9170	O	-1	-1	0
)	PMC3820476	9170	9171	O	-1	-1	0
in	PMC3820476	9172	9174	O	-1	-1	0
years	PMC3820476	9175	9180	O	-1	-1	0

(	PMC3820476	9181	9182	O	-1	-1	0
IQR	PMC3820476	9182	9185	O	-1	-1	0
)	PMC3820476	9185	9186	O	-1	-1	0

Age	PMC3820476	9187	9190	O	-1	-1	0
group	PMC3820476	9191	9196	O	-1	-1	0
,	PMC3820476	9196	9197	O	-1	-1	0
n	PMC3820476	9198	9199	O	-1	-1	0
(	PMC3820476	9200	9201	O	-1	-1	0
%	PMC3820476	9201	9202	O	-1	-1	0
)	PMC3820476	9202	9203	O	-1	-1	0

15–49	PMC3820476	9204	9209	O	-1	-1	0
years	PMC3820476	9210	9215	O	-1	-1	0
380	PMC3820476	9216	9219	O	-1	-1	0
(	PMC3820476	9220	9221	O	-1	-1	0
19	PMC3820476	9221	9223	O	-1	-1	0
)	PMC3820476	9223	9224	O	-1	-1	0
416	PMC3820476	9225	9228	O	-1	-1	0

(	PMC3820476	9229	9230	O	-1	-1	0
21	PMC3820476	9230	9232	O	-1	-1	0
)	PMC3820476	9232	9233	O	-1	-1	0
50–74	PMC3820476	9234	9239	O	-1	-1	0
years	PMC3820476	9240	9245	O	-1	-1	0
1,134	PMC3820476	9246	9251	O	-1	-1	0
(	PMC3820476	9252	9253	O	-1	-1	0
57	PMC3820476	9253	9255	O	-1	-1	0
)	PMC3820476	9255	9256	O	-1	-1	0
1,156	PMC3820476	9257	9262	O	-1	-1	0
(	PMC3820476	9263	9264	O	-1	-1	0
58	PMC3820476	9264	9266	O	-1	-1	0
)	PMC3820476	9266	9267	O	-1	-1	0
466	PMC3820476	9268	9271	O	-1	-1	0
(	PMC3820476	9272	9273	O	-1	-1	0
24	PMC3820476	9273	9275	O	-1	-1	0
)	PMC3820476	9275	9276	O	-1	-1	0
422	PMC3820476	9277	9280	O	-1	-1	0
(	PMC3820476	9281	9282	O	-1	-1	0
21	PMC3820476	9282	9284	O	-1	-1	0
)	PMC3820476	9284	9285	O	-1	-1	0
$	PMC3820476	9286	9287	O	-1	-1	0
75	PMC3820476	9287	9289	O	-1	-1	0
years	PMC3820476	9290	9295	O	-1	-1	0

CCI	PMC3820476	9296	9299	O	-1	-1	0
score	PMC3820476	9300	9305	O	-1	-1	0
,	PMC3820476	9305	9306	O	-1	-1	0
n	PMC3820476	9307	9308	O	-1	-1	0
(	PMC3820476	9309	9310	O	-1	-1	0
%	PMC3820476	9310	9311	O	-1	-1	0
)	PMC3820476	9311	9312	O	-1	-1	0
0	PMC3820476	9313	9314	O	-1	-1	0

1,567	PMC3820476	9315	9320	O	-1	-1	0
(	PMC3820476	9321	9322	O	-1	-1	0
79	PMC3820476	9322	9324	O	-1	-1	0
)	PMC3820476	9324	9325	O	-1	-1	0

1,557	PMC3820476	9326	9331	O	-1	-1	0
(	PMC3820476	9332	9333	O	-1	-1	0
78	PMC3820476	9333	9335	O	-1	-1	0
)	PMC3820476	9335	9336	O	-1	-1	0
1–2	PMC3820476	9337	9340	O	-1	-1	0
344	PMC3820476	9341	9344	O	-1	-1	0
(	PMC3820476	9345	9346	O	-1	-1	0
17	PMC3820476	9346	9348	O	-1	-1	0
)	PMC3820476	9348	9349	O	-1	-1	0
349	PMC3820476	9350	9353	O	-1	-1	0
(	PMC3820476	9354	9355	O	-1	-1	0
18	PMC3820476	9355	9357	O	-1	-1	0
)	PMC3820476	9357	9358	O	-1	-1	0
69	PMC3820476	9359	9361	O	-1	-1	0

(	PMC3820476	9362	9363	O	-1	-1	0
3	PMC3820476	9363	9364	O	-1	-1	0
)	PMC3820476	9364	9365	O	-1	-1	0
88	PMC3820476	9366	9368	O	-1	-1	0
(	PMC3820476	9369	9370	O	-1	-1	0
4	PMC3820476	9370	9371	O	-1	-1	0
)	PMC3820476	9371	9372	O	-1	-1	0
$	PMC3820476	9373	9374	O	-1	-1	0
3	PMC3820476	9374	9375	O	-1	-1	0
Median	PMC3820476	9376	9382	O	-1	-1	0
age	PMC3820476	9383	9386	O	-1	-1	0
in	PMC3820476	9387	9389	O	-1	-1	0
years	PMC3820476	9390	9395	O	-1	-1	0
(	PMC3820476	9396	9397	O	-1	-1	0
IQR	PMC3820476	9397	9400	O	-1	-1	0
)	PMC3820476	9400	9401	O	-1	-1	0
by	PMC3820476	9402	9404	O	-1	-1	0
CCI	PMC3820476	9405	9408	O	-1	-1	0
score	PMC3820476	9409	9414	O	-1	-1	0

0	PMC3820476	9415	9416	O	-1	-1	0

60	PMC3820476	9417	9419	O	-1	-1	0
(	PMC3820476	9420	9421	O	-1	-1	0
51	PMC3820476	9421	9423	O	-1	-1	0
,	PMC3820476	9423	9424	O	-1	-1	0
71	PMC3820476	9425	9427	O	-1	-1	0
)	PMC3820476	9427	9428	O	-1	-1	0
59	PMC3820476	9429	9431	O	-1	-1	0
(	PMC3820476	9432	9433	O	-1	-1	0
50	PMC3820476	9433	9435	O	-1	-1	0
,	PMC3820476	9435	9436	O	-1	-1	0
69	PMC3820476	9437	9439	O	-1	-1	0
)	PMC3820476	9439	9440	O	-1	-1	0

1–2	PMC3820476	9441	9444	O	-1	-1	0

71	PMC3820476	9445	9447	O	-1	-1	0
(	PMC3820476	9448	9449	O	-1	-1	0
60	PMC3820476	9449	9451	O	-1	-1	0
,	PMC3820476	9451	9452	O	-1	-1	0
80	PMC3820476	9453	9455	O	-1	-1	0
)	PMC3820476	9455	9456	O	-1	-1	0

71	PMC3820476	9457	9459	O	-1	-1	0
(	PMC3820476	9460	9461	O	-1	-1	0
60	PMC3820476	9461	9463	O	-1	-1	0
,	PMC3820476	9463	9464	O	-1	-1	0
80	PMC3820476	9465	9467	O	-1	-1	0
)	PMC3820476	9467	9468	O	-1	-1	0

74	PMC3820476	9469	9471	O	-1	-1	0
(	PMC3820476	9472	9473	O	-1	-1	0
65	PMC3820476	9473	9475	O	-1	-1	0
,	PMC3820476	9475	9476	O	-1	-1	0
81	PMC3820476	9477	9479	O	-1	-1	0
)	PMC3820476	9479	9480	O	-1	-1	0
75	PMC3820476	9481	9483	O	-1	-1	0
(	PMC3820476	9484	9485	O	-1	-1	0
63	PMC3820476	9485	9487	O	-1	-1	0
,	PMC3820476	9487	9488	O	-1	-1	0
81	PMC3820476	9489	9491	O	-1	-1	0
)	PMC3820476	9491	9492	O	-1	-1	0

$	PMC3820476	9493	9494	O	-1	-1	0
3	PMC3820476	9494	9495	O	-1	-1	0


	PMC3820476	9495	9497	O	-1	-1	0
2006–2008	PMC3820476	9497	9506	O	-1	-1	0


	PMC3820476	9506	9508	O	-1	-1	0
2009–2011	PMC3820476	9508	9517	O	-1	-1	0


	PMC3820476	9517	9519	O	-1	-1	0
2,410	PMC3820476	9519	9524	O	-1	-1	0
(	PMC3820476	9525	9526	O	-1	-1	0
26	PMC3820476	9526	9528	O	-1	-1	0
)	PMC3820476	9528	9529	O	-1	-1	0

63	PMC3820476	9530	9532	O	-1	-1	0
(	PMC3820476	9533	9534	O	-1	-1	0
54	PMC3820476	9534	9536	O	-1	-1	0
,	PMC3820476	9536	9537	O	-1	-1	0
71	PMC3820476	9538	9540	O	-1	-1	0
)	PMC3820476	9540	9541	O	-1	-1	0


	PMC3820476	9541	9543	O	-1	-1	0
2,945	PMC3820476	9543	9548	O	-1	-1	0
(	PMC3820476	9549	9550	O	-1	-1	0
32	PMC3820476	9550	9552	O	-1	-1	0
)	PMC3820476	9552	9553	O	-1	-1	0

63	PMC3820476	9554	9556	O	-1	-1	0
(	PMC3820476	9557	9558	O	-1	-1	0
54	PMC3820476	9558	9560	O	-1	-1	0
,	PMC3820476	9560	9561	O	-1	-1	0
70	PMC3820476	9562	9564	O	-1	-1	0
)	PMC3820476	9564	9565	O	-1	-1	0


	PMC3820476	9565	9567	O	-1	-1	0
395	PMC3820476	9567	9570	O	-1	-1	0
(	PMC3820476	9571	9572	O	-1	-1	0
16	PMC3820476	9572	9574	O	-1	-1	0
)	PMC3820476	9574	9575	O	-1	-1	0

1,569	PMC3820476	9576	9581	O	-1	-1	0
(	PMC3820476	9582	9583	O	-1	-1	0
65	PMC3820476	9583	9585	O	-1	-1	0
)	PMC3820476	9585	9586	O	-1	-1	0
446	PMC3820476	9587	9590	O	-1	-1	0
(	PMC3820476	9591	9592	O	-1	-1	0
19	PMC3820476	9592	9594	O	-1	-1	0
)	PMC3820476	9594	9595	O	-1	-1	0


	PMC3820476	9595	9597	O	-1	-1	0
459	PMC3820476	9597	9600	O	-1	-1	0
(	PMC3820476	9601	9602	O	-1	-1	0
16	PMC3820476	9602	9604	O	-1	-1	0
)	PMC3820476	9604	9605	O	-1	-1	0
1,996	PMC3820476	9606	9611	O	-1	-1	0
(	PMC3820476	9612	9613	O	-1	-1	0
68	PMC3820476	9613	9615	O	-1	-1	0
)	PMC3820476	9615	9616	O	-1	-1	0
490	PMC3820476	9617	9620	O	-1	-1	0
(	PMC3820476	9621	9622	O	-1	-1	0
17	PMC3820476	9622	9624	O	-1	-1	0
)	PMC3820476	9624	9625	O	-1	-1	0


	PMC3820476	9625	9627	O	-1	-1	0
1,862	PMC3820476	9627	9632	O	-1	-1	0
(	PMC3820476	9633	9634	O	-1	-1	0
77	PMC3820476	9634	9636	O	-1	-1	0
)	PMC3820476	9636	9637	O	-1	-1	0
445	PMC3820476	9638	9641	O	-1	-1	0
(	PMC3820476	9642	9643	O	-1	-1	0
18	PMC3820476	9643	9645	O	-1	-1	0
)	PMC3820476	9645	9646	O	-1	-1	0
103	PMC3820476	9647	9650	O	-1	-1	0

(	PMC3820476	9651	9652	O	-1	-1	0
4	PMC3820476	9652	9653	O	-1	-1	0
)	PMC3820476	9653	9654	O	-1	-1	0


	PMC3820476	9654	9656	O	-1	-1	0
2,290	PMC3820476	9656	9661	O	-1	-1	0
(	PMC3820476	9662	9663	O	-1	-1	0
78	PMC3820476	9663	9665	O	-1	-1	0
)	PMC3820476	9665	9666	O	-1	-1	0
536	PMC3820476	9667	9670	O	-1	-1	0
(	PMC3820476	9671	9672	O	-1	-1	0
18	PMC3820476	9672	9674	O	-1	-1	0
)	PMC3820476	9674	9675	O	-1	-1	0
119	PMC3820476	9676	9679	O	-1	-1	0
(	PMC3820476	9680	9681	O	-1	-1	0
4	PMC3820476	9681	9682	O	-1	-1	0
)	PMC3820476	9682	9683	O	-1	-1	0


	PMC3820476	9683	9685	O	-1	-1	0
61	PMC3820476	9685	9687	O	-1	-1	0
(	PMC3820476	9688	9689	O	-1	-1	0
53	PMC3820476	9689	9691	O	-1	-1	0
,	PMC3820476	9691	9692	O	-1	-1	0
68	PMC3820476	9693	9695	O	-1	-1	0
)	PMC3820476	9695	9696	O	-1	-1	0
68	PMC3820476	9697	9699	O	-1	-1	0
(	PMC3820476	9700	9701	O	-1	-1	0
61	PMC3820476	9701	9703	O	-1	-1	0
,	PMC3820476	9703	9704	O	-1	-1	0
78	PMC3820476	9705	9707	O	-1	-1	0
)	PMC3820476	9707	9708	O	-1	-1	0
71	PMC3820476	9709	9711	O	-1	-1	0
(	PMC3820476	9712	9713	O	-1	-1	0
63	PMC3820476	9713	9715	O	-1	-1	0
,	PMC3820476	9715	9716	O	-1	-1	0
79	PMC3820476	9717	9719	O	-1	-1	0
)	PMC3820476	9719	9720	O	-1	-1	0


	PMC3820476	9720	9722	O	-1	-1	0
62	PMC3820476	9722	9724	O	-1	-1	0

(	PMC3820476	9725	9726	O	-1	-1	0
53	PMC3820476	9726	9728	O	-1	-1	0
,	PMC3820476	9728	9729	O	-1	-1	0
68	PMC3820476	9730	9732	O	-1	-1	0
)	PMC3820476	9732	9733	O	-1	-1	0

68	PMC3820476	9734	9736	O	-1	-1	0
(	PMC3820476	9737	9738	O	-1	-1	0
61	PMC3820476	9738	9740	O	-1	-1	0
,	PMC3820476	9740	9741	O	-1	-1	0
78	PMC3820476	9742	9744	O	-1	-1	0
)	PMC3820476	9744	9745	O	-1	-1	0

71	PMC3820476	9746	9748	O	-1	-1	0
(	PMC3820476	9749	9750	O	-1	-1	0
65	PMC3820476	9750	9752	O	-1	-1	0
,	PMC3820476	9752	9753	O	-1	-1	0
79	PMC3820476	9754	9756	O	-1	-1	0
)	PMC3820476	9756	9757	O	-1	-1	0


	PMC3820476	9757	9759	O	-1	-1	0

Abbreviations	PMC3820476	9759	9772	O	-1	-1	0
:	PMC3820476	9772	9773	O	-1	-1	0
CCI	PMC3820476	9774	9777	O	-1	-1	0
,	PMC3820476	9777	9778	O	-1	-1	0
Charlson	PMC3820476	9779	9787	O	-1	-1	0
Comorbity	PMC3820476	9788	9797	O	-1	-1	0
Index	PMC3820476	9798	9803	O	-1	-1	0
;	PMC3820476	9803	9804	O	-1	-1	0
IQR	PMC3820476	9805	9808	O	-1	-1	0
,	PMC3820476	9808	9809	O	-1	-1	0
interquartile	PMC3820476	9810	9823	O	-1	-1	0
range	PMC3820476	9824	9829	O	-1	-1	0
.	PMC3820476	9829	9830	O	-1	-1	0


	PMC3820476	9830	9832	O	-1	-1	0

constant	PMC3820476	9832	9840	O	-1	-1	0
over	PMC3820476	9841	9845	O	-1	-1	0
the	PMC3820476	9846	9849	O	-1	-1	0
4	PMC3820476	9850	9851	O	-1	-1	0
calendar	PMC3820476	9852	9860	O	-1	-1	0
time	PMC3820476	9861	9865	O	-1	-1	0
periods	PMC3820476	9866	9873	O	-1	-1	0
.	PMC3820476	9873	9874	O	-1	-1	0

The	PMC3820476	9875	9878	O	-1	-1	0
number	PMC3820476	9879	9885	O	-1	-1	0
of	PMC3820476	9886	9888	O	-1	-1	0
breast	PMC3820476	9889	9895	O	-1	-1	0
cancer	PMC3820476	9896	9902	O	-1	-1	0
patient	PMC3820476	9903	9910	O	-1	-1	0
diagnoses	PMC3820476	9911	9920	O	-1	-1	0
increased	PMC3820476	9921	9930	O	-1	-1	0
markedly	PMC3820476	9931	9939	O	-1	-1	0
between	PMC3820476	9940	9947	O	-1	-1	0
2000	PMC3820476	9948	9952	O	-1	-1	0
and	PMC3820476	9953	9956	O	-1	-1	0
2011	PMC3820476	9957	9961	O	-1	-1	0
,	PMC3820476	9961	9962	O	-1	-1	0
almost	PMC3820476	9963	9969	O	-1	-1	0
doubling	PMC3820476	9970	9978	O	-1	-1	0
for	PMC3820476	9979	9982	O	-1	-1	0
patients	PMC3820476	9983	9991	O	-1	-1	0
aged	PMC3820476	9992	9996	O	-1	-1	0
between	PMC3820476	9997	10004	O	-1	-1	0
50	PMC3820476	10005	10007	O	-1	-1	0
and	PMC3820476	10008	10011	O	-1	-1	0
74	PMC3820476	10012	10014	O	-1	-1	0
years	PMC3820476	10015	10020	O	-1	-1	0
.	PMC3820476	10020	10021	O	-1	-1	0

The	PMC3820476	10022	10025	O	-1	-1	0
proportion	PMC3820476	10026	10036	O	-1	-1	0
of	PMC3820476	10037	10039	O	-1	-1	0
patients	PMC3820476	10040	10048	O	-1	-1	0
aged	PMC3820476	10049	10053	O	-1	-1	0
50	PMC3820476	10054	10056	O	-1	-1	0
to	PMC3820476	10057	10059	O	-1	-1	0
74	PMC3820476	10060	10062	O	-1	-1	0
years	PMC3820476	10063	10068	O	-1	-1	0
increased	PMC3820476	10069	10078	O	-1	-1	0
markedly	PMC3820476	10079	10087	O	-1	-1	0
in	PMC3820476	10088	10090	O	-1	-1	0
each	PMC3820476	10091	10095	O	-1	-1	0
time	PMC3820476	10096	10100	O	-1	-1	0
period	PMC3820476	10101	10107	O	-1	-1	0
from	PMC3820476	10108	10112	O	-1	-1	0
57	PMC3820476	10113	10115	O	-1	-1	0
%	PMC3820476	10115	10116	O	-1	-1	0
in	PMC3820476	10117	10119	O	-1	-1	0
2000–2002	PMC3820476	10120	10129	O	-1	-1	0
to	PMC3820476	10130	10132	O	-1	-1	0
68	PMC3820476	10133	10135	O	-1	-1	0
%	PMC3820476	10135	10136	O	-1	-1	0
in	PMC3820476	10137	10139	O	-1	-1	0
2009–2011	PMC3820476	10140	10149	O	-1	-1	0
.	PMC3820476	10149	10150	O	-1	-1	0

In	PMC3820476	10151	10153	O	-1	-1	0
contrast	PMC3820476	10154	10162	O	-1	-1	0
,	PMC3820476	10162	10163	O	-1	-1	0
the	PMC3820476	10164	10167	O	-1	-1	0
proportion	PMC3820476	10168	10178	O	-1	-1	0
of	PMC3820476	10179	10181	O	-1	-1	0
patients	PMC3820476	10182	10190	O	-1	-1	0
aged	PMC3820476	10191	10195	O	-1	-1	0
75	PMC3820476	10196	10198	O	-1	-1	0

+	PMC3820476	10198	10199	O	-1	-1	0
years	PMC3820476	10200	10205	O	-1	-1	0
fell	PMC3820476	10206	10210	O	-1	-1	0
from	PMC3820476	10211	10215	O	-1	-1	0
24	PMC3820476	10216	10218	O	-1	-1	0
%	PMC3820476	10218	10219	O	-1	-1	0
to	PMC3820476	10220	10222	O	-1	-1	0
17	PMC3820476	10223	10225	O	-1	-1	0
%	PMC3820476	10225	10226	O	-1	-1	0
.	PMC3820476	10226	10227	O	-1	-1	0


	PMC3820476	10227	10229	O	-1	-1	0

Survival	PMC3820476	10229	10237	O	-1	-1	0
Table	PMC3820476	10238	10243	O	-1	-1	0
2	PMC3820476	10244	10245	O	-1	-1	0
presents	PMC3820476	10246	10254	O	-1	-1	0
survival	PMC3820476	10255	10263	O	-1	-1	0
and	PMC3820476	10264	10267	O	-1	-1	0
relative	PMC3820476	10268	10276	O	-1	-1	0
mortality	PMC3820476	10277	10286	O	-1	-1	0
across	PMC3820476	10287	10293	O	-1	-1	0
calendar	PMC3820476	10294	10302	O	-1	-1	0
periods	PMC3820476	10303	10310	O	-1	-1	0
and	PMC3820476	10311	10314	O	-1	-1	0
age	PMC3820476	10315	10318	O	-1	-1	0
groups	PMC3820476	10319	10325	O	-1	-1	0
.	PMC3820476	10325	10326	O	-1	-1	0

Overall	PMC3820476	10327	10334	O	-1	-1	0
,	PMC3820476	10334	10335	O	-1	-1	0
the	PMC3820476	10336	10339	O	-1	-1	0
1-year	PMC3820476	10340	10346	O	-1	-1	0
survival	PMC3820476	10347	10355	O	-1	-1	0
improved	PMC3820476	10356	10364	O	-1	-1	0
between	PMC3820476	10365	10372	O	-1	-1	0
2000–2002	PMC3820476	10373	10382	O	-1	-1	0
and	PMC3820476	10383	10386	O	-1	-1	0
2009–2011	PMC3820476	10387	10396	O	-1	-1	0
,	PMC3820476	10396	10397	O	-1	-1	0
from	PMC3820476	10398	10402	O	-1	-1	0
91	PMC3820476	10403	10405	O	-1	-1	0
%	PMC3820476	10405	10406	O	-1	-1	0
to	PMC3820476	10407	10409	O	-1	-1	0
95	PMC3820476	10410	10412	O	-1	-1	0
%	PMC3820476	10412	10413	O	-1	-1	0
,	PMC3820476	10413	10414	O	-1	-1	0
while	PMC3820476	10415	10420	O	-1	-1	0
5-year	PMC3820476	10421	10427	O	-1	-1	0
survival	PMC3820476	10428	10436	O	-1	-1	0
improved	PMC3820476	10437	10445	O	-1	-1	0
from	PMC3820476	10446	10450	O	-1	-1	0
72	PMC3820476	10451	10453	O	-1	-1	0
%	PMC3820476	10453	10454	O	-1	-1	0
to	PMC3820476	10455	10457	O	-1	-1	0
78	PMC3820476	10458	10460	O	-1	-1	0
%	PMC3820476	10460	10461	O	-1	-1	0
.	PMC3820476	10461	10462	O	-1	-1	0

The	PMC3820476	10463	10466	O	-1	-1	0
1-	PMC3820476	10467	10469	O	-1	-1	0
and	PMC3820476	10470	10473	O	-1	-1	0
5-year	PMC3820476	10474	10480	O	-1	-1	0
survival	PMC3820476	10481	10489	O	-1	-1	0
remained	PMC3820476	10490	10498	O	-1	-1	0
rather	PMC3820476	10499	10505	O	-1	-1	0
constant	PMC3820476	10506	10514	O	-1	-1	0
over	PMC3820476	10515	10519	O	-1	-1	0
time	PMC3820476	10520	10524	O	-1	-1	0
among	PMC3820476	10525	10530	O	-1	-1	0
patients	PMC3820476	10531	10539	O	-1	-1	0
aged	PMC3820476	10540	10544	O	-1	-1	0
15–49	PMC3820476	10545	10550	O	-1	-1	0
years	PMC3820476	10551	10556	O	-1	-1	0
and	PMC3820476	10557	10560	O	-1	-1	0
for	PMC3820476	10561	10564	O	-1	-1	0
patients	PMC3820476	10565	10573	O	-1	-1	0

aged	PMC3820476	10574	10578	O	-1	-1	0
$	PMC3820476	10579	10580	O	-1	-1	0
75	PMC3820476	10580	10582	O	-1	-1	0
years	PMC3820476	10583	10588	O	-1	-1	0
,	PMC3820476	10588	10589	O	-1	-1	0
but	PMC3820476	10590	10593	O	-1	-1	0
increased	PMC3820476	10594	10603	O	-1	-1	0
from	PMC3820476	10604	10608	O	-1	-1	0
93	PMC3820476	10609	10611	O	-1	-1	0
%	PMC3820476	10611	10612	O	-1	-1	0
to	PMC3820476	10613	10615	O	-1	-1	0
97	PMC3820476	10616	10618	O	-1	-1	0
%	PMC3820476	10618	10619	O	-1	-1	0
and	PMC3820476	10620	10623	O	-1	-1	0
from	PMC3820476	10624	10628	O	-1	-1	0
77	PMC3820476	10629	10631	O	-1	-1	0
%	PMC3820476	10631	10632	O	-1	-1	0
to	PMC3820476	10633	10635	O	-1	-1	0
84	PMC3820476	10636	10638	O	-1	-1	0
%	PMC3820476	10638	10639	O	-1	-1	0
,	PMC3820476	10639	10640	O	-1	-1	0
respectively	PMC3820476	10641	10653	O	-1	-1	0
,	PMC3820476	10653	10654	O	-1	-1	0
for	PMC3820476	10655	10658	O	-1	-1	0
patients	PMC3820476	10659	10667	O	-1	-1	0
aged	PMC3820476	10668	10672	O	-1	-1	0
between	PMC3820476	10673	10680	O	-1	-1	0
50	PMC3820476	10681	10683	O	-1	-1	0
and	PMC3820476	10684	10687	O	-1	-1	0
74	PMC3820476	10688	10690	O	-1	-1	0

(	PMC3820476	10691	10692	O	-1	-1	0
Table	PMC3820476	10692	10697	O	-1	-1	0
2	PMC3820476	10698	10699	O	-1	-1	0
)	PMC3820476	10699	10700	O	-1	-1	0
.	PMC3820476	10700	10701	O	-1	-1	0

Figure	PMC3820476	10702	10708	O	-1	-1	0
1	PMC3820476	10709	10710	O	-1	-1	0
shows	PMC3820476	10711	10716	O	-1	-1	0
the	PMC3820476	10717	10720	O	-1	-1	0
Kaplan	PMC3820476	10721	10727	O	-1	-1	0
–	PMC3820476	10727	10728	O	-1	-1	0
Meier	PMC3820476	10728	10733	O	-1	-1	0
survival	PMC3820476	10734	10742	O	-1	-1	0
curves	PMC3820476	10743	10749	O	-1	-1	0
for	PMC3820476	10750	10753	O	-1	-1	0
breast	PMC3820476	10754	10760	O	-1	-1	0
cancer	PMC3820476	10761	10767	O	-1	-1	0
patients	PMC3820476	10768	10776	O	-1	-1	0
in	PMC3820476	10777	10779	O	-1	-1	0
the	PMC3820476	10780	10783	O	-1	-1	0
four	PMC3820476	10784	10788	O	-1	-1	0
calendar	PMC3820476	10789	10797	O	-1	-1	0
time	PMC3820476	10798	10802	O	-1	-1	0
periods	PMC3820476	10803	10810	O	-1	-1	0
stratified	PMC3820476	10811	10821	O	-1	-1	0
by	PMC3820476	10822	10824	O	-1	-1	0
CCI	PMC3820476	10825	10828	O	-1	-1	0
score	PMC3820476	10829	10834	O	-1	-1	0
.	PMC3820476	10834	10835	O	-1	-1	0

For	PMC3820476	10836	10839	O	-1	-1	0
patients	PMC3820476	10840	10848	O	-1	-1	0
with	PMC3820476	10849	10853	O	-1	-1	0
a	PMC3820476	10854	10855	O	-1	-1	0
CCI	PMC3820476	10856	10859	O	-1	-1	0
score	PMC3820476	10860	10865	O	-1	-1	0
of	PMC3820476	10866	10868	O	-1	-1	0
$	PMC3820476	10869	10870	O	-1	-1	0
3	PMC3820476	10870	10871	O	-1	-1	0
,	PMC3820476	10871	10872	O	-1	-1	0
survival	PMC3820476	10873	10881	O	-1	-1	0
improved	PMC3820476	10882	10890	O	-1	-1	0
markedly	PMC3820476	10891	10899	O	-1	-1	0
after	PMC3820476	10900	10905	O	-1	-1	0
the	PMC3820476	10906	10909	O	-1	-1	0
period	PMC3820476	10910	10916	O	-1	-1	0
2000–2002	PMC3820476	10917	10926	O	-1	-1	0
.	PMC3820476	10926	10927	O	-1	-1	0

Table	PMC3820476	10928	10933	O	-1	-1	0
3	PMC3820476	10934	10935	O	-1	-1	0
shows	PMC3820476	10936	10941	O	-1	-1	0
that	PMC3820476	10942	10946	O	-1	-1	0
patients	PMC3820476	10947	10955	O	-1	-1	0
with	PMC3820476	10956	10960	O	-1	-1	0
high	PMC3820476	10961	10965	O	-1	-1	0
CCI	PMC3820476	10966	10969	O	-1	-1	0
scores	PMC3820476	10970	10976	O	-1	-1	0
had	PMC3820476	10977	10980	O	-1	-1	0
higher	PMC3820476	10981	10987	O	-1	-1	0
1-	PMC3820476	10988	10990	O	-1	-1	0
and	PMC3820476	10991	10994	O	-1	-1	0
5-year	PMC3820476	10995	11001	O	-1	-1	0
mortality	PMC3820476	11002	11011	O	-1	-1	0
compared	PMC3820476	11012	11020	O	-1	-1	0
with	PMC3820476	11021	11025	O	-1	-1	0
those	PMC3820476	11026	11031	O	-1	-1	0
with	PMC3820476	11032	11036	O	-1	-1	0
low	PMC3820476	11037	11040	O	-1	-1	0
CCI	PMC3820476	11041	11044	O	-1	-1	0
scores	PMC3820476	11045	11051	O	-1	-1	0
,	PMC3820476	11051	11052	O	-1	-1	0
regardless	PMC3820476	11053	11063	O	-1	-1	0
of	PMC3820476	11064	11066	O	-1	-1	0
calendar	PMC3820476	11067	11075	O	-1	-1	0
period	PMC3820476	11076	11082	O	-1	-1	0
.	PMC3820476	11082	11083	O	-1	-1	0

However	PMC3820476	11084	11091	O	-1	-1	0
,	PMC3820476	11091	11092	O	-1	-1	0
1-year	PMC3820476	11093	11099	O	-1	-1	0
survival	PMC3820476	11100	11108	O	-1	-1	0
improved	PMC3820476	11109	11117	O	-1	-1	0
over	PMC3820476	11118	11122	O	-1	-1	0
time	PMC3820476	11123	11127	O	-1	-1	0
for	PMC3820476	11128	11131	O	-1	-1	0
all	PMC3820476	11132	11135	O	-1	-1	0
three	PMC3820476	11136	11141	O	-1	-1	0
CCI	PMC3820476	11142	11145	O	-1	-1	0
­categories	PMC3820476	11146	11157	O	-1	-1	0
.	PMC3820476	11157	11158	O	-1	-1	0

Most	PMC3820476	11159	11163	O	-1	-1	0
of	PMC3820476	11164	11166	O	-1	-1	0
the	PMC3820476	11167	11170	O	-1	-1	0
1-year	PMC3820476	11171	11177	O	-1	-1	0
survival	PMC3820476	11178	11186	O	-1	-1	0
improvement	PMC3820476	11187	11198	O	-1	-1	0
in	PMC3820476	11199	11201	O	-1	-1	0
all	PMC3820476	11202	11205	O	-1	-1	0
CCI	PMC3820476	11206	11209	O	-1	-1	0
categories	PMC3820476	11210	11220	O	-1	-1	0
seemed	PMC3820476	11221	11227	O	-1	-1	0
to	PMC3820476	11228	11230	O	-1	-1	0
happen	PMC3820476	11231	11237	O	-1	-1	0
early	PMC3820476	11238	11243	O	-1	-1	0
in	PMC3820476	11244	11246	O	-1	-1	0
the	PMC3820476	11247	11250	O	-1	-1	0
study	PMC3820476	11251	11256	O	-1	-1	0
period	PMC3820476	11257	11263	O	-1	-1	0
,	PMC3820476	11263	11264	O	-1	-1	0
ie	PMC3820476	11265	11267	O	-1	-1	0
,	PMC3820476	11267	11268	O	-1	-1	0
between	PMC3820476	11269	11276	O	-1	-1	0
2000–2002	PMC3820476	11277	11286	O	-1	-1	0
and	PMC3820476	11287	11290	O	-1	-1	0
2003–2005	PMC3820476	11291	11300	O	-1	-1	0
,	PMC3820476	11300	11301	O	-1	-1	0
in	PMC3820476	11302	11304	O	-1	-1	0
particular	PMC3820476	11305	11315	O	-1	-1	0
for	PMC3820476	11316	11319	O	-1	-1	0
the	PMC3820476	11320	11323	O	-1	-1	0
CCI	PMC3820476	11324	11327	O	-1	-1	0
score	PMC3820476	11328	11333	O	-1	-1	0
$	PMC3820476	11334	11335	O	-1	-1	0
3	PMC3820476	11335	11336	O	-1	-1	0
patients	PMC3820476	11337	11345	O	-1	-1	0
.	PMC3820476	11345	11346	O	-1	-1	0

5-year	PMC3820476	11347	11353	O	-1	-1	0
survival	PMC3820476	11354	11362	O	-1	-1	0
also	PMC3820476	11363	11367	O	-1	-1	0
improved	PMC3820476	11368	11376	O	-1	-1	0
over	PMC3820476	11377	11381	O	-1	-1	0
time	PMC3820476	11382	11386	O	-1	-1	0


	PMC3820476	11386	11388	O	-1	-1	0
Clinical	PMC3820476	11388	11396	O	-1	-1	0
Epidemiology	PMC3820476	11397	11409	O	-1	-1	0
2013:5	PMC3820476	11410	11416	O	-1	-1	0

(	PMC3820476	11417	11418	O	-1	-1	0
Suppl	PMC3820476	11418	11423	O	-1	-1	0
1	PMC3820476	11424	11425	O	-1	-1	0
)	PMC3820476	11425	11426	O	-1	-1	0


	PMC3820476	11426	11428	O	-1	-1	0
Table	PMC3820476	11428	11433	O	-1	-1	0
2	PMC3820476	11434	11435	O	-1	-1	0

One-	PMC3820476	11436	11440	O	-1	-1	0
and	PMC3820476	11441	11444	O	-1	-1	0
5-year	PMC3820476	11445	11451	O	-1	-1	0
survival	PMC3820476	11452	11460	O	-1	-1	0
and	PMC3820476	11461	11464	O	-1	-1	0
relative	PMC3820476	11465	11473	O	-1	-1	0
mortality	PMC3820476	11474	11483	O	-1	-1	0
stratified	PMC3820476	11484	11494	O	-1	-1	0
by	PMC3820476	11495	11497	O	-1	-1	0
four	PMC3820476	11498	11502	O	-1	-1	0
calendar	PMC3820476	11503	11511	O	-1	-1	0
time	PMC3820476	11512	11516	O	-1	-1	0
periods	PMC3820476	11517	11524	O	-1	-1	0
and	PMC3820476	11525	11528	O	-1	-1	0
age	PMC3820476	11529	11532	O	-1	-1	0
group	PMC3820476	11533	11538	O	-1	-1	0
of	PMC3820476	11539	11541	O	-1	-1	0
breast	PMC3820476	11542	11548	O	-1	-1	0
cancer	PMC3820476	11549	11555	O	-1	-1	0

diagnosis	PMC3820476	11556	11565	O	-1	-1	0

Year	PMC3820476	11566	11570	O	-1	-1	0
of	PMC3820476	11571	11573	O	-1	-1	0
diagnosis	PMC3820476	11574	11583	O	-1	-1	0

1	PMC3820476	11584	11585	O	-1	-1	0
year	PMC3820476	11586	11590	O	-1	-1	0

Survival	PMC3820476	11591	11599	O	-1	-1	0

 	PMC3820476	11599	11601	O	-1	-1	0
Adjusted	PMC3820476	11601	11610	O	-1	-1	0

MRRa	PMC3820476	11611	11615	O	-1	-1	0

5	PMC3820476	11616	11617	O	-1	-1	0
years	PMC3820476	11618	11623	O	-1	-1	0

Survival	PMC3820476	11624	11632	O	-1	-1	0

 	PMC3820476	11632	11634	O	-1	-1	0
Adjusted	PMC3820476	11634	11643	O	-1	-1	0

MRRa	PMC3820476	11644	11648	O	-1	-1	0

Age	PMC3820476	11649	11652	O	-1	-1	0
group	PMC3820476	11653	11658	O	-1	-1	0

15–49	PMC3820476	11659	11664	O	-1	-1	0
years	PMC3820476	11665	11670	O	-1	-1	0

 	PMC3820476	11670	11672	O	-1	-1	0

1-year	PMC3820476	11672	11679	O	-1	-1	0
survival	PMC3820476	11680	11688	O	-1	-1	0

 	PMC3820476	11688	11690	O	-1	-1	0
5-year	PMC3820476	11690	11697	O	-1	-1	0
survival	PMC3820476	11698	11706	O	-1	-1	0

50–74	PMC3820476	11707	11712	O	-1	-1	0
years	PMC3820476	11713	11718	O	-1	-1	0

 	PMC3820476	11718	11720	O	-1	-1	0

1-year	PMC3820476	11720	11727	O	-1	-1	0

survival	PMC3820476	11728	11736	O	-1	-1	0

 	PMC3820476	11736	11738	O	-1	-1	0

5-year	PMC3820476	11738	11745	O	-1	-1	0

survival	PMC3820476	11746	11754	O	-1	-1	0
$	PMC3820476	11755	11756	O	-1	-1	0
75	PMC3820476	11756	11758	O	-1	-1	0
years	PMC3820476	11759	11764	O	-1	-1	0

 	PMC3820476	11764	11766	O	-1	-1	0

1-year	PMC3820476	11766	11773	O	-1	-1	0

survival	PMC3820476	11774	11782	O	-1	-1	0

 	PMC3820476	11782	11784	O	-1	-1	0

5-year	PMC3820476	11784	11791	O	-1	-1	0

survival	PMC3820476	11792	11800	O	-1	-1	0


	PMC3820476	11800	11802	O	-1	-1	0

2000–2002	PMC3820476	11802	11811	O	-1	-1	0


	PMC3820476	11811	11813	O	-1	-1	0

2003–2005	PMC3820476	11813	11822	O	-1	-1	0


	PMC3820476	11822	11824	O	-1	-1	0

2006–2008	PMC3820476	11824	11833	O	-1	-1	0


	PMC3820476	11833	11835	O	-1	-1	0

2009–2011	PMC3820476	11835	11844	O	-1	-1	0


	PMC3820476	11844	11846	O	-1	-1	0

91	PMC3820476	11846	11848	O	-1	-1	0
%	PMC3820476	11848	11849	O	-1	-1	0
(	PMC3820476	11850	11851	O	-1	-1	0
90%–93	PMC3820476	11851	11857	O	-1	-1	0
%	PMC3820476	11857	11858	O	-1	-1	0
)	PMC3820476	11858	11859	O	-1	-1	0

1	PMC3820476	11860	11861	O	-1	-1	0

(	PMC3820476	11862	11863	O	-1	-1	0
reference	PMC3820476	11863	11872	O	-1	-1	0
)	PMC3820476	11872	11873	O	-1	-1	0


	PMC3820476	11873	11875	O	-1	-1	0

94	PMC3820476	11875	11877	O	-1	-1	0
%	PMC3820476	11877	11878	O	-1	-1	0
(	PMC3820476	11879	11880	O	-1	-1	0
93%–95	PMC3820476	11880	11886	O	-1	-1	0
%	PMC3820476	11886	11887	O	-1	-1	0
)	PMC3820476	11887	11888	O	-1	-1	0
0.66	PMC3820476	11889	11893	O	-1	-1	0

(	PMC3820476	11894	11895	O	-1	-1	0
0.52–0.83	PMC3820476	11895	11904	O	-1	-1	0
)	PMC3820476	11904	11905	O	-1	-1	0


	PMC3820476	11905	11907	O	-1	-1	0

94	PMC3820476	11907	11909	O	-1	-1	0
%	PMC3820476	11909	11910	O	-1	-1	0
(	PMC3820476	11911	11912	O	-1	-1	0
93%–95	PMC3820476	11912	11918	O	-1	-1	0
%	PMC3820476	11918	11919	O	-1	-1	0
)	PMC3820476	11919	11920	O	-1	-1	0

0.73	PMC3820476	11921	11925	O	-1	-1	0

(	PMC3820476	11926	11927	O	-1	-1	0
0.59–0.91	PMC3820476	11927	11936	O	-1	-1	0
)	PMC3820476	11936	11937	O	-1	-1	0


	PMC3820476	11937	11939	O	-1	-1	0

95	PMC3820476	11939	11941	O	-1	-1	0
%	PMC3820476	11941	11942	O	-1	-1	0
(	PMC3820476	11943	11944	O	-1	-1	0
94%–96	PMC3820476	11944	11950	O	-1	-1	0
%	PMC3820476	11950	11951	O	-1	-1	0
)	PMC3820476	11951	11952	O	-1	-1	0
0.59	PMC3820476	11953	11957	O	-1	-1	0

(	PMC3820476	11958	11959	O	-1	-1	0
0.47–0.74	PMC3820476	11959	11968	O	-1	-1	0
)	PMC3820476	11968	11969	O	-1	-1	0


	PMC3820476	11969	11971	O	-1	-1	0
72	PMC3820476	11971	11973	O	-1	-1	0
%	PMC3820476	11973	11974	O	-1	-1	0
(	PMC3820476	11975	11976	O	-1	-1	0
70%–74	PMC3820476	11976	11982	O	-1	-1	0
%	PMC3820476	11982	11983	O	-1	-1	0
)	PMC3820476	11983	11984	O	-1	-1	0

1	PMC3820476	11985	11986	O	-1	-1	0

(	PMC3820476	11987	11988	O	-1	-1	0
reference	PMC3820476	11988	11997	O	-1	-1	0
)	PMC3820476	11997	11998	O	-1	-1	0


	PMC3820476	11998	12000	O	-1	-1	0

75	PMC3820476	12000	12002	O	-1	-1	0
%	PMC3820476	12002	12003	O	-1	-1	0
(	PMC3820476	12004	12005	O	-1	-1	0
73%–77	PMC3820476	12005	12011	O	-1	-1	0
%	PMC3820476	12011	12012	O	-1	-1	0
)	PMC3820476	12012	12013	O	-1	-1	0

0.87	PMC3820476	12014	12018	O	-1	-1	0

(	PMC3820476	12019	12020	O	-1	-1	0
0.77–0.98	PMC3820476	12020	12029	O	-1	-1	0
)	PMC3820476	12029	12030	O	-1	-1	0


	PMC3820476	12030	12032	O	-1	-1	0

75	PMC3820476	12032	12034	O	-1	-1	0
%	PMC3820476	12034	12035	O	-1	-1	0
(	PMC3820476	12036	12037	O	-1	-1	0
74%–77%)b	PMC3820476	12037	12046	O	-1	-1	0

0.87	PMC3820476	12047	12051	O	-1	-1	0

(	PMC3820476	12052	12053	O	-1	-1	0
0.77–0.98)b	PMC3820476	12053	12064	O	-1	-1	0


	PMC3820476	12064	12066	O	-1	-1	0

78	PMC3820476	12066	12068	O	-1	-1	0
%	PMC3820476	12068	12069	O	-1	-1	0

(	PMC3820476	12070	12071	O	-1	-1	0
76%–80%)b	PMC3820476	12071	12080	O	-1	-1	0

0.78	PMC3820476	12081	12085	O	-1	-1	0

(	PMC3820476	12086	12087	O	-1	-1	0
0.69–0.87)b	PMC3820476	12087	12098	O	-1	-1	0


	PMC3820476	12098	12100	O	-1	-1	0

97	PMC3820476	12100	12102	O	-1	-1	0
%	PMC3820476	12102	12103	O	-1	-1	0
(	PMC3820476	12104	12105	O	-1	-1	0
95%–98	PMC3820476	12105	12111	O	-1	-1	0
%	PMC3820476	12111	12112	O	-1	-1	0
)	PMC3820476	12112	12113	O	-1	-1	0

85	PMC3820476	12114	12116	O	-1	-1	0
%	PMC3820476	12116	12117	O	-1	-1	0
(	PMC3820476	12118	12119	O	-1	-1	0
81%–88	PMC3820476	12119	12125	O	-1	-1	0
%	PMC3820476	12125	12126	O	-1	-1	0
)	PMC3820476	12126	12127	O	-1	-1	0


	PMC3820476	12127	12129	O	-1	-1	0
99	PMC3820476	12129	12131	O	-1	-1	0
%	PMC3820476	12131	12132	O	-1	-1	0

(	PMC3820476	12133	12134	O	-1	-1	0
97%–99	PMC3820476	12134	12140	O	-1	-1	0
%	PMC3820476	12140	12141	O	-1	-1	0
)	PMC3820476	12141	12142	O	-1	-1	0

86	PMC3820476	12143	12145	O	-1	-1	0
%	PMC3820476	12145	12146	O	-1	-1	0
(	PMC3820476	12147	12148	O	-1	-1	0
82%–89	PMC3820476	12148	12154	O	-1	-1	0
%	PMC3820476	12154	12155	O	-1	-1	0
)	PMC3820476	12155	12156	O	-1	-1	0


	PMC3820476	12156	12158	O	-1	-1	0
99	PMC3820476	12158	12160	O	-1	-1	0
%	PMC3820476	12160	12161	O	-1	-1	0

(	PMC3820476	12162	12163	O	-1	-1	0
97%–99	PMC3820476	12163	12169	O	-1	-1	0
%	PMC3820476	12169	12170	O	-1	-1	0
)	PMC3820476	12170	12171	O	-1	-1	0

89	PMC3820476	12172	12174	O	-1	-1	0
%	PMC3820476	12174	12175	O	-1	-1	0

(	PMC3820476	12176	12177	O	-1	-1	0
86%–92%)b	PMC3820476	12177	12186	O	-1	-1	0


	PMC3820476	12186	12188	O	-1	-1	0
97	PMC3820476	12188	12190	O	-1	-1	0
%	PMC3820476	12190	12191	O	-1	-1	0
(	PMC3820476	12192	12193	O	-1	-1	0
95%–98	PMC3820476	12193	12199	O	-1	-1	0
%	PMC3820476	12199	12200	O	-1	-1	0
)	PMC3820476	12200	12201	O	-1	-1	0

87	PMC3820476	12202	12204	O	-1	-1	0
%	PMC3820476	12204	12205	O	-1	-1	0

(	PMC3820476	12206	12207	O	-1	-1	0
84%–90%)b	PMC3820476	12207	12216	O	-1	-1	0


	PMC3820476	12216	12218	O	-1	-1	0
93	PMC3820476	12218	12220	O	-1	-1	0
%	PMC3820476	12220	12221	O	-1	-1	0

(	PMC3820476	12222	12223	O	-1	-1	0
92%–95	PMC3820476	12223	12229	O	-1	-1	0
%	PMC3820476	12229	12230	O	-1	-1	0
)	PMC3820476	12230	12231	O	-1	-1	0

77	PMC3820476	12232	12234	O	-1	-1	0
%	PMC3820476	12234	12235	O	-1	-1	0
(	PMC3820476	12236	12237	O	-1	-1	0
74%–79	PMC3820476	12237	12243	O	-1	-1	0
%	PMC3820476	12243	12244	O	-1	-1	0
)	PMC3820476	12244	12245	O	-1	-1	0


	PMC3820476	12245	12247	O	-1	-1	0
96	PMC3820476	12247	12249	O	-1	-1	0
%	PMC3820476	12249	12250	O	-1	-1	0

(	PMC3820476	12251	12252	O	-1	-1	0
94%–97	PMC3820476	12252	12258	O	-1	-1	0
%	PMC3820476	12258	12259	O	-1	-1	0
)	PMC3820476	12259	12260	O	-1	-1	0

80	PMC3820476	12261	12263	O	-1	-1	0
%	PMC3820476	12263	12264	O	-1	-1	0
(	PMC3820476	12265	12266	O	-1	-1	0
78%–82	PMC3820476	12266	12272	O	-1	-1	0
%	PMC3820476	12272	12273	O	-1	-1	0
)	PMC3820476	12273	12274	O	-1	-1	0


	PMC3820476	12274	12276	O	-1	-1	0

95	PMC3820476	12276	12278	O	-1	-1	0
%	PMC3820476	12278	12279	O	-1	-1	0
(	PMC3820476	12280	12281	O	-1	-1	0
94%–96	PMC3820476	12281	12287	O	-1	-1	0
%	PMC3820476	12287	12288	O	-1	-1	0
)	PMC3820476	12288	12289	O	-1	-1	0

80	PMC3820476	12290	12292	O	-1	-1	0
%	PMC3820476	12292	12293	O	-1	-1	0

(	PMC3820476	12294	12295	O	-1	-1	0
78%–82%)b	PMC3820476	12295	12304	O	-1	-1	0


	PMC3820476	12304	12306	O	-1	-1	0
97	PMC3820476	12306	12308	O	-1	-1	0
%	PMC3820476	12308	12309	O	-1	-1	0
(	PMC3820476	12310	12311	O	-1	-1	0
96%–98	PMC3820476	12311	12317	O	-1	-1	0
%	PMC3820476	12317	12318	O	-1	-1	0
)	PMC3820476	12318	12319	O	-1	-1	0

84	PMC3820476	12320	12322	O	-1	-1	0
%	PMC3820476	12322	12323	O	-1	-1	0

(	PMC3820476	12324	12325	O	-1	-1	0
82%–85%)b	PMC3820476	12325	12334	O	-1	-1	0


	PMC3820476	12334	12336	O	-1	-1	0
82	PMC3820476	12336	12338	O	-1	-1	0
%	PMC3820476	12338	12339	O	-1	-1	0
(	PMC3820476	12340	12341	O	-1	-1	0
78%–85	PMC3820476	12341	12347	O	-1	-1	0
%	PMC3820476	12347	12348	O	-1	-1	0
)	PMC3820476	12348	12349	O	-1	-1	0

50	PMC3820476	12350	12352	O	-1	-1	0
%	PMC3820476	12352	12353	O	-1	-1	0
(	PMC3820476	12354	12355	O	-1	-1	0
45%–54	PMC3820476	12355	12361	O	-1	-1	0
%	PMC3820476	12361	12362	O	-1	-1	0
)	PMC3820476	12362	12363	O	-1	-1	0


	PMC3820476	12363	12365	O	-1	-1	0

85	PMC3820476	12365	12367	O	-1	-1	0
%	PMC3820476	12367	12368	O	-1	-1	0
(	PMC3820476	12369	12370	O	-1	-1	0
82%–88	PMC3820476	12370	12376	O	-1	-1	0
%	PMC3820476	12376	12377	O	-1	-1	0
)	PMC3820476	12377	12378	O	-1	-1	0

50	PMC3820476	12379	12381	O	-1	-1	0
%	PMC3820476	12381	12382	O	-1	-1	0
(	PMC3820476	12383	12384	O	-1	-1	0
45%–54	PMC3820476	12384	12390	O	-1	-1	0
%	PMC3820476	12390	12391	O	-1	-1	0
)	PMC3820476	12391	12392	O	-1	-1	0


	PMC3820476	12392	12394	O	-1	-1	0
83	PMC3820476	12394	12396	O	-1	-1	0
%	PMC3820476	12396	12397	O	-1	-1	0

(	PMC3820476	12398	12399	O	-1	-1	0
79%–86	PMC3820476	12399	12405	O	-1	-1	0
%	PMC3820476	12405	12406	O	-1	-1	0
)	PMC3820476	12406	12407	O	-1	-1	0
48	PMC3820476	12408	12410	O	-1	-1	0
%	PMC3820476	12410	12411	O	-1	-1	0

(	PMC3820476	12412	12413	O	-1	-1	0
43%–52%)b	PMC3820476	12413	12422	O	-1	-1	0


	PMC3820476	12422	12424	O	-1	-1	0
84	PMC3820476	12424	12426	O	-1	-1	0
%	PMC3820476	12426	12427	O	-1	-1	0
(	PMC3820476	12428	12429	O	-1	-1	0
80%–87	PMC3820476	12429	12435	O	-1	-1	0
%	PMC3820476	12435	12436	O	-1	-1	0
)	PMC3820476	12436	12437	O	-1	-1	0

48	PMC3820476	12438	12440	O	-1	-1	0
%	PMC3820476	12440	12441	O	-1	-1	0

(	PMC3820476	12442	12443	O	-1	-1	0
43%–52%)b	PMC3820476	12443	12452	O	-1	-1	0


	PMC3820476	12452	12454	O	-1	-1	0
Notes	PMC3820476	12454	12459	O	-1	-1	0
:	PMC3820476	12459	12460	O	-1	-1	0

95	PMC3820476	12461	12463	O	-1	-1	0
%	PMC3820476	12463	12464	O	-1	-1	0
confidence	PMC3820476	12465	12475	O	-1	-1	0
intervals	PMC3820476	12476	12485	O	-1	-1	0
are	PMC3820476	12486	12489	O	-1	-1	0
presented	PMC3820476	12490	12499	O	-1	-1	0
in	PMC3820476	12500	12502	O	-1	-1	0
brackets	PMC3820476	12503	12511	O	-1	-1	0
.	PMC3820476	12511	12512	O	-1	-1	0

aAdjusted	PMC3820476	12513	12522	O	-1	-1	0
for	PMC3820476	12523	12526	O	-1	-1	0
differences	PMC3820476	12527	12538	O	-1	-1	0
in	PMC3820476	12539	12541	O	-1	-1	0
age	PMC3820476	12542	12545	O	-1	-1	0
and	PMC3820476	12546	12549	O	-1	-1	0
comorbidity	PMC3820476	12550	12561	O	-1	-1	0
;	PMC3820476	12561	12562	O	-1	-1	0
bpredicted	PMC3820476	12563	12573	O	-1	-1	0
values	PMC3820476	12574	12580	O	-1	-1	0
.	PMC3820476	12580	12581	O	-1	-1	0

Abbreviation	PMC3820476	12582	12594	O	-1	-1	0
:	PMC3820476	12594	12595	O	-1	-1	0
MRR	PMC3820476	12596	12599	O	-1	-1	0
,	PMC3820476	12599	12600	O	-1	-1	0
mortality	PMC3820476	12601	12610	O	-1	-1	0
rate	PMC3820476	12611	12615	O	-1	-1	0
ratio	PMC3820476	12616	12621	O	-1	-1	0
.	PMC3820476	12621	12622	O	-1	-1	0


	PMC3820476	12622	12624	O	-1	-1	0

in	PMC3820476	12624	12626	O	-1	-1	0
all	PMC3820476	12627	12630	O	-1	-1	0
CCI	PMC3820476	12631	12634	O	-1	-1	0
categories	PMC3820476	12635	12645	O	-1	-1	0
,	PMC3820476	12645	12646	O	-1	-1	0
with	PMC3820476	12647	12651	O	-1	-1	0
most	PMC3820476	12652	12656	O	-1	-1	0
pronounced	PMC3820476	12657	12667	O	-1	-1	0
­improvements	PMC3820476	12668	12681	O	-1	-1	0
seen	PMC3820476	12682	12686	O	-1	-1	0
among	PMC3820476	12687	12692	O	-1	-1	0
CCI	PMC3820476	12693	12696	O	-1	-1	0
score	PMC3820476	12697	12702	O	-1	-1	0

$	PMC3820476	12703	12704	O	-1	-1	0
3	PMC3820476	12704	12705	O	-1	-1	0
patients	PMC3820476	12706	12714	O	-1	-1	0
–	PMC3820476	12715	12716	O	-1	-1	0
from	PMC3820476	12717	12721	O	-1	-1	0
25	PMC3820476	12722	12724	O	-1	-1	0
%	PMC3820476	12724	12725	O	-1	-1	0
in	PMC3820476	12726	12728	O	-1	-1	0
2000–2002	PMC3820476	12729	12738	O	-1	-1	0
to	PMC3820476	12739	12741	O	-1	-1	0
a	PMC3820476	12742	12743	O	-1	-1	0
predicted	PMC3820476	12744	12753	O	-1	-1	0
50	PMC3820476	12754	12756	O	-1	-1	0
%	PMC3820476	12756	12757	O	-1	-1	0
in	PMC3820476	12758	12760	O	-1	-1	0
2009–2011	PMC3820476	12761	12770	O	-1	-1	0
(	PMC3820476	12771	12772	O	-1	-1	0
Table	PMC3820476	12772	12777	O	-1	-1	0
3	PMC3820476	12778	12779	O	-1	-1	0
)	PMC3820476	12779	12780	O	-1	-1	0
.	PMC3820476	12780	12781	O	-1	-1	0


	PMC3820476	12781	12783	O	-1	-1	0

Mortality	PMC3820476	12783	12792	O	-1	-1	0

The	PMC3820476	12793	12796	O	-1	-1	0
mortality	PMC3820476	12797	12806	O	-1	-1	0
across	PMC3820476	12807	12813	O	-1	-1	0
calendar	PMC3820476	12814	12822	O	-1	-1	0
periods	PMC3820476	12823	12830	O	-1	-1	0
was	PMC3820476	12831	12834	O	-1	-1	0
rather	PMC3820476	12835	12841	O	-1	-1	0
constant	PMC3820476	12842	12850	O	-1	-1	0
from	PMC3820476	12851	12855	O	-1	-1	0
2003–2005	PMC3820476	12856	12865	O	-1	-1	0
(	PMC3820476	12866	12867	O	-1	-1	0
Table	PMC3820476	12867	12872	O	-1	-1	0
3	PMC3820476	12873	12874	O	-1	-1	0
)	PMC3820476	12874	12875	O	-1	-1	0
.	PMC3820476	12875	12876	O	-1	-1	0

Compared	PMC3820476	12877	12885	O	-1	-1	0
with	PMC3820476	12886	12890	O	-1	-1	0
1-year	PMC3820476	12891	12897	O	-1	-1	0
mortality	PMC3820476	12898	12907	O	-1	-1	0
in	PMC3820476	12908	12910	O	-1	-1	0
patients	PMC3820476	12911	12919	O	-1	-1	0
with	PMC3820476	12920	12924	O	-1	-1	0
no	PMC3820476	12925	12927	O	-1	-1	0
recorded	PMC3820476	12928	12936	O	-1	-1	0
comorbidity	PMC3820476	12937	12948	O	-1	-1	0
,	PMC3820476	12948	12949	O	-1	-1	0
the	PMC3820476	12950	12953	O	-1	-1	0
adjusted	PMC3820476	12954	12962	O	-1	-1	0
1-year	PMC3820476	12963	12969	O	-1	-1	0
mortality	PMC3820476	12970	12979	O	-1	-1	0
hazard	PMC3820476	12980	12986	O	-1	-1	0
ratio	PMC3820476	12987	12992	O	-1	-1	0
(	PMC3820476	12993	12994	O	-1	-1	0
HR	PMC3820476	12994	12996	O	-1	-1	0
)	PMC3820476	12996	12997	O	-1	-1	0
for	PMC3820476	12998	13001	O	-1	-1	0
patients	PMC3820476	13002	13010	O	-1	-1	0
with	PMC3820476	13011	13015	O	-1	-1	0
a	PMC3820476	13016	13017	O	-1	-1	0
CCI	PMC3820476	13018	13021	O	-1	-1	0
score	PMC3820476	13022	13027	O	-1	-1	0
of	PMC3820476	13028	13030	O	-1	-1	0
1–2	PMC3820476	13031	13034	O	-1	-1	0
remained	PMC3820476	13035	13043	O	-1	-1	0
similar	PMC3820476	13044	13051	O	-1	-1	0
over	PMC3820476	13052	13056	O	-1	-1	0
time	PMC3820476	13057	13061	O	-1	-1	0
,	PMC3820476	13061	13062	O	-1	-1	0
ie	PMC3820476	13063	13065	O	-1	-1	0
,	PMC3820476	13065	13066	O	-1	-1	0
HR	PMC3820476	13067	13069	O	-1	-1	0
=	PMC3820476	13070	13071	O	-1	-1	0
1.8	PMC3820476	13072	13075	O	-1	-1	0

(	PMC3820476	13076	13077	O	-1	-1	0
95	PMC3820476	13077	13079	O	-1	-1	0
%	PMC3820476	13079	13080	O	-1	-1	0
confidence	PMC3820476	13081	13091	O	-1	-1	0
interval	PMC3820476	13092	13100	O	-1	-1	0
[	PMC3820476	13101	13102	O	-1	-1	0
CI	PMC3820476	13102	13104	O	-1	-1	0
]	PMC3820476	13104	13105	O	-1	-1	0
:	PMC3820476	13105	13106	O	-1	-1	0
1.3	PMC3820476	13107	13110	O	-1	-1	0
,	PMC3820476	13110	13111	O	-1	-1	0
2.6	PMC3820476	13112	13115	O	-1	-1	0
)	PMC3820476	13115	13116	O	-1	-1	0
in	PMC3820476	13117	13119	O	-1	-1	0
2000–2002	PMC3820476	13120	13129	O	-1	-1	0
and	PMC3820476	13130	13133	O	-1	-1	0
HR	PMC3820476	13134	13136	O	-1	-1	0
=	PMC3820476	13137	13138	O	-1	-1	0
1.9	PMC3820476	13139	13142	O	-1	-1	0

(	PMC3820476	13143	13144	O	-1	-1	0
95	PMC3820476	13144	13146	O	-1	-1	0
%	PMC3820476	13146	13147	O	-1	-1	0
CI	PMC3820476	13148	13150	O	-1	-1	0
:	PMC3820476	13150	13151	O	-1	-1	0
1.2	PMC3820476	13152	13155	O	-1	-1	0
,	PMC3820476	13155	13156	O	-1	-1	0
2.8	PMC3820476	13157	13160	O	-1	-1	0
)	PMC3820476	13160	13161	O	-1	-1	0
in	PMC3820476	13162	13164	O	-1	-1	0
2009–2011	PMC3820476	13165	13174	O	-1	-1	0
.	PMC3820476	13174	13175	O	-1	-1	0

The	PMC3820476	13176	13179	O	-1	-1	0
corresponding	PMC3820476	13180	13193	O	-1	-1	0
5-year	PMC3820476	13194	13200	O	-1	-1	0
mortality	PMC3820476	13201	13210	O	-1	-1	0

HRs	PMC3820476	13211	13214	O	-1	-1	0
were	PMC3820476	13215	13219	O	-1	-1	0
1.4	PMC3820476	13220	13223	O	-1	-1	0
(	PMC3820476	13224	13225	O	-1	-1	0
95	PMC3820476	13225	13227	O	-1	-1	0
%	PMC3820476	13227	13228	O	-1	-1	0
CI	PMC3820476	13229	13231	O	-1	-1	0
:	PMC3820476	13231	13232	O	-1	-1	0
1.1	PMC3820476	13233	13236	O	-1	-1	0
,	PMC3820476	13236	13237	O	-1	-1	0
1.7	PMC3820476	13238	13241	O	-1	-1	0
)	PMC3820476	13241	13242	O	-1	-1	0
in	PMC3820476	13243	13245	O	-1	-1	0
2000–2002	PMC3820476	13246	13255	O	-1	-1	0
and	PMC3820476	13256	13259	O	-1	-1	0
1.8	PMC3820476	13260	13263	O	-1	-1	0
(	PMC3820476	13264	13265	O	-1	-1	0
95	PMC3820476	13265	13267	O	-1	-1	0
%	PMC3820476	13267	13268	O	-1	-1	0
CI	PMC3820476	13269	13271	O	-1	-1	0
:	PMC3820476	13271	13272	O	-1	-1	0
1.5	PMC3820476	13273	13276	O	-1	-1	0
,	PMC3820476	13276	13277	O	-1	-1	0
2.2	PMC3820476	13278	13281	O	-1	-1	0
)	PMC3820476	13281	13282	O	-1	-1	0
in	PMC3820476	13283	13285	O	-1	-1	0
2009–2011	PMC3820476	13286	13295	O	-1	-1	0
.	PMC3820476	13295	13296	O	-1	-1	0

For	PMC3820476	13297	13300	O	-1	-1	0
patients	PMC3820476	13301	13309	O	-1	-1	0
with	PMC3820476	13310	13314	O	-1	-1	0
a	PMC3820476	13315	13316	O	-1	-1	0
CCI	PMC3820476	13317	13320	O	-1	-1	0
score	PMC3820476	13321	13326	O	-1	-1	0
of	PMC3820476	13327	13329	O	-1	-1	0
$	PMC3820476	13330	13331	O	-1	-1	0
3	PMC3820476	13331	13332	O	-1	-1	0
,	PMC3820476	13332	13333	O	-1	-1	0
the	PMC3820476	13334	13337	O	-1	-1	0
adjusted	PMC3820476	13338	13346	O	-1	-1	0
1-year	PMC3820476	13347	13353	O	-1	-1	0
mortality	PMC3820476	13354	13363	O	-1	-1	0
HRs	PMC3820476	13364	13367	O	-1	-1	0
compared	PMC3820476	13368	13376	O	-1	-1	0
with	PMC3820476	13377	13381	O	-1	-1	0
patients	PMC3820476	13382	13390	O	-1	-1	0
with	PMC3820476	13391	13395	O	-1	-1	0
no	PMC3820476	13396	13398	O	-1	-1	0
recorded	PMC3820476	13399	13407	O	-1	-1	0
comorbidity	PMC3820476	13408	13419	O	-1	-1	0
were	PMC3820476	13420	13424	O	-1	-1	0
5.4	PMC3820476	13425	13428	O	-1	-1	0
(	PMC3820476	13429	13430	O	-1	-1	0
3.5	PMC3820476	13430	13433	O	-1	-1	0
,	PMC3820476	13433	13434	O	-1	-1	0
8.5	PMC3820476	13435	13438	O	-1	-1	0
)	PMC3820476	13438	13439	O	-1	-1	0
in	PMC3820476	13440	13442	O	-1	-1	0
2000–2002	PMC3820476	13443	13452	O	-1	-1	0
and	PMC3820476	13453	13456	O	-1	-1	0
5.7	PMC3820476	13457	13460	O	-1	-1	0
(	PMC3820476	13461	13462	O	-1	-1	0
3.6	PMC3820476	13462	13465	O	-1	-1	0
,	PMC3820476	13465	13466	O	-1	-1	0
9.2	PMC3820476	13467	13470	O	-1	-1	0
)	PMC3820476	13470	13471	O	-1	-1	0
in	PMC3820476	13472	13474	O	-1	-1	0
2009–2011	PMC3820476	13475	13484	O	-1	-1	0
.	PMC3820476	13484	13485	O	-1	-1	0

The	PMC3820476	13486	13489	O	-1	-1	0
5-year	PMC3820476	13490	13496	O	-1	-1	0
mortality	PMC3820476	13497	13506	O	-1	-1	0
HRs	PMC3820476	13507	13510	O	-1	-1	0
were	PMC3820476	13511	13515	O	-1	-1	0
4.0	PMC3820476	13516	13519	O	-1	-1	0
(	PMC3820476	13520	13521	O	-1	-1	0
95	PMC3820476	13521	13523	O	-1	-1	0
%	PMC3820476	13523	13524	O	-1	-1	0
CI	PMC3820476	13525	13527	O	-1	-1	0
:	PMC3820476	13527	13528	O	-1	-1	0
3.0	PMC3820476	13529	13532	O	-1	-1	0
,	PMC3820476	13532	13533	O	-1	-1	0
5.4	PMC3820476	13534	13537	O	-1	-1	0
)	PMC3820476	13537	13538	O	-1	-1	0
in	PMC3820476	13539	13541	O	-1	-1	0
2000–2002	PMC3820476	13542	13551	O	-1	-1	0
and	PMC3820476	13552	13555	O	-1	-1	0
2.7	PMC3820476	13556	13559	O	-1	-1	0

(	PMC3820476	13560	13561	O	-1	-1	0
95	PMC3820476	13561	13563	O	-1	-1	0
%	PMC3820476	13563	13564	O	-1	-1	0
CI	PMC3820476	13565	13567	O	-1	-1	0
:	PMC3820476	13567	13568	O	-1	-1	0
2.0	PMC3820476	13569	13572	O	-1	-1	0
,	PMC3820476	13572	13573	O	-1	-1	0
3.6	PMC3820476	13574	13577	O	-1	-1	0
)	PMC3820476	13577	13578	O	-1	-1	0
in	PMC3820476	13579	13581	O	-1	-1	0
2009–2011	PMC3820476	13582	13591	O	-1	-1	0
,	PMC3820476	13591	13592	O	-1	-1	0
compared	PMC3820476	13593	13601	O	-1	-1	0
with	PMC3820476	13602	13606	O	-1	-1	0
patients	PMC3820476	13607	13615	O	-1	-1	0
without	PMC3820476	13616	13623	O	-1	-1	0
comorbidity	PMC3820476	13624	13635	O	-1	-1	0
.	PMC3820476	13635	13636	O	-1	-1	0


	PMC3820476	13636	13638	O	-1	-1	0

submit	PMC3820476	13638	13644	O	-1	-1	0
your	PMC3820476	13645	13649	O	-1	-1	0
manuscript	PMC3820476	13650	13660	O	-1	-1	0

|	PMC3820476	13661	13662	O	-1	-1	0

www.dovepress.com	PMC3820476	13663	13680	O	-1	-1	0


	PMC3820476	13680	13682	O	-1	-1	0

Dovepress	PMC3820476	13682	13691	O	-1	-1	0


	PMC3820476	13691	13693	O	-1	-1	0
41	PMC3820476	13693	13695	O	-1	-1	0


	PMC3820476	13695	13697	O	-1	-1	0

Dovepress	PMC3820476	13697	13706	O	-1	-1	0


	PMC3820476	13706	13708	O	-1	-1	0

Ording	PMC3820476	13708	13714	O	-1	-1	0
et	PMC3820476	13715	13717	O	-1	-1	0
al	PMC3820476	13718	13720	O	-1	-1	0


	PMC3820476	13720	13722	O	-1	-1	0
Table	PMC3820476	13722	13727	O	-1	-1	0
3	PMC3820476	13728	13729	O	-1	-1	0
One-	PMC3820476	13730	13734	O	-1	-1	0
and	PMC3820476	13735	13738	O	-1	-1	0
5-year	PMC3820476	13739	13745	O	-1	-1	0
survival	PMC3820476	13746	13754	O	-1	-1	0
and	PMC3820476	13755	13758	O	-1	-1	0
relative	PMC3820476	13759	13767	O	-1	-1	0
mortality	PMC3820476	13768	13777	O	-1	-1	0
for	PMC3820476	13778	13781	O	-1	-1	0
patients	PMC3820476	13782	13790	O	-1	-1	0
diagnosed	PMC3820476	13791	13800	O	-1	-1	0
with	PMC3820476	13801	13805	O	-1	-1	0
breast	PMC3820476	13806	13812	O	-1	-1	0
cancer	PMC3820476	13813	13819	O	-1	-1	0
in	PMC3820476	13820	13822	O	-1	-1	0
four	PMC3820476	13823	13827	O	-1	-1	0
calendar	PMC3820476	13828	13836	O	-1	-1	0
time	PMC3820476	13837	13841	O	-1	-1	0
periods	PMC3820476	13842	13849	O	-1	-1	0
stratified	PMC3820476	13850	13860	O	-1	-1	0
by	PMC3820476	13861	13863	O	-1	-1	0
Charlson	PMC3820476	13864	13872	O	-1	-1	0
Comorbidity	PMC3820476	13873	13884	O	-1	-1	0
Index	PMC3820476	13885	13890	O	-1	-1	0
score	PMC3820476	13891	13896	O	-1	-1	0

Year	PMC3820476	13897	13901	O	-1	-1	0
of	PMC3820476	13902	13904	O	-1	-1	0
diagnosis	PMC3820476	13905	13914	O	-1	-1	0

2000–2002	PMC3820476	13915	13924	O	-1	-1	0

1	PMC3820476	13925	13926	O	-1	-1	0
year	PMC3820476	13927	13931	O	-1	-1	0

Survival	PMC3820476	13932	13940	O	-1	-1	0

Adjusted	PMC3820476	13941	13949	O	-1	-1	0
MRRa	PMC3820476	13950	13954	O	-1	-1	0

5	PMC3820476	13955	13956	O	-1	-1	0
years	PMC3820476	13957	13962	O	-1	-1	0

Survival	PMC3820476	13963	13971	O	-1	-1	0

Adjusted	PMC3820476	13972	13980	O	-1	-1	0
MRRa	PMC3820476	13981	13985	O	-1	-1	0

2003–2005	PMC3820476	13986	13995	O	-1	-1	0

1	PMC3820476	13996	13997	O	-1	-1	0
year	PMC3820476	13998	14002	O	-1	-1	0

Survival	PMC3820476	14003	14011	O	-1	-1	0

Adjusted	PMC3820476	14012	14020	O	-1	-1	0
MRRa	PMC3820476	14021	14025	O	-1	-1	0

5	PMC3820476	14026	14027	O	-1	-1	0
years	PMC3820476	14028	14033	O	-1	-1	0

Survival	PMC3820476	14034	14042	O	-1	-1	0

Adjusted	PMC3820476	14043	14051	O	-1	-1	0
MRRa	PMC3820476	14052	14056	O	-1	-1	0

2006–2008	PMC3820476	14057	14066	O	-1	-1	0

1	PMC3820476	14067	14068	O	-1	-1	0
year	PMC3820476	14069	14073	O	-1	-1	0

Survival	PMC3820476	14074	14082	O	-1	-1	0

Adjusted	PMC3820476	14083	14091	O	-1	-1	0
MRRa	PMC3820476	14092	14096	O	-1	-1	0

5	PMC3820476	14097	14098	O	-1	-1	0
years	PMC3820476	14099	14104	O	-1	-1	0

Survival	PMC3820476	14105	14113	O	-1	-1	0

Adjusted	PMC3820476	14114	14122	O	-1	-1	0
MRRa	PMC3820476	14123	14127	O	-1	-1	0
2009–2011	PMC3820476	14128	14137	O	-1	-1	0

1	PMC3820476	14138	14139	O	-1	-1	0
year	PMC3820476	14140	14144	O	-1	-1	0

Survival	PMC3820476	14145	14153	O	-1	-1	0

Adjusted	PMC3820476	14154	14162	O	-1	-1	0
MRRa	PMC3820476	14163	14167	O	-1	-1	0

5	PMC3820476	14168	14169	O	-1	-1	0
years	PMC3820476	14170	14175	O	-1	-1	0

Survival	PMC3820476	14176	14184	O	-1	-1	0

Adjusted	PMC3820476	14185	14193	O	-1	-1	0
MRRa	PMC3820476	14194	14198	O	-1	-1	0


	PMC3820476	14198	14200	O	-1	-1	0

Charlson	PMC3820476	14200	14208	O	-1	-1	0
comorbidity	PMC3820476	14209	14220	O	-1	-1	0
index	PMC3820476	14221	14226	O	-1	-1	0
score	PMC3820476	14227	14232	O	-1	-1	0

0	PMC3820476	14233	14234	O	-1	-1	0


	PMC3820476	14234	14236	O	-1	-1	0

1–2	PMC3820476	14236	14239	O	-1	-1	0


	PMC3820476	14239	14241	O	-1	-1	0

$	PMC3820476	14241	14242	O	-1	-1	0
3	PMC3820476	14242	14243	O	-1	-1	0


	PMC3820476	14243	14245	O	-1	-1	0
94	PMC3820476	14245	14247	O	-1	-1	0
%	PMC3820476	14247	14248	O	-1	-1	0
(	PMC3820476	14249	14250	O	-1	-1	0
93%–95	PMC3820476	14250	14256	O	-1	-1	0
%	PMC3820476	14256	14257	O	-1	-1	0
)	PMC3820476	14257	14258	O	-1	-1	0

1	PMC3820476	14259	14260	O	-1	-1	0

(	PMC3820476	14261	14262	O	-1	-1	0
reference	PMC3820476	14262	14271	O	-1	-1	0
)	PMC3820476	14271	14272	O	-1	-1	0


	PMC3820476	14272	14274	O	-1	-1	0

86	PMC3820476	14274	14276	O	-1	-1	0
%	PMC3820476	14276	14277	O	-1	-1	0
(	PMC3820476	14278	14279	O	-1	-1	0
82%–89	PMC3820476	14279	14285	O	-1	-1	0
%	PMC3820476	14285	14286	O	-1	-1	0
)	PMC3820476	14286	14287	O	-1	-1	0
1.8	PMC3820476	14288	14291	O	-1	-1	0

(	PMC3820476	14292	14293	O	-1	-1	0
1.3–2.6	PMC3820476	14293	14300	O	-1	-1	0
)	PMC3820476	14300	14301	O	-1	-1	0


	PMC3820476	14301	14303	O	-1	-1	0
62	PMC3820476	14303	14305	O	-1	-1	0
%	PMC3820476	14305	14306	O	-1	-1	0
(	PMC3820476	14307	14308	O	-1	-1	0
50%–73	PMC3820476	14308	14314	O	-1	-1	0
%	PMC3820476	14314	14315	O	-1	-1	0
)	PMC3820476	14315	14316	O	-1	-1	0
5.4	PMC3820476	14317	14320	O	-1	-1	0

(	PMC3820476	14321	14322	O	-1	-1	0
3.5–8.5	PMC3820476	14322	14329	O	-1	-1	0
)	PMC3820476	14329	14330	O	-1	-1	0


	PMC3820476	14330	14332	O	-1	-1	0
76	PMC3820476	14332	14334	O	-1	-1	0
%	PMC3820476	14334	14335	O	-1	-1	0
(	PMC3820476	14336	14337	O	-1	-1	0
74%–78	PMC3820476	14337	14343	O	-1	-1	0
%	PMC3820476	14343	14344	O	-1	-1	0
)	PMC3820476	14344	14345	O	-1	-1	0
1	PMC3820476	14346	14347	O	-1	-1	0

(	PMC3820476	14348	14349	O	-1	-1	0
reference	PMC3820476	14349	14358	O	-1	-1	0
)	PMC3820476	14358	14359	O	-1	-1	0


	PMC3820476	14359	14361	O	-1	-1	0

63	PMC3820476	14361	14363	O	-1	-1	0
%	PMC3820476	14363	14364	O	-1	-1	0
(	PMC3820476	14365	14366	O	-1	-1	0
57%–68	PMC3820476	14366	14372	O	-1	-1	0
%	PMC3820476	14372	14373	O	-1	-1	0
)	PMC3820476	14373	14374	O	-1	-1	0

1.4	PMC3820476	14375	14378	O	-1	-1	0

(	PMC3820476	14379	14380	O	-1	-1	0
1.1–1.7	PMC3820476	14380	14387	O	-1	-1	0
)	PMC3820476	14387	14388	O	-1	-1	0


	PMC3820476	14388	14390	O	-1	-1	0
25	PMC3820476	14390	14392	O	-1	-1	0
%	PMC3820476	14392	14393	O	-1	-1	0
(	PMC3820476	14394	14395	O	-1	-1	0
15%–35	PMC3820476	14395	14401	O	-1	-1	0
%	PMC3820476	14401	14402	O	-1	-1	0
)	PMC3820476	14402	14403	O	-1	-1	0

4.0	PMC3820476	14404	14407	O	-1	-1	0

(	PMC3820476	14408	14409	O	-1	-1	0
3.0–5.4	PMC3820476	14409	14416	O	-1	-1	0
)	PMC3820476	14416	14417	O	-1	-1	0


	PMC3820476	14417	14419	O	-1	-1	0
96	PMC3820476	14419	14421	O	-1	-1	0
%	PMC3820476	14421	14422	O	-1	-1	0
(	PMC3820476	14423	14424	O	-1	-1	0
95%–97	PMC3820476	14424	14430	O	-1	-1	0
%	PMC3820476	14430	14431	O	-1	-1	0
)	PMC3820476	14431	14432	O	-1	-1	0
1	PMC3820476	14433	14434	O	-1	-1	0

(	PMC3820476	14435	14436	O	-1	-1	0
reference	PMC3820476	14436	14445	O	-1	-1	0
)	PMC3820476	14445	14446	O	-1	-1	0


	PMC3820476	14446	14448	O	-1	-1	0

90	PMC3820476	14448	14450	O	-1	-1	0
%	PMC3820476	14450	14451	O	-1	-1	0
(	PMC3820476	14452	14453	O	-1	-1	0
87%–93	PMC3820476	14453	14459	O	-1	-1	0
%	PMC3820476	14459	14460	O	-1	-1	0
)	PMC3820476	14460	14461	O	-1	-1	0

1.6	PMC3820476	14462	14465	O	-1	-1	0

(	PMC3820476	14466	14467	O	-1	-1	0
1.1–2.5	PMC3820476	14467	14474	O	-1	-1	0
)	PMC3820476	14474	14475	O	-1	-1	0


	PMC3820476	14475	14477	O	-1	-1	0
77	PMC3820476	14477	14479	O	-1	-1	0
%	PMC3820476	14479	14480	O	-1	-1	0
(	PMC3820476	14481	14482	O	-1	-1	0
67%–85	PMC3820476	14482	14488	O	-1	-1	0
%	PMC3820476	14488	14489	O	-1	-1	0
)	PMC3820476	14489	14490	O	-1	-1	0

3.49	PMC3820476	14491	14495	O	-1	-1	0

(	PMC3820476	14496	14497	O	-1	-1	0
2.1–5.9	PMC3820476	14497	14504	O	-1	-1	0
)	PMC3820476	14504	14505	O	-1	-1	0


	PMC3820476	14505	14507	O	-1	-1	0
80	PMC3820476	14507	14509	O	-1	-1	0
%	PMC3820476	14509	14510	O	-1	-1	0
(	PMC3820476	14511	14512	O	-1	-1	0
78%–82	PMC3820476	14512	14518	O	-1	-1	0
%	PMC3820476	14518	14519	O	-1	-1	0
)	PMC3820476	14519	14520	O	-1	-1	0
1	PMC3820476	14521	14522	O	-1	-1	0

(	PMC3820476	14523	14524	O	-1	-1	0
reference	PMC3820476	14524	14533	O	-1	-1	0
)	PMC3820476	14533	14534	O	-1	-1	0


	PMC3820476	14534	14536	O	-1	-1	0

61	PMC3820476	14536	14538	O	-1	-1	0
%	PMC3820476	14538	14539	O	-1	-1	0
(	PMC3820476	14540	14541	O	-1	-1	0
56%–66	PMC3820476	14541	14547	O	-1	-1	0
%	PMC3820476	14547	14548	O	-1	-1	0
)	PMC3820476	14548	14549	O	-1	-1	0
1.7	PMC3820476	14550	14553	O	-1	-1	0
(	PMC3820476	14554	14555	O	-1	-1	0
1.3–2.0	PMC3820476	14555	14562	O	-1	-1	0
)	PMC3820476	14562	14563	O	-1	-1	0


	PMC3820476	14563	14565	O	-1	-1	0
43	PMC3820476	14565	14567	O	-1	-1	0
%	PMC3820476	14567	14568	O	-1	-1	0
(	PMC3820476	14569	14570	O	-1	-1	0
33%–53	PMC3820476	14570	14576	O	-1	-1	0
%	PMC3820476	14576	14577	O	-1	-1	0
)	PMC3820476	14577	14578	O	-1	-1	0
2.5	PMC3820476	14579	14582	O	-1	-1	0

(	PMC3820476	14583	14584	O	-1	-1	0
1.9–3.4	PMC3820476	14584	14591	O	-1	-1	0
)	PMC3820476	14591	14592	O	-1	-1	0


	PMC3820476	14592	14594	O	-1	-1	0
95	PMC3820476	14594	14596	O	-1	-1	0
%	PMC3820476	14596	14597	O	-1	-1	0
(	PMC3820476	14598	14599	O	-1	-1	0
94%–96	PMC3820476	14599	14605	O	-1	-1	0
%	PMC3820476	14605	14606	O	-1	-1	0
)	PMC3820476	14606	14607	O	-1	-1	0
1	PMC3820476	14608	14609	O	-1	-1	0

(	PMC3820476	14610	14611	O	-1	-1	0
reference	PMC3820476	14611	14620	O	-1	-1	0
)	PMC3820476	14620	14621	O	-1	-1	0


	PMC3820476	14621	14623	O	-1	-1	0

91	PMC3820476	14623	14625	O	-1	-1	0
%	PMC3820476	14625	14626	O	-1	-1	0
(	PMC3820476	14627	14628	O	-1	-1	0
88%–93	PMC3820476	14628	14634	O	-1	-1	0
%	PMC3820476	14634	14635	O	-1	-1	0
)	PMC3820476	14635	14636	O	-1	-1	0

1.4	PMC3820476	14637	14640	O	-1	-1	0

(	PMC3820476	14641	14642	O	-1	-1	0
0.9–2.0	PMC3820476	14642	14649	O	-1	-1	0
)	PMC3820476	14649	14650	O	-1	-1	0


	PMC3820476	14650	14652	O	-1	-1	0
75	PMC3820476	14652	14654	O	-1	-1	0
%	PMC3820476	14654	14655	O	-1	-1	0
(	PMC3820476	14656	14657	O	-1	-1	0
65%–82	PMC3820476	14657	14663	O	-1	-1	0
%	PMC3820476	14663	14664	O	-1	-1	0
)	PMC3820476	14664	14665	O	-1	-1	0

3.8	PMC3820476	14666	14669	O	-1	-1	0

(	PMC3820476	14670	14671	O	-1	-1	0
2.4–6.0	PMC3820476	14671	14678	O	-1	-1	0
)	PMC3820476	14678	14679	O	-1	-1	0


	PMC3820476	14679	14681	O	-1	-1	0
80	PMC3820476	14681	14683	O	-1	-1	0
%	PMC3820476	14683	14684	O	-1	-1	0
(	PMC3820476	14685	14686	O	-1	-1	0
78%–82%)b	PMC3820476	14686	14695	O	-1	-1	0
1	PMC3820476	14696	14697	O	-1	-1	0
(	PMC3820476	14698	14699	O	-1	-1	0
reference	PMC3820476	14699	14708	O	-1	-1	0
)	PMC3820476	14708	14709	O	-1	-1	0


	PMC3820476	14709	14711	O	-1	-1	0

62	PMC3820476	14711	14713	O	-1	-1	0
%	PMC3820476	14713	14714	O	-1	-1	0

(	PMC3820476	14715	14716	O	-1	-1	0
58%–67%)b	PMC3820476	14716	14725	O	-1	-1	0
1.6	PMC3820476	14726	14729	O	-1	-1	0

(	PMC3820476	14730	14731	O	-1	-1	0
1.3–1.9)b	PMC3820476	14731	14740	O	-1	-1	0


	PMC3820476	14740	14742	O	-1	-1	0

47	PMC3820476	14742	14744	O	-1	-1	0
%	PMC3820476	14744	14745	O	-1	-1	0

(	PMC3820476	14746	14747	O	-1	-1	0
37%–56%)b	PMC3820476	14747	14756	O	-1	-1	0
2.4	PMC3820476	14757	14760	O	-1	-1	0

(	PMC3820476	14761	14762	O	-1	-1	0
1.8–3.3)b	PMC3820476	14762	14771	O	-1	-1	0


	PMC3820476	14771	14773	O	-1	-1	0

97	PMC3820476	14773	14775	O	-1	-1	0
%	PMC3820476	14775	14776	O	-1	-1	0
(	PMC3820476	14777	14778	O	-1	-1	0
96%–98	PMC3820476	14778	14784	O	-1	-1	0
%	PMC3820476	14784	14785	O	-1	-1	0
)	PMC3820476	14785	14786	O	-1	-1	0
1	PMC3820476	14787	14788	O	-1	-1	0

(	PMC3820476	14789	14790	O	-1	-1	0
reference	PMC3820476	14790	14799	O	-1	-1	0
)	PMC3820476	14799	14800	O	-1	-1	0


	PMC3820476	14800	14802	O	-1	-1	0

92	PMC3820476	14802	14804	O	-1	-1	0
%	PMC3820476	14804	14805	O	-1	-1	0
(	PMC3820476	14806	14807	O	-1	-1	0
89%–94	PMC3820476	14807	14813	O	-1	-1	0
%	PMC3820476	14813	14814	O	-1	-1	0
)	PMC3820476	14814	14815	O	-1	-1	0

1.9	PMC3820476	14816	14819	O	-1	-1	0
(	PMC3820476	14820	14821	O	-1	-1	0
1.2–2.8	PMC3820476	14821	14828	O	-1	-1	0
)	PMC3820476	14828	14829	O	-1	-1	0


	PMC3820476	14829	14831	O	-1	-1	0
74	PMC3820476	14831	14833	O	-1	-1	0
%	PMC3820476	14833	14834	O	-1	-1	0
(	PMC3820476	14835	14836	O	-1	-1	0
64%–81	PMC3820476	14836	14842	O	-1	-1	0
%	PMC3820476	14842	14843	O	-1	-1	0
)	PMC3820476	14843	14844	O	-1	-1	0
5.7	PMC3820476	14845	14848	O	-1	-1	0
(	PMC3820476	14849	14850	O	-1	-1	0
3.6–9.2	PMC3820476	14850	14857	O	-1	-1	0
)	PMC3820476	14857	14858	O	-1	-1	0


	PMC3820476	14858	14860	O	-1	-1	0
83	PMC3820476	14860	14862	O	-1	-1	0
%	PMC3820476	14862	14863	O	-1	-1	0

(	PMC3820476	14864	14865	O	-1	-1	0
81%–84%)b	PMC3820476	14865	14874	O	-1	-1	0
1	PMC3820476	14875	14876	O	-1	-1	0
(	PMC3820476	14877	14878	O	-1	-1	0
reference	PMC3820476	14878	14887	O	-1	-1	0
)	PMC3820476	14887	14888	O	-1	-1	0


	PMC3820476	14888	14890	O	-1	-1	0

64	PMC3820476	14890	14892	O	-1	-1	0
%	PMC3820476	14892	14893	O	-1	-1	0
(	PMC3820476	14894	14895	O	-1	-1	0
59%–68%)b	PMC3820476	14895	14904	O	-1	-1	0
1.8	PMC3820476	14905	14908	O	-1	-1	0

(	PMC3820476	14909	14910	O	-1	-1	0
1.5–2.2)b	PMC3820476	14910	14919	O	-1	-1	0


	PMC3820476	14919	14921	O	-1	-1	0

50	PMC3820476	14921	14923	O	-1	-1	0
%	PMC3820476	14923	14924	O	-1	-1	0

(	PMC3820476	14925	14926	O	-1	-1	0
40%–59%)b	PMC3820476	14926	14935	O	-1	-1	0

2.7	PMC3820476	14936	14939	O	-1	-1	0

(	PMC3820476	14940	14941	O	-1	-1	0
2.0–3.6)b	PMC3820476	14941	14950	O	-1	-1	0


	PMC3820476	14950	14952	O	-1	-1	0
Notes	PMC3820476	14952	14957	O	-1	-1	0
:	PMC3820476	14957	14958	O	-1	-1	0

95	PMC3820476	14959	14961	O	-1	-1	0
%	PMC3820476	14961	14962	O	-1	-1	0
confidence	PMC3820476	14963	14973	O	-1	-1	0
intervals	PMC3820476	14974	14983	O	-1	-1	0
are	PMC3820476	14984	14987	O	-1	-1	0
presented	PMC3820476	14988	14997	O	-1	-1	0
in	PMC3820476	14998	15000	O	-1	-1	0
brackets	PMC3820476	15001	15009	O	-1	-1	0
.	PMC3820476	15009	15010	O	-1	-1	0

aAdjusted	PMC3820476	15011	15020	O	-1	-1	0
for	PMC3820476	15021	15024	O	-1	-1	0
differences	PMC3820476	15025	15036	O	-1	-1	0
in	PMC3820476	15037	15039	O	-1	-1	0
age	PMC3820476	15040	15043	O	-1	-1	0
;	PMC3820476	15043	15044	O	-1	-1	0
bpredicted	PMC3820476	15045	15055	O	-1	-1	0
values	PMC3820476	15056	15062	O	-1	-1	0
.	PMC3820476	15062	15063	O	-1	-1	0

Abbreviation	PMC3820476	15064	15076	O	-1	-1	0
:	PMC3820476	15076	15077	O	-1	-1	0
MRR	PMC3820476	15078	15081	O	-1	-1	0
,	PMC3820476	15081	15082	O	-1	-1	0
mortality	PMC3820476	15083	15092	O	-1	-1	0
rate	PMC3820476	15093	15097	O	-1	-1	0
ratio	PMC3820476	15098	15103	O	-1	-1	0
.	PMC3820476	15103	15104	O	-1	-1	0


	PMC3820476	15104	15106	O	-1	-1	0

Discussion	PMC3820476	15106	15116	O	-1	-1	0

This	PMC3820476	15117	15121	O	-1	-1	0
large	PMC3820476	15122	15127	O	-1	-1	0
,	PMC3820476	15127	15128	O	-1	-1	0
population	PMC3820476	15129	15139	O	-1	-1	0
-	PMC3820476	15139	15140	O	-1	-1	0
based	PMC3820476	15140	15145	O	-1	-1	0
study	PMC3820476	15146	15151	O	-1	-1	0
showed	PMC3820476	15152	15158	O	-1	-1	0
improved	PMC3820476	15159	15167	O	-1	-1	0

1-	PMC3820476	15168	15170	O	-1	-1	0

and	PMC3820476	15171	15174	O	-1	-1	0
5-year	PMC3820476	15175	15181	O	-1	-1	0
survival	PMC3820476	15182	15190	O	-1	-1	0
of	PMC3820476	15191	15193	O	-1	-1	0
breast	PMC3820476	15194	15200	O	-1	-1	0
cancer	PMC3820476	15201	15207	O	-1	-1	0
patients	PMC3820476	15208	15216	O	-1	-1	0
diagnosed	PMC3820476	15217	15226	O	-1	-1	0
in	PMC3820476	15227	15229	O	-1	-1	0
the	PMC3820476	15230	15233	O	-1	-1	0
Central	PMC3820476	15234	15241	B-Location	-1	-1	0
Denmark	PMC3820476	15242	15249	I-Location	-1	-1	0
Region	PMC3820476	15250	15256	I-Location	-1	-1	0
from	PMC3820476	15257	15261	O	-1	-1	0
2000	PMC3820476	15262	15266	O	-1	-1	0
through	PMC3820476	15267	15274	O	-1	-1	0
2011	PMC3820476	15275	15279	O	-1	-1	0
.	PMC3820476	15279	15280	O	-1	-1	0

Comorbidity	PMC3820476	15281	15292	O	-1	-1	0
was	PMC3820476	15293	15296	O	-1	-1	0
a	PMC3820476	15297	15298	O	-1	-1	0
strong	PMC3820476	15299	15305	O	-1	-1	0
predictor	PMC3820476	15306	15315	O	-1	-1	0
of	PMC3820476	15316	15318	O	-1	-1	0
breast	PMC3820476	15319	15325	O	-1	-1	0
cancer	PMC3820476	15326	15332	O	-1	-1	0
survival	PMC3820476	15333	15341	O	-1	-1	0
.	PMC3820476	15341	15342	O	-1	-1	0

Nonetheless	PMC3820476	15343	15354	O	-1	-1	0
,	PMC3820476	15354	15355	O	-1	-1	0
we	PMC3820476	15356	15358	O	-1	-1	0
observed	PMC3820476	15359	15367	O	-1	-1	0
marked	PMC3820476	15368	15374	O	-1	-1	0
improvements	PMC3820476	15375	15387	O	-1	-1	0
in	PMC3820476	15388	15390	O	-1	-1	0
survival	PMC3820476	15391	15399	O	-1	-1	0
for	PMC3820476	15400	15403	O	-1	-1	0
all	PMC3820476	15404	15407	O	-1	-1	0
comorbidity	PMC3820476	15408	15419	O	-1	-1	0
groups	PMC3820476	15420	15426	O	-1	-1	0
.	PMC3820476	15426	15427	O	-1	-1	0

This	PMC3820476	15428	15432	O	-1	-1	0
survival	PMC3820476	15433	15441	O	-1	-1	0
improvement	PMC3820476	15442	15453	O	-1	-1	0
over	PMC3820476	15454	15458	O	-1	-1	0
time	PMC3820476	15459	15463	O	-1	-1	0
was	PMC3820476	15464	15467	O	-1	-1	0
even	PMC3820476	15468	15472	O	-1	-1	0
seen	PMC3820476	15473	15477	O	-1	-1	0
among	PMC3820476	15478	15483	O	-1	-1	0
patients	PMC3820476	15484	15492	O	-1	-1	0
with	PMC3820476	15493	15497	O	-1	-1	0
the	PMC3820476	15498	15501	O	-1	-1	0
highest	PMC3820476	15502	15509	O	-1	-1	0
comorbidity	PMC3820476	15510	15521	O	-1	-1	0
burden	PMC3820476	15522	15528	O	-1	-1	0
(	PMC3820476	15529	15530	O	-1	-1	0
CCI	PMC3820476	15530	15533	O	-1	-1	0
scores	PMC3820476	15534	15540	O	-1	-1	0
3	PMC3820476	15541	15543	O	-1	-1	0
)	PMC3820476	15543	15544	O	-1	-1	0
,	PMC3820476	15544	15545	O	-1	-1	0
and	PMC3820476	15546	15549	O	-1	-1	0
corresponded	PMC3820476	15550	15562	O	-1	-1	0
to	PMC3820476	15563	15565	O	-1	-1	0
a	PMC3820476	15566	15567	O	-1	-1	0
decreased	PMC3820476	15568	15577	O	-1	-1	0
5-year	PMC3820476	15578	15584	O	-1	-1	0
mortality	PMC3820476	15585	15594	O	-1	-1	0
HR	PMC3820476	15595	15597	O	-1	-1	0
compared	PMC3820476	15598	15606	O	-1	-1	0
with	PMC3820476	15607	15611	O	-1	-1	0
patients	PMC3820476	15612	15620	O	-1	-1	0
with	PMC3820476	15621	15625	O	-1	-1	0
no	PMC3820476	15626	15628	O	-1	-1	0
comorbid	PMC3820476	15629	15637	O	-1	-1	0
diseases	PMC3820476	15638	15646	O	-1	-1	0
(	PMC3820476	15647	15648	O	-1	-1	0
CCI	PMC3820476	15648	15651	O	-1	-1	0
score	PMC3820476	15652	15657	O	-1	-1	0
=	PMC3820476	15658	15659	O	-1	-1	0
0	PMC3820476	15660	15661	O	-1	-1	0
)	PMC3820476	15661	15662	O	-1	-1	0
.	PMC3820476	15662	15663	O	-1	-1	0

42	PMC3820476	15664	15666	O	-1	-1	0


	PMC3820476	15666	15668	O	-1	-1	0
submit	PMC3820476	15668	15674	O	-1	-1	0
your	PMC3820476	15675	15679	O	-1	-1	0
manuscript	PMC3820476	15680	15690	O	-1	-1	0
|	PMC3820476	15691	15692	O	-1	-1	0

www.dovepress.com	PMC3820476	15693	15710	O	-1	-1	0


	PMC3820476	15710	15712	O	-1	-1	0

Dovepress	PMC3820476	15712	15721	O	-1	-1	0


	PMC3820476	15721	15723	O	-1	-1	0

Our	PMC3820476	15723	15726	O	-1	-1	0
study	PMC3820476	15727	15732	O	-1	-1	0
has	PMC3820476	15733	15736	O	-1	-1	0
both	PMC3820476	15737	15741	O	-1	-1	0
strengths	PMC3820476	15742	15751	O	-1	-1	0
and	PMC3820476	15752	15755	O	-1	-1	0
weaknesses	PMC3820476	15756	15766	O	-1	-1	0
.	PMC3820476	15766	15767	O	-1	-1	0

We	PMC3820476	15768	15770	O	-1	-1	0
used	PMC3820476	15771	15775	O	-1	-1	0
nationwide	PMC3820476	15776	15786	O	-1	-1	0
administrative	PMC3820476	15787	15801	O	-1	-1	0
and	PMC3820476	15802	15805	O	-1	-1	0
medical	PMC3820476	15806	15813	O	-1	-1	0
registries	PMC3820476	15814	15824	O	-1	-1	0
with	PMC3820476	15825	15829	O	-1	-1	0
prospectively	PMC3820476	15830	15843	O	-1	-1	0
collected	PMC3820476	15844	15853	O	-1	-1	0
data	PMC3820476	15854	15858	O	-1	-1	0
to	PMC3820476	15859	15861	O	-1	-1	0
identify	PMC3820476	15862	15870	O	-1	-1	0
breast	PMC3820476	15871	15877	O	-1	-1	0
cancer	PMC3820476	15878	15884	O	-1	-1	0
patients	PMC3820476	15885	15893	O	-1	-1	0
,	PMC3820476	15893	15894	O	-1	-1	0
comorbid	PMC3820476	15895	15903	O	-1	-1	0
diseases	PMC3820476	15904	15912	O	-1	-1	0
,	PMC3820476	15912	15913	O	-1	-1	0
and	PMC3820476	15914	15917	O	-1	-1	0
vital	PMC3820476	15918	15923	O	-1	-1	0
status	PMC3820476	15924	15930	O	-1	-1	0
,	PMC3820476	15930	15931	O	-1	-1	0
thereby	PMC3820476	15932	15939	O	-1	-1	0
avoiding	PMC3820476	15940	15948	O	-1	-1	0
selection	PMC3820476	15949	15958	O	-1	-1	0
bias	PMC3820476	15959	15963	O	-1	-1	0
and	PMC3820476	15964	15967	O	-1	-1	0
loss	PMC3820476	15968	15972	O	-1	-1	0
to	PMC3820476	15973	15975	O	-1	-1	0
follow	PMC3820476	15976	15982	O	-1	-1	0
-	PMC3820476	15982	15983	O	-1	-1	0
up	PMC3820476	15983	15985	O	-1	-1	0
.	PMC3820476	15985	15986	O	-1	-1	0

We	PMC3820476	15987	15989	O	-1	-1	0
obtained	PMC3820476	15990	15998	O	-1	-1	0
our	PMC3820476	15999	16002	O	-1	-1	0
information	PMC3820476	16003	16014	O	-1	-1	0
on	PMC3820476	16015	16017	O	-1	-1	0
breast	PMC3820476	16018	16024	O	-1	-1	0
cancer	PMC3820476	16025	16031	O	-1	-1	0
diagnoses	PMC3820476	16032	16041	O	-1	-1	0
from	PMC3820476	16042	16046	O	-1	-1	0
the	PMC3820476	16047	16050	O	-1	-1	0
NRP	PMC3820476	16051	16054	O	-1	-1	0
,	PMC3820476	16054	16055	O	-1	-1	0
which	PMC3820476	16056	16061	O	-1	-1	0
is	PMC3820476	16062	16064	O	-1	-1	0
regularly	PMC3820476	16065	16074	O	-1	-1	0
updated	PMC3820476	16075	16082	O	-1	-1	0
,	PMC3820476	16082	16083	O	-1	-1	0
allowing	PMC3820476	16084	16092	O	-1	-1	0
us	PMC3820476	16093	16095	O	-1	-1	0
to	PMC3820476	16096	16098	O	-1	-1	0
include	PMC3820476	16099	16106	O	-1	-1	0
the	PMC3820476	16107	16110	O	-1	-1	0
newest	PMC3820476	16111	16117	O	-1	-1	0
available	PMC3820476	16118	16127	O	-1	-1	0
data	PMC3820476	16128	16132	O	-1	-1	0
on	PMC3820476	16133	16135	O	-1	-1	0
breast	PMC3820476	16136	16142	O	-1	-1	0
cancer	PMC3820476	16143	16149	O	-1	-1	0
cases	PMC3820476	16150	16155	O	-1	-1	0
in	PMC3820476	16156	16158	O	-1	-1	0
Denmark	PMC3820476	16159	16166	B-Location	-1	-1	0
.	PMC3820476	16166	16167	O	-1	-1	0

Moreover	PMC3820476	16168	16176	O	-1	-1	0
,	PMC3820476	16176	16177	O	-1	-1	0
the	PMC3820476	16178	16181	O	-1	-1	0
validity	PMC3820476	16182	16190	O	-1	-1	0
of	PMC3820476	16191	16193	O	-1	-1	0
breast	PMC3820476	16194	16200	O	-1	-1	0
cancer	PMC3820476	16201	16207	O	-1	-1	0
diagnoses	PMC3820476	16208	16217	O	-1	-1	0
recorded	PMC3820476	16218	16226	O	-1	-1	0
in	PMC3820476	16227	16229	O	-1	-1	0
the	PMC3820476	16230	16233	O	-1	-1	0
NRP	PMC3820476	16234	16237	O	-1	-1	0
is	PMC3820476	16238	16240	O	-1	-1	0
high.20	PMC3820476	16241	16248	O	-1	-1	0

We	PMC3820476	16249	16251	O	-1	-1	0
used	PMC3820476	16252	16256	O	-1	-1	0
the	PMC3820476	16257	16260	O	-1	-1	0
CCI	PMC3820476	16261	16264	O	-1	-1	0
as	PMC3820476	16265	16267	O	-1	-1	0
a	PMC3820476	16268	16269	O	-1	-1	0
measure	PMC3820476	16270	16277	O	-1	-1	0
of	PMC3820476	16278	16280	O	-1	-1	0
the	PMC3820476	16281	16284	O	-1	-1	0
comorbidity	PMC3820476	16285	16296	O	-1	-1	0
burden	PMC3820476	16297	16303	O	-1	-1	0
.	PMC3820476	16303	16304	O	-1	-1	0

This	PMC3820476	16305	16309	O	-1	-1	0
index	PMC3820476	16310	16315	O	-1	-1	0
has	PMC3820476	16316	16319	O	-1	-1	0
been	PMC3820476	16320	16324	O	-1	-1	0
validated	PMC3820476	16325	16334	O	-1	-1	0
as	PMC3820476	16335	16337	O	-1	-1	0
a	PMC3820476	16338	16339	O	-1	-1	0
predictor	PMC3820476	16340	16349	O	-1	-1	0
of	PMC3820476	16350	16352	O	-1	-1	0
mortality	PMC3820476	16353	16362	O	-1	-1	0
in	PMC3820476	16363	16365	O	-1	-1	0
breast	PMC3820476	16366	16372	O	-1	-1	0
cancer	PMC3820476	16373	16379	O	-1	-1	0
patients	PMC3820476	16380	16388	O	-1	-1	0
and	PMC3820476	16389	16392	O	-1	-1	0
is	PMC3820476	16393	16395	O	-1	-1	0
often	PMC3820476	16396	16401	O	-1	-1	0
used	PMC3820476	16402	16406	O	-1	-1	0
in	PMC3820476	16407	16409	O	-1	-1	0
breast	PMC3820476	16410	16416	O	-1	-1	0
cancer	PMC3820476	16417	16423	O	-1	-1	0
research	PMC3820476	16424	16432	O	-1	-1	0
,	PMC3820476	16432	16433	O	-1	-1	0
allowing	PMC3820476	16434	16442	O	-1	-1	0
for	PMC3820476	16443	16446	O	-1	-1	0
comparison	PMC3820476	16447	16457	O	-1	-1	0
of	PMC3820476	16458	16460	O	-1	-1	0
our	PMC3820476	16461	16464	O	-1	-1	0
results	PMC3820476	16465	16472	O	-1	-1	0
with	PMC3820476	16473	16477	O	-1	-1	0
previous	PMC3820476	16478	16486	O	-1	-1	0
studies	PMC3820476	16487	16494	O	-1	-1	0
.	PMC3820476	16494	16495	O	-1	-1	0

The	PMC3820476	16496	16499	O	-1	-1	0
positive	PMC3820476	16500	16508	O	-1	-1	0
predictive	PMC3820476	16509	16519	O	-1	-1	0
values	PMC3820476	16520	16526	O	-1	-1	0
of	PMC3820476	16527	16529	O	-1	-1	0
diseases	PMC3820476	16530	16538	O	-1	-1	0
included	PMC3820476	16539	16547	O	-1	-1	0
in	PMC3820476	16548	16550	O	-1	-1	0
the	PMC3820476	16551	16554	O	-1	-1	0
CCI	PMC3820476	16555	16558	O	-1	-1	0
collected	PMC3820476	16559	16568	O	-1	-1	0
from	PMC3820476	16569	16573	O	-1	-1	0
the	PMC3820476	16574	16577	O	-1	-1	0
NRP	PMC3820476	16578	16581	O	-1	-1	0
have	PMC3820476	16582	16586	O	-1	-1	0
been	PMC3820476	16587	16591	O	-1	-1	0
shown	PMC3820476	16592	16597	O	-1	-1	0
to	PMC3820476	16598	16600	O	-1	-1	0
be	PMC3820476	16601	16603	O	-1	-1	0
high.21	PMC3820476	16604	16611	O	-1	-1	0

However	PMC3820476	16612	16619	O	-1	-1	0
,	PMC3820476	16619	16620	O	-1	-1	0
as	PMC3820476	16621	16623	O	-1	-1	0
outpatient	PMC3820476	16624	16634	O	-1	-1	0
diagnoses	PMC3820476	16635	16644	O	-1	-1	0
were	PMC3820476	16645	16649	O	-1	-1	0
first	PMC3820476	16650	16655	O	-1	-1	0
added	PMC3820476	16656	16661	O	-1	-1	0
to	PMC3820476	16662	16664	O	-1	-1	0
the	PMC3820476	16665	16668	O	-1	-1	0
NRP	PMC3820476	16669	16672	O	-1	-1	0
in	PMC3820476	16673	16675	O	-1	-1	0
1995	PMC3820476	16676	16680	O	-1	-1	0
,	PMC3820476	16680	16681	O	-1	-1	0
our	PMC3820476	16682	16685	O	-1	-1	0
study	PMC3820476	16686	16691	O	-1	-1	0
may	PMC3820476	16692	16695	O	-1	-1	0
be	PMC3820476	16696	16698	O	-1	-1	0
prone	PMC3820476	16699	16704	O	-1	-1	0
to	PMC3820476	16705	16707	O	-1	-1	0
nondifferential	PMC3820476	16708	16723	O	-1	-1	0
misclassification	PMC3820476	16724	16741	O	-1	-1	0
of	PMC3820476	16742	16744	O	-1	-1	0
the	PMC3820476	16745	16748	O	-1	-1	0
CCI	PMC3820476	16749	16752	O	-1	-1	0
score	PMC3820476	16753	16758	O	-1	-1	0
.	PMC3820476	16758	16759	O	-1	-1	0

Such	PMC3820476	16760	16764	O	-1	-1	0
misclassification	PMC3820476	16765	16782	O	-1	-1	0
would	PMC3820476	16783	16788	O	-1	-1	0
result	PMC3820476	16789	16795	O	-1	-1	0
if	PMC3820476	16796	16798	O	-1	-1	0
the	PMC3820476	16799	16802	O	-1	-1	0
inclusion	PMC3820476	16803	16812	O	-1	-1	0
of	PMC3820476	16813	16815	O	-1	-1	0
outpatient	PMC3820476	16816	16826	O	-1	-1	0
diagnoses	PMC3820476	16827	16836	O	-1	-1	0
increases	PMC3820476	16837	16846	O	-1	-1	0
the	PMC3820476	16847	16850	O	-1	-1	0
recorded	PMC3820476	16851	16859	O	-1	-1	0
comorbidity	PMC3820476	16860	16871	O	-1	-1	0
in	PMC3820476	16872	16874	O	-1	-1	0
the	PMC3820476	16875	16878	O	-1	-1	0
NRP	PMC3820476	16879	16882	O	-1	-1	0
and	PMC3820476	16883	16886	O	-1	-1	0
the	PMC3820476	16887	16890	O	-1	-1	0
measured	PMC3820476	16891	16899	O	-1	-1	0
comorbidity	PMC3820476	16900	16911	O	-1	-1	0
burden	PMC3820476	16912	16918	O	-1	-1	0
over	PMC3820476	16919	16923	O	-1	-1	0
time	PMC3820476	16924	16928	O	-1	-1	0
.	PMC3820476	16928	16929	O	-1	-1	0

Outpatient	PMC3820476	16930	16940	O	-1	-1	0
diagnoses	PMC3820476	16941	16950	O	-1	-1	0
are	PMC3820476	16951	16954	O	-1	-1	0
likely	PMC3820476	16955	16961	O	-1	-1	0
to	PMC3820476	16962	16964	O	-1	-1	0
be	PMC3820476	16965	16967	O	-1	-1	0
less	PMC3820476	16968	16972	O	-1	-1	0
severe	PMC3820476	16973	16979	O	-1	-1	0
than	PMC3820476	16980	16984	O	-1	-1	0
inpatient	PMC3820476	16985	16994	O	-1	-1	0
diagnoses	PMC3820476	16995	17004	O	-1	-1	0
,	PMC3820476	17004	17005	O	-1	-1	0
which	PMC3820476	17006	17011	O	-1	-1	0
may	PMC3820476	17012	17015	O	-1	-1	0
have	PMC3820476	17016	17020	O	-1	-1	0
contributed	PMC3820476	17021	17032	O	-1	-1	0
to	PMC3820476	17033	17035	O	-1	-1	0
the	PMC3820476	17036	17039	O	-1	-1	0
improvement	PMC3820476	17040	17051	O	-1	-1	0
in	PMC3820476	17052	17054	O	-1	-1	0
survival	PMC3820476	17055	17063	O	-1	-1	0
among	PMC3820476	17064	17069	O	-1	-1	0
patients	PMC3820476	17070	17078	O	-1	-1	0
with	PMC3820476	17079	17083	O	-1	-1	0
severe	PMC3820476	17084	17090	O	-1	-1	0
comorbidity	PMC3820476	17091	17102	O	-1	-1	0
.	PMC3820476	17102	17103	O	-1	-1	0

On	PMC3820476	17104	17106	O	-1	-1	0
the	PMC3820476	17107	17110	O	-1	-1	0
other	PMC3820476	17111	17116	O	-1	-1	0
hand	PMC3820476	17117	17121	O	-1	-1	0
,	PMC3820476	17121	17122	O	-1	-1	0
the	PMC3820476	17123	17126	O	-1	-1	0
effect	PMC3820476	17127	17133	O	-1	-1	0
of	PMC3820476	17134	17136	O	-1	-1	0
including	PMC3820476	17137	17146	O	-1	-1	0
outpatient	PMC3820476	17147	17157	O	-1	-1	0
diagnoses	PMC3820476	17158	17167	O	-1	-1	0
since	PMC3820476	17168	17173	O	-1	-1	0
1995	PMC3820476	17174	17178	O	-1	-1	0
should	PMC3820476	17179	17185	O	-1	-1	0
have	PMC3820476	17186	17190	O	-1	-1	0
resulted	PMC3820476	17191	17199	O	-1	-1	0
in	PMC3820476	17200	17202	O	-1	-1	0
a	PMC3820476	17203	17204	O	-1	-1	0
survival	PMC3820476	17205	17213	O	-1	-1	0
improvement	PMC3820476	17214	17225	O	-1	-1	0
before	PMC3820476	17226	17232	O	-1	-1	0
2011	PMC3820476	17233	17237	O	-1	-1	0
,	PMC3820476	17237	17238	O	-1	-1	0
which	PMC3820476	17239	17244	O	-1	-1	0
was	PMC3820476	17245	17248	O	-1	-1	0
not	PMC3820476	17249	17252	O	-1	-1	0
the	PMC3820476	17253	17256	O	-1	-1	0
case.5,14	PMC3820476	17257	17266	O	-1	-1	0

Furthermore	PMC3820476	17267	17278	O	-1	-1	0
,	PMC3820476	17278	17279	O	-1	-1	0
we	PMC3820476	17280	17282	O	-1	-1	0
lacked	PMC3820476	17283	17289	O	-1	-1	0
information	PMC3820476	17290	17301	O	-1	-1	0
on	PMC3820476	17302	17304	O	-1	-1	0
lifestyle	PMC3820476	17305	17314	O	-1	-1	0
-	PMC3820476	17314	17315	O	-1	-1	0
related	PMC3820476	17315	17322	O	-1	-1	0
risk	PMC3820476	17323	17327	O	-1	-1	0
factors	PMC3820476	17328	17335	O	-1	-1	0
(	PMC3820476	17336	17337	O	-1	-1	0
such	PMC3820476	17337	17341	O	-1	-1	0
as	PMC3820476	17342	17344	O	-1	-1	0
body	PMC3820476	17345	17349	O	-1	-1	0
mass	PMC3820476	17350	17354	O	-1	-1	0
index	PMC3820476	17355	17360	O	-1	-1	0
,	PMC3820476	17360	17361	O	-1	-1	0
smoking	PMC3820476	17362	17369	O	-1	-1	0
habits	PMC3820476	17370	17376	O	-1	-1	0
,	PMC3820476	17376	17377	O	-1	-1	0
and	PMC3820476	17378	17381	O	-1	-1	0
alcohol	PMC3820476	17382	17389	O	-1	-1	0
consumption	PMC3820476	17390	17401	O	-1	-1	0
)	PMC3820476	17401	17402	O	-1	-1	0
,	PMC3820476	17402	17403	O	-1	-1	0
breast	PMC3820476	17404	17410	O	-1	-1	0
cancer	PMC3820476	17411	17417	O	-1	-1	0
stage	PMC3820476	17418	17423	O	-1	-1	0
,	PMC3820476	17423	17424	O	-1	-1	0
cancer	PMC3820476	17425	17431	O	-1	-1	0
treatment	PMC3820476	17432	17441	O	-1	-1	0
,	PMC3820476	17441	17442	O	-1	-1	0
and	PMC3820476	17443	17446	O	-1	-1	0
medication	PMC3820476	17447	17457	O	-1	-1	0
prescribed	PMC3820476	17458	17468	O	-1	-1	0
for	PMC3820476	17469	17472	O	-1	-1	0
the	PMC3820476	17473	17476	O	-1	-1	0
comorbid	PMC3820476	17477	17485	O	-1	-1	0
diseases	PMC3820476	17486	17494	O	-1	-1	0
,	PMC3820476	17494	17495	O	-1	-1	0
which	PMC3820476	17496	17501	O	-1	-1	0
could	PMC3820476	17502	17507	O	-1	-1	0
all	PMC3820476	17508	17511	O	-1	-1	0
affect	PMC3820476	17512	17518	O	-1	-1	0
the	PMC3820476	17519	17522	O	-1	-1	0
mortality	PMC3820476	17523	17532	O	-1	-1	0
rate	PMC3820476	17533	17537	O	-1	-1	0
.	PMC3820476	17537	17538	O	-1	-1	0

We	PMC3820476	17539	17541	O	-1	-1	0
note	PMC3820476	17542	17546	O	-1	-1	0
relatively	PMC3820476	17547	17557	O	-1	-1	0
few	PMC3820476	17558	17561	O	-1	-1	0
patients	PMC3820476	17562	17570	O	-1	-1	0
with	PMC3820476	17571	17575	O	-1	-1	0
a	PMC3820476	17576	17577	O	-1	-1	0
CCI	PMC3820476	17578	17581	O	-1	-1	0
score	PMC3820476	17582	17587	O	-1	-1	0
$	PMC3820476	17588	17589	O	-1	-1	0
3	PMC3820476	17589	17590	O	-1	-1	0
,	PMC3820476	17590	17591	O	-1	-1	0
and	PMC3820476	17592	17595	O	-1	-1	0
estimates	PMC3820476	17596	17605	O	-1	-1	0
were	PMC3820476	17606	17610	O	-1	-1	0
therefore	PMC3820476	17611	17620	O	-1	-1	0
imprecise	PMC3820476	17621	17630	O	-1	-1	0
.	PMC3820476	17630	17631	O	-1	-1	0

Nonetheless	PMC3820476	17632	17643	O	-1	-1	0
,	PMC3820476	17643	17644	O	-1	-1	0
our	PMC3820476	17645	17648	O	-1	-1	0
findings	PMC3820476	17649	17657	O	-1	-1	0
are	PMC3820476	17658	17661	O	-1	-1	0
consistent	PMC3820476	17662	17672	O	-1	-1	0
with	PMC3820476	17673	17677	O	-1	-1	0
previous	PMC3820476	17678	17686	O	-1	-1	0
studies	PMC3820476	17687	17694	O	-1	-1	0
,	PMC3820476	17694	17695	O	-1	-1	0
which	PMC3820476	17696	17701	O	-1	-1	0
have	PMC3820476	17702	17706	O	-1	-1	0
indicated	PMC3820476	17707	17716	O	-1	-1	0
higher	PMC3820476	17717	17723	O	-1	-1	0
mortality	PMC3820476	17724	17733	O	-1	-1	0
among	PMC3820476	17734	17739	O	-1	-1	0
breast	PMC3820476	17740	17746	O	-1	-1	0
cancer	PMC3820476	17747	17753	O	-1	-1	0
patients	PMC3820476	17754	17762	O	-1	-1	0
with	PMC3820476	17763	17767	O	-1	-1	0
comorbidity	PMC3820476	17768	17779	O	-1	-1	0
compared	PMC3820476	17780	17788	O	-1	-1	0
with	PMC3820476	17789	17793	O	-1	-1	0
those	PMC3820476	17794	17799	O	-1	-1	0
without	PMC3820476	17800	17807	O	-1	-1	0

comorbidity.5,14	PMC3820476	17808	17824	O	-1	-1	0

There	PMC3820476	17825	17830	O	-1	-1	0
are	PMC3820476	17831	17834	O	-1	-1	0
several	PMC3820476	17835	17842	O	-1	-1	0
plausible	PMC3820476	17843	17852	O	-1	-1	0
explanations	PMC3820476	17853	17865	O	-1	-1	0
for	PMC3820476	17866	17869	O	-1	-1	0
this	PMC3820476	17870	17874	O	-1	-1	0
survival	PMC3820476	17875	17883	O	-1	-1	0
disparity	PMC3820476	17884	17893	O	-1	-1	0
.	PMC3820476	17893	17894	O	-1	-1	0

First	PMC3820476	17895	17900	O	-1	-1	0
,	PMC3820476	17900	17901	O	-1	-1	0
severe	PMC3820476	17902	17908	O	-1	-1	0
comorbidity	PMC3820476	17909	17920	O	-1	-1	0
could	PMC3820476	17921	17926	O	-1	-1	0
increase	PMC3820476	17927	17935	O	-1	-1	0
mortality	PMC3820476	17936	17945	O	-1	-1	0
independent	PMC3820476	17946	17957	O	-1	-1	0
of	PMC3820476	17958	17960	O	-1	-1	0
breast	PMC3820476	17961	17967	O	-1	-1	0
­cancer	PMC3820476	17968	17975	O	-1	-1	0
,	PMC3820476	17975	17976	O	-1	-1	0
which	PMC3820476	17977	17982	O	-1	-1	0
in	PMC3820476	17983	17985	O	-1	-1	0
itself	PMC3820476	17986	17992	O	-1	-1	0
has	PMC3820476	17993	17996	O	-1	-1	0
a	PMC3820476	17997	17998	O	-1	-1	0
good	PMC3820476	17999	18003	O	-1	-1	0
prognosis	PMC3820476	18004	18013	O	-1	-1	0
.	PMC3820476	18013	18014	O	-1	-1	0

Second	PMC3820476	18015	18021	O	-1	-1	0
,	PMC3820476	18021	18022	O	-1	-1	0
women	PMC3820476	18023	18028	O	-1	-1	0
with	PMC3820476	18029	18033	O	-1	-1	0
extensive	PMC3820476	18034	18043	O	-1	-1	0
comorbid	PMC3820476	18044	18052	O	-1	-1	0
disease	PMC3820476	18053	18060	O	-1	-1	0
may	PMC3820476	18061	18064	O	-1	-1	0
have	PMC3820476	18065	18069	O	-1	-1	0
their	PMC3820476	18070	18075	O	-1	-1	0
cancer	PMC3820476	18076	18082	O	-1	-1	0
diagnosed	PMC3820476	18083	18092	O	-1	-1	0
at	PMC3820476	18093	18095	O	-1	-1	0
a	PMC3820476	18096	18097	O	-1	-1	0
later	PMC3820476	18098	18103	O	-1	-1	0
stage	PMC3820476	18104	18109	O	-1	-1	0
because	PMC3820476	18110	18117	O	-1	-1	0
comorbidity	PMC3820476	18118	18129	O	-1	-1	0
may	PMC3820476	18130	18133	O	-1	-1	0
mask	PMC3820476	18134	18138	O	-1	-1	0
any	PMC3820476	18139	18142	O	-1	-1	0
evidence	PMC3820476	18143	18151	O	-1	-1	0
of	PMC3820476	18152	18154	O	-1	-1	0
an	PMC3820476	18155	18157	O	-1	-1	0
underlying	PMC3820476	18158	18168	O	-1	-1	0
cancer.22	PMC3820476	18169	18178	O	-1	-1	0
On	PMC3820476	18179	18181	O	-1	-1	0
the	PMC3820476	18182	18185	O	-1	-1	0
other	PMC3820476	18186	18191	O	-1	-1	0
hand	PMC3820476	18192	18196	O	-1	-1	0
,	PMC3820476	18196	18197	O	-1	-1	0
other	PMC3820476	18198	18203	O	-1	-1	0
studies	PMC3820476	18204	18211	O	-1	-1	0
have	PMC3820476	18212	18216	O	-1	-1	0
found	PMC3820476	18217	18222	O	-1	-1	0
a	PMC3820476	18223	18224	O	-1	-1	0
higher	PMC3820476	18225	18231	O	-1	-1	0
prevalence	PMC3820476	18232	18242	O	-1	-1	0
of	PMC3820476	18243	18245	O	-1	-1	0
comorbidity	PMC3820476	18246	18257	O	-1	-1	0
in	PMC3820476	18258	18260	O	-1	-1	0
earlier	PMC3820476	18261	18268	O	-1	-1	0
stages	PMC3820476	18269	18275	O	-1	-1	0
of	PMC3820476	18276	18278	O	-1	-1	0
breast	PMC3820476	18279	18285	O	-1	-1	0
cancer	PMC3820476	18286	18292	O	-1	-1	0
,	PMC3820476	18292	18293	O	-1	-1	0
probably	PMC3820476	18294	18302	O	-1	-1	0
because	PMC3820476	18303	18310	O	-1	-1	0
patients	PMC3820476	18311	18319	O	-1	-1	0
with	PMC3820476	18320	18324	O	-1	-1	0
comorbidity	PMC3820476	18325	18336	O	-1	-1	0
often	PMC3820476	18337	18342	O	-1	-1	0
require	PMC3820476	18343	18350	O	-1	-1	0
frequent	PMC3820476	18351	18359	O	-1	-1	0
medical	PMC3820476	18360	18367	O	-1	-1	0
care.23,24	PMC3820476	18368	18378	O	-1	-1	0
Third	PMC3820476	18379	18384	O	-1	-1	0
,	PMC3820476	18384	18385	O	-1	-1	0
treatment	PMC3820476	18386	18395	O	-1	-1	0
options	PMC3820476	18396	18403	O	-1	-1	0
may	PMC3820476	18404	18407	O	-1	-1	0
be	PMC3820476	18408	18410	O	-1	-1	0
restricted	PMC3820476	18411	18421	O	-1	-1	0
in	PMC3820476	18422	18424	O	-1	-1	0
patients	PMC3820476	18425	18433	O	-1	-1	0
with	PMC3820476	18434	18438	O	-1	-1	0
severe	PMC3820476	18439	18445	O	-1	-1	0
comorbidity	PMC3820476	18446	18457	O	-1	-1	0
,	PMC3820476	18457	18458	O	-1	-1	0
who	PMC3820476	18459	18462	O	-1	-1	0
may	PMC3820476	18463	18466	O	-1	-1	0
not	PMC3820476	18467	18470	O	-1	-1	0
tolerate	PMC3820476	18471	18479	O	-1	-1	0
aggressive	PMC3820476	18480	18490	O	-1	-1	0
cancer	PMC3820476	18491	18497	O	-1	-1	0
treatment.25,26	PMC3820476	18498	18513	O	-1	-1	0

Yet	PMC3820476	18514	18517	O	-1	-1	0
,	PMC3820476	18517	18518	O	-1	-1	0
in	PMC3820476	18519	18521	O	-1	-1	0
contrast	PMC3820476	18522	18530	O	-1	-1	0
to	PMC3820476	18531	18533	O	-1	-1	0
a	PMC3820476	18534	18535	O	-1	-1	0
recent	PMC3820476	18536	18542	O	-1	-1	0
Danish	PMC3820476	18543	18549	O	-1	-1	0
5-year	PMC3820476	18550	18556	O	-1	-1	0
follow	PMC3820476	18557	18563	O	-1	-1	0
-	PMC3820476	18563	18564	O	-1	-1	0
up	PMC3820476	18564	18566	O	-1	-1	0
of	PMC3820476	18567	18569	O	-1	-1	0
breast	PMC3820476	18570	18576	O	-1	-1	0
cancer	PMC3820476	18577	18583	O	-1	-1	0
patients	PMC3820476	18584	18592	O	-1	-1	0
diagnosed	PMC3820476	18593	18602	O	-1	-1	0
from	PMC3820476	18603	18607	O	-1	-1	0
1990	PMC3820476	18608	18612	O	-1	-1	0
to	PMC3820476	18613	18615	O	-1	-1	0
2004	PMC3820476	18616	18620	O	-1	-1	0
,	PMC3820476	18620	18621	O	-1	-1	0
which	PMC3820476	18622	18627	O	-1	-1	0
did	PMC3820476	18628	18631	O	-1	-1	0
Clinical	PMC3820476	18632	18640	O	-1	-1	0
Epidemiology	PMC3820476	18641	18653	O	-1	-1	0
2013:5	PMC3820476	18654	18660	O	-1	-1	0

(	PMC3820476	18661	18662	O	-1	-1	0
Suppl	PMC3820476	18662	18667	O	-1	-1	0
1	PMC3820476	18668	18669	O	-1	-1	0
)	PMC3820476	18669	18670	O	-1	-1	0


	PMC3820476	18670	18672	O	-1	-1	0

Dovepress	PMC3820476	18672	18681	O	-1	-1	0


	PMC3820476	18681	18683	O	-1	-1	0
Comorbidity	PMC3820476	18683	18694	O	-1	-1	0
and	PMC3820476	18695	18698	O	-1	-1	0
survival	PMC3820476	18699	18707	O	-1	-1	0
of	PMC3820476	18708	18710	O	-1	-1	0
Danish	PMC3820476	18711	18717	O	-1	-1	0
breast	PMC3820476	18718	18724	O	-1	-1	0
cancer	PMC3820476	18725	18731	O	-1	-1	0
patients	PMC3820476	18732	18740	O	-1	-1	0


	PMC3820476	18740	18742	O	-1	-1	0

Breast	PMC3820476	18742	18748	O	-1	-1	0
cancer	PMC3820476	18749	18755	O	-1	-1	0

A	PMC3820476	18756	18757	O	-1	-1	0

100	PMC3820476	18758	18761	O	-1	-1	0


	PMC3820476	18761	18763	O	-1	-1	0
Survival	PMC3820476	18763	18771	O	-1	-1	0
probability	PMC3820476	18772	18783	O	-1	-1	0
(	PMC3820476	18784	18785	O	-1	-1	0
%	PMC3820476	18785	18786	O	-1	-1	0
)	PMC3820476	18786	18787	O	-1	-1	0


	PMC3820476	18787	18789	O	-1	-1	0
90	PMC3820476	18789	18791	O	-1	-1	0

80	PMC3820476	18792	18794	O	-1	-1	0

70	PMC3820476	18795	18797	O	-1	-1	0

60	PMC3820476	18798	18800	O	-1	-1	0

50	PMC3820476	18801	18803	O	-1	-1	0

40	PMC3820476	18804	18806	O	-1	-1	0

30	PMC3820476	18807	18809	O	-1	-1	0

2000–2002	PMC3820476	18810	18819	O	-1	-1	0

2003–2005	PMC3820476	18820	18829	O	-1	-1	0

2006–2008	PMC3820476	18830	18839	O	-1	-1	0

2009–2011	PMC3820476	18840	18849	O	-1	-1	0


	PMC3820476	18849	18851	O	-1	-1	0

20	PMC3820476	18851	18853	O	-1	-1	0

10	PMC3820476	18854	18856	O	-1	-1	0


	PMC3820476	18856	18858	O	-1	-1	0

Predicted	PMC3820476	18858	18867	O	-1	-1	0

Predicted	PMC3820476	18868	18877	O	-1	-1	0

Predicted	PMC3820476	18878	18887	O	-1	-1	0


	PMC3820476	18887	18889	O	-1	-1	0
0	PMC3820476	18889	18890	O	-1	-1	0
0	PMC3820476	18891	18892	O	-1	-1	0


	PMC3820476	18892	18894	O	-1	-1	0

1	PMC3820476	18894	18895	O	-1	-1	0


	PMC3820476	18895	18897	O	-1	-1	0

2	PMC3820476	18897	18898	O	-1	-1	0


	PMC3820476	18898	18900	O	-1	-1	0

3	PMC3820476	18900	18901	O	-1	-1	0


	PMC3820476	18901	18903	O	-1	-1	0

4	PMC3820476	18903	18904	O	-1	-1	0


	PMC3820476	18904	18906	O	-1	-1	0

5	PMC3820476	18906	18907	O	-1	-1	0


	PMC3820476	18907	18909	O	-1	-1	0

6	PMC3820476	18909	18910	O	-1	-1	0


	PMC3820476	18910	18912	O	-1	-1	0

7	PMC3820476	18912	18913	O	-1	-1	0


	PMC3820476	18913	18915	O	-1	-1	0

8	PMC3820476	18915	18916	O	-1	-1	0


	PMC3820476	18916	18918	O	-1	-1	0

9	PMC3820476	18918	18919	O	-1	-1	0


	PMC3820476	18919	18921	O	-1	-1	0

10	PMC3820476	18921	18923	O	-1	-1	0


	PMC3820476	18923	18925	O	-1	-1	0

Years	PMC3820476	18925	18930	O	-1	-1	0
after	PMC3820476	18931	18936	O	-1	-1	0
diagnosis	PMC3820476	18937	18946	O	-1	-1	0

B	PMC3820476	18947	18948	O	-1	-1	0

100	PMC3820476	18949	18952	O	-1	-1	0

90	PMC3820476	18953	18955	O	-1	-1	0


	PMC3820476	18955	18957	O	-1	-1	0

2000–2002	PMC3820476	18957	18966	O	-1	-1	0

2003–2005	PMC3820476	18967	18976	O	-1	-1	0

2006–2008	PMC3820476	18977	18986	O	-1	-1	0

2009–2011	PMC3820476	18987	18996	O	-1	-1	0


	PMC3820476	18996	18998	O	-1	-1	0

Survival	PMC3820476	18998	19006	O	-1	-1	0
probability	PMC3820476	19007	19018	O	-1	-1	0
(	PMC3820476	19019	19020	O	-1	-1	0
%	PMC3820476	19020	19021	O	-1	-1	0
)	PMC3820476	19021	19022	O	-1	-1	0


	PMC3820476	19022	19024	O	-1	-1	0
80	PMC3820476	19024	19026	O	-1	-1	0


	PMC3820476	19026	19028	O	-1	-1	0

Predicted	PMC3820476	19028	19037	O	-1	-1	0

Predicted	PMC3820476	19038	19047	O	-1	-1	0

Predicted	PMC3820476	19048	19057	O	-1	-1	0


	PMC3820476	19057	19059	O	-1	-1	0
70	PMC3820476	19059	19061	O	-1	-1	0

60	PMC3820476	19062	19064	O	-1	-1	0

50	PMC3820476	19065	19067	O	-1	-1	0

40	PMC3820476	19068	19070	O	-1	-1	0

30	PMC3820476	19071	19073	O	-1	-1	0

20	PMC3820476	19074	19076	O	-1	-1	0

10	PMC3820476	19077	19079	O	-1	-1	0

0	PMC3820476	19080	19081	O	-1	-1	0

0	PMC3820476	19082	19083	O	-1	-1	0


	PMC3820476	19083	19085	O	-1	-1	0

1	PMC3820476	19085	19086	O	-1	-1	0


	PMC3820476	19086	19088	O	-1	-1	0

2	PMC3820476	19088	19089	O	-1	-1	0


	PMC3820476	19089	19091	O	-1	-1	0

3	PMC3820476	19091	19092	O	-1	-1	0


	PMC3820476	19092	19094	O	-1	-1	0

4	PMC3820476	19094	19095	O	-1	-1	0


	PMC3820476	19095	19097	O	-1	-1	0

5	PMC3820476	19097	19098	O	-1	-1	0


	PMC3820476	19098	19100	O	-1	-1	0

6	PMC3820476	19100	19101	O	-1	-1	0


	PMC3820476	19101	19103	O	-1	-1	0

7	PMC3820476	19103	19104	O	-1	-1	0


	PMC3820476	19104	19106	O	-1	-1	0

8	PMC3820476	19106	19107	O	-1	-1	0


	PMC3820476	19107	19109	O	-1	-1	0

9	PMC3820476	19109	19110	O	-1	-1	0


	PMC3820476	19110	19112	O	-1	-1	0

10	PMC3820476	19112	19114	O	-1	-1	0


	PMC3820476	19114	19116	O	-1	-1	0

Years	PMC3820476	19116	19121	O	-1	-1	0
after	PMC3820476	19122	19127	O	-1	-1	0
diagnosis	PMC3820476	19128	19137	O	-1	-1	0


	PMC3820476	19137	19139	O	-1	-1	0
C	PMC3820476	19139	19140	O	-1	-1	0

100	PMC3820476	19141	19144	O	-1	-1	0

90	PMC3820476	19145	19147	O	-1	-1	0


	PMC3820476	19147	19149	O	-1	-1	0

2000–2002	PMC3820476	19149	19158	O	-1	-1	0

2003–2005	PMC3820476	19159	19168	O	-1	-1	0

2006–2008	PMC3820476	19169	19178	O	-1	-1	0

2009–2011	PMC3820476	19179	19188	O	-1	-1	0


	PMC3820476	19188	19190	O	-1	-1	0

Survival	PMC3820476	19190	19198	O	-1	-1	0
probability	PMC3820476	19199	19210	O	-1	-1	0
(	PMC3820476	19211	19212	O	-1	-1	0
%	PMC3820476	19212	19213	O	-1	-1	0
)	PMC3820476	19213	19214	O	-1	-1	0


	PMC3820476	19214	19216	O	-1	-1	0
80	PMC3820476	19216	19218	O	-1	-1	0


	PMC3820476	19218	19220	O	-1	-1	0

Predicted	PMC3820476	19220	19229	O	-1	-1	0

Predicted	PMC3820476	19230	19239	O	-1	-1	0

Predicted	PMC3820476	19240	19249	O	-1	-1	0


	PMC3820476	19249	19251	O	-1	-1	0
70	PMC3820476	19251	19253	O	-1	-1	0

60	PMC3820476	19254	19256	O	-1	-1	0

50	PMC3820476	19257	19259	O	-1	-1	0

40	PMC3820476	19260	19262	O	-1	-1	0

30	PMC3820476	19263	19265	O	-1	-1	0

20	PMC3820476	19266	19268	O	-1	-1	0

10	PMC3820476	19269	19271	O	-1	-1	0

0	PMC3820476	19272	19273	O	-1	-1	0

0	PMC3820476	19274	19275	O	-1	-1	0


	PMC3820476	19275	19277	O	-1	-1	0

1	PMC3820476	19277	19278	O	-1	-1	0


	PMC3820476	19278	19280	O	-1	-1	0

2	PMC3820476	19280	19281	O	-1	-1	0


	PMC3820476	19281	19283	O	-1	-1	0

3	PMC3820476	19283	19284	O	-1	-1	0


	PMC3820476	19284	19286	O	-1	-1	0

4	PMC3820476	19286	19287	O	-1	-1	0


	PMC3820476	19287	19289	O	-1	-1	0

5	PMC3820476	19289	19290	O	-1	-1	0


	PMC3820476	19290	19292	O	-1	-1	0

6	PMC3820476	19292	19293	O	-1	-1	0


	PMC3820476	19293	19295	O	-1	-1	0

7	PMC3820476	19295	19296	O	-1	-1	0


	PMC3820476	19296	19298	O	-1	-1	0

8	PMC3820476	19298	19299	O	-1	-1	0


	PMC3820476	19299	19301	O	-1	-1	0

9	PMC3820476	19301	19302	O	-1	-1	0


	PMC3820476	19302	19304	O	-1	-1	0

10	PMC3820476	19304	19306	O	-1	-1	0


	PMC3820476	19306	19308	O	-1	-1	0

Years	PMC3820476	19308	19313	O	-1	-1	0
after	PMC3820476	19314	19319	O	-1	-1	0
diagnosis	PMC3820476	19320	19329	O	-1	-1	0

Figure	PMC3820476	19330	19336	O	-1	-1	0
1	PMC3820476	19337	19338	O	-1	-1	0
Kaplan	PMC3820476	19339	19345	O	-1	-1	0
–	PMC3820476	19345	19346	O	-1	-1	0
Meier	PMC3820476	19346	19351	O	-1	-1	0
survival	PMC3820476	19352	19360	O	-1	-1	0
curves	PMC3820476	19361	19367	O	-1	-1	0
for	PMC3820476	19368	19371	O	-1	-1	0
breast	PMC3820476	19372	19378	O	-1	-1	0
cancer	PMC3820476	19379	19385	O	-1	-1	0
patients	PMC3820476	19386	19394	O	-1	-1	0
in	PMC3820476	19395	19397	O	-1	-1	0
four	PMC3820476	19398	19402	O	-1	-1	0
calendar	PMC3820476	19403	19411	O	-1	-1	0
time	PMC3820476	19412	19416	O	-1	-1	0
periods	PMC3820476	19417	19424	O	-1	-1	0
stratified	PMC3820476	19425	19435	O	-1	-1	0
by	PMC3820476	19436	19438	O	-1	-1	0
Charlson	PMC3820476	19439	19447	O	-1	-1	0
Comorbidity	PMC3820476	19448	19459	O	-1	-1	0
Index	PMC3820476	19460	19465	O	-1	-1	0
score	PMC3820476	19466	19471	O	-1	-1	0
.	PMC3820476	19471	19472	O	-1	-1	0

Notes	PMC3820476	19473	19478	O	-1	-1	0
:	PMC3820476	19478	19479	O	-1	-1	0
(	PMC3820476	19480	19481	O	-1	-1	0
A	PMC3820476	19481	19482	O	-1	-1	0
)	PMC3820476	19482	19483	O	-1	-1	0
Charlson	PMC3820476	19484	19492	O	-1	-1	0
score	PMC3820476	19493	19498	O	-1	-1	0
=	PMC3820476	19499	19500	O	-1	-1	0
0	PMC3820476	19501	19502	O	-1	-1	0
;	PMC3820476	19502	19503	O	-1	-1	0
(	PMC3820476	19504	19505	O	-1	-1	0
B	PMC3820476	19505	19506	O	-1	-1	0
)	PMC3820476	19506	19507	O	-1	-1	0

Charlson	PMC3820476	19508	19516	O	-1	-1	0
score	PMC3820476	19517	19522	O	-1	-1	0

=	PMC3820476	19523	19524	O	-1	-1	0

1–2	PMC3820476	19525	19528	O	-1	-1	0

;	PMC3820476	19528	19529	O	-1	-1	0
(	PMC3820476	19530	19531	O	-1	-1	0
C	PMC3820476	19531	19532	O	-1	-1	0
)	PMC3820476	19532	19533	O	-1	-1	0
Charlson	PMC3820476	19534	19542	O	-1	-1	0
score	PMC3820476	19543	19548	O	-1	-1	0
$	PMC3820476	19549	19550	O	-1	-1	0
3	PMC3820476	19550	19551	O	-1	-1	0
.	PMC3820476	19551	19552	O	-1	-1	0


	PMC3820476	19552	19554	O	-1	-1	0

Clinical	PMC3820476	19554	19562	O	-1	-1	0
Epidemiology	PMC3820476	19563	19575	O	-1	-1	0
2013:5	PMC3820476	19576	19582	O	-1	-1	0

(	PMC3820476	19583	19584	O	-1	-1	0
Suppl	PMC3820476	19584	19589	O	-1	-1	0
1	PMC3820476	19590	19591	O	-1	-1	0
)	PMC3820476	19591	19592	O	-1	-1	0


	PMC3820476	19592	19594	O	-1	-1	0
submit	PMC3820476	19594	19600	O	-1	-1	0
your	PMC3820476	19601	19605	O	-1	-1	0
manuscript	PMC3820476	19606	19616	O	-1	-1	0
|	PMC3820476	19617	19618	O	-1	-1	0

www.dovepress.com	PMC3820476	19619	19636	O	-1	-1	0


	PMC3820476	19636	19638	O	-1	-1	0

Dovepress	PMC3820476	19638	19647	O	-1	-1	0


	PMC3820476	19647	19649	O	-1	-1	0
43	PMC3820476	19649	19651	O	-1	-1	0


	PMC3820476	19651	19653	O	-1	-1	0

Ording	PMC3820476	19653	19659	O	-1	-1	0
et	PMC3820476	19660	19662	O	-1	-1	0
al	PMC3820476	19663	19665	O	-1	-1	0


	PMC3820476	19665	19667	O	-1	-1	0
not	PMC3820476	19667	19670	O	-1	-1	0
indicate	PMC3820476	19671	19679	O	-1	-1	0
any	PMC3820476	19680	19683	O	-1	-1	0
improvement	PMC3820476	19684	19695	O	-1	-1	0
in	PMC3820476	19696	19698	O	-1	-1	0
5-year	PMC3820476	19699	19705	O	-1	-1	0
survival	PMC3820476	19706	19714	O	-1	-1	0
for	PMC3820476	19715	19718	O	-1	-1	0
patients	PMC3820476	19719	19727	O	-1	-1	0
with	PMC3820476	19728	19732	O	-1	-1	0
a	PMC3820476	19733	19734	O	-1	-1	0
CCI	PMC3820476	19735	19738	O	-1	-1	0
score	PMC3820476	19739	19744	O	-1	-1	0
of	PMC3820476	19745	19747	O	-1	-1	0
$	PMC3820476	19748	19749	O	-1	-1	0
3,14	PMC3820476	19749	19753	O	-1	-1	0
we	PMC3820476	19754	19756	O	-1	-1	0
observed	PMC3820476	19757	19765	O	-1	-1	0
a	PMC3820476	19766	19767	O	-1	-1	0
marked	PMC3820476	19768	19774	O	-1	-1	0
improvement	PMC3820476	19775	19786	O	-1	-1	0
in	PMC3820476	19787	19789	O	-1	-1	0
predicted	PMC3820476	19790	19799	O	-1	-1	0
5-year	PMC3820476	19800	19806	O	-1	-1	0
survival	PMC3820476	19807	19815	O	-1	-1	0
for	PMC3820476	19816	19819	O	-1	-1	0
patients	PMC3820476	19820	19828	O	-1	-1	0
with	PMC3820476	19829	19833	O	-1	-1	0
a	PMC3820476	19834	19835	O	-1	-1	0
CCI	PMC3820476	19836	19839	O	-1	-1	0
score	PMC3820476	19840	19845	O	-1	-1	0
of	PMC3820476	19846	19848	O	-1	-1	0
$	PMC3820476	19849	19850	O	-1	-1	0
3	PMC3820476	19850	19851	O	-1	-1	0
during	PMC3820476	19852	19858	O	-1	-1	0
the	PMC3820476	19859	19862	O	-1	-1	0
calendar	PMC3820476	19863	19871	O	-1	-1	0
period	PMC3820476	19872	19878	O	-1	-1	0
from	PMC3820476	19879	19883	O	-1	-1	0
2000–2011	PMC3820476	19884	19893	O	-1	-1	0
.	PMC3820476	19893	19894	O	-1	-1	0

However	PMC3820476	19895	19902	O	-1	-1	0
,	PMC3820476	19902	19903	O	-1	-1	0
this	PMC3820476	19904	19908	O	-1	-1	0
may	PMC3820476	19909	19912	O	-1	-1	0
be	PMC3820476	19913	19915	O	-1	-1	0
due	PMC3820476	19916	19919	O	-1	-1	0
to	PMC3820476	19920	19922	O	-1	-1	0
chance	PMC3820476	19923	19929	O	-1	-1	0
,	PMC3820476	19929	19930	O	-1	-1	0
because	PMC3820476	19931	19938	O	-1	-1	0
the	PMC3820476	19939	19942	O	-1	-1	0
survival	PMC3820476	19943	19951	O	-1	-1	0
of	PMC3820476	19952	19954	O	-1	-1	0
the	PMC3820476	19955	19958	O	-1	-1	0
69	PMC3820476	19959	19961	O	-1	-1	0
patients	PMC3820476	19962	19970	O	-1	-1	0
diagnosed	PMC3820476	19971	19980	O	-1	-1	0
in	PMC3820476	19981	19983	O	-1	-1	0
the	PMC3820476	19984	19987	O	-1	-1	0
reference	PMC3820476	19988	19997	O	-1	-1	0
period	PMC3820476	19998	20004	O	-1	-1	0
(	PMC3820476	20005	20006	O	-1	-1	0
2000–2002	PMC3820476	20006	20015	O	-1	-1	0
)	PMC3820476	20015	20016	O	-1	-1	0
was	PMC3820476	20017	20020	O	-1	-1	0
relatively	PMC3820476	20021	20031	O	-1	-1	0
poor	PMC3820476	20032	20036	O	-1	-1	0
compared	PMC3820476	20037	20045	O	-1	-1	0
with	PMC3820476	20046	20050	O	-1	-1	0
the	PMC3820476	20051	20054	O	-1	-1	0
following	PMC3820476	20055	20064	O	-1	-1	0
calendar	PMC3820476	20065	20073	O	-1	-1	0
time	PMC3820476	20074	20078	O	-1	-1	0
periods	PMC3820476	20079	20086	O	-1	-1	0
,	PMC3820476	20086	20087	O	-1	-1	0
so	PMC3820476	20088	20090	O	-1	-1	0
it	PMC3820476	20091	20093	O	-1	-1	0
is	PMC3820476	20094	20096	O	-1	-1	0
difficult	PMC3820476	20097	20106	O	-1	-1	0
to	PMC3820476	20107	20109	O	-1	-1	0
make	PMC3820476	20110	20114	O	-1	-1	0
any	PMC3820476	20115	20118	O	-1	-1	0
conclusions	PMC3820476	20119	20130	O	-1	-1	0
on	PMC3820476	20131	20133	O	-1	-1	0
these	PMC3820476	20134	20139	O	-1	-1	0
findings	PMC3820476	20140	20148	O	-1	-1	0
.	PMC3820476	20148	20149	O	-1	-1	0

Introduction	PMC3820476	20150	20162	O	-1	-1	0
of	PMC3820476	20163	20165	O	-1	-1	0
the	PMC3820476	20166	20169	O	-1	-1	0
national	PMC3820476	20170	20178	O	-1	-1	0
Danish	PMC3820476	20179	20185	O	-1	-1	0
mammography	PMC3820476	20186	20197	O	-1	-1	0
screening	PMC3820476	20198	20207	O	-1	-1	0
program	PMC3820476	20208	20215	O	-1	-1	0
for	PMC3820476	20216	20219	O	-1	-1	0
women	PMC3820476	20220	20225	O	-1	-1	0

50–69	PMC3820476	20226	20231	O	-1	-1	0
years	PMC3820476	20232	20237	O	-1	-1	0
of	PMC3820476	20238	20240	O	-1	-1	0
age	PMC3820476	20241	20244	O	-1	-1	0
in	PMC3820476	20245	20247	O	-1	-1	0
2007	PMC3820476	20248	20252	O	-1	-1	0
is	PMC3820476	20253	20255	O	-1	-1	0
expected	PMC3820476	20256	20264	O	-1	-1	0
to	PMC3820476	20265	20267	O	-1	-1	0
result	PMC3820476	20268	20274	O	-1	-1	0
in	PMC3820476	20275	20277	O	-1	-1	0
an	PMC3820476	20278	20280	O	-1	-1	0
increased	PMC3820476	20281	20290	O	-1	-1	0
number	PMC3820476	20291	20297	O	-1	-1	0
of	PMC3820476	20298	20300	O	-1	-1	0
patients	PMC3820476	20301	20309	O	-1	-1	0
in	PMC3820476	20310	20312	O	-1	-1	0
this	PMC3820476	20313	20317	O	-1	-1	0
age	PMC3820476	20318	20321	O	-1	-1	0
group	PMC3820476	20322	20327	O	-1	-1	0
,	PMC3820476	20327	20328	O	-1	-1	0
which	PMC3820476	20329	20334	O	-1	-1	0
is	PMC3820476	20335	20337	O	-1	-1	0
consistent	PMC3820476	20338	20348	O	-1	-1	0
with	PMC3820476	20349	20353	O	-1	-1	0
our	PMC3820476	20354	20357	O	-1	-1	0
findings	PMC3820476	20358	20366	O	-1	-1	0
,	PMC3820476	20366	20367	O	-1	-1	0
as	PMC3820476	20368	20370	O	-1	-1	0
well	PMC3820476	20371	20375	O	-1	-1	0
as	PMC3820476	20376	20378	O	-1	-1	0
more	PMC3820476	20379	20383	O	-1	-1	0
patients	PMC3820476	20384	20392	O	-1	-1	0
diagnosed	PMC3820476	20393	20402	O	-1	-1	0
with	PMC3820476	20403	20407	O	-1	-1	0
early	PMC3820476	20408	20413	O	-1	-1	0
-	PMC3820476	20413	20414	O	-1	-1	0
stage	PMC3820476	20414	20419	O	-1	-1	0
breast	PMC3820476	20420	20426	O	-1	-1	0
cancer	PMC3820476	20427	20433	O	-1	-1	0
and	PMC3820476	20434	20437	O	-1	-1	0
thereby	PMC3820476	20438	20445	O	-1	-1	0
in	PMC3820476	20446	20448	O	-1	-1	0
need	PMC3820476	20449	20453	O	-1	-1	0
of	PMC3820476	20454	20456	O	-1	-1	0
less	PMC3820476	20457	20461	O	-1	-1	0
extensive	PMC3820476	20462	20471	O	-1	-1	0
treatment	PMC3820476	20472	20481	O	-1	-1	0
,	PMC3820476	20481	20482	O	-1	-1	0
since	PMC3820476	20483	20488	O	-1	-1	0
less	PMC3820476	20489	20493	O	-1	-1	0
extensive	PMC3820476	20494	20503	O	-1	-1	0
treatment	PMC3820476	20504	20513	O	-1	-1	0
is	PMC3820476	20514	20516	O	-1	-1	0
well	PMC3820476	20517	20521	O	-1	-1	0
tolerated	PMC3820476	20522	20531	O	-1	-1	0
regardless	PMC3820476	20532	20542	O	-1	-1	0
of	PMC3820476	20543	20545	O	-1	-1	0
comorbidity	PMC3820476	20546	20557	O	-1	-1	0
level	PMC3820476	20558	20563	O	-1	-1	0
.	PMC3820476	20563	20564	O	-1	-1	0

This	PMC3820476	20565	20569	O	-1	-1	0
may	PMC3820476	20570	20573	O	-1	-1	0
decrease	PMC3820476	20574	20582	O	-1	-1	0
the	PMC3820476	20583	20586	O	-1	-1	0
survival	PMC3820476	20587	20595	O	-1	-1	0
gap	PMC3820476	20596	20599	O	-1	-1	0
related	PMC3820476	20600	20607	O	-1	-1	0
to	PMC3820476	20608	20610	O	-1	-1	0
comorbidity	PMC3820476	20611	20622	O	-1	-1	0
.	PMC3820476	20622	20623	O	-1	-1	0

Although	PMC3820476	20624	20632	O	-1	-1	0
comorbidity	PMC3820476	20633	20644	O	-1	-1	0
is	PMC3820476	20645	20647	O	-1	-1	0
associated	PMC3820476	20648	20658	O	-1	-1	0
with	PMC3820476	20659	20663	O	-1	-1	0
a	PMC3820476	20664	20665	O	-1	-1	0
poorer	PMC3820476	20666	20672	O	-1	-1	0
prognosis	PMC3820476	20673	20682	O	-1	-1	0
in	PMC3820476	20683	20685	O	-1	-1	0
breast	PMC3820476	20686	20692	O	-1	-1	0
cancer	PMC3820476	20693	20699	O	-1	-1	0
,	PMC3820476	20699	20700	O	-1	-1	0
we	PMC3820476	20701	20703	O	-1	-1	0
observed	PMC3820476	20704	20712	O	-1	-1	0
a	PMC3820476	20713	20714	O	-1	-1	0
modest	PMC3820476	20715	20721	O	-1	-1	0
improvement	PMC3820476	20722	20733	O	-1	-1	0
in	PMC3820476	20734	20736	O	-1	-1	0
survival	PMC3820476	20737	20745	O	-1	-1	0
,	PMC3820476	20745	20746	O	-1	-1	0
which	PMC3820476	20747	20752	O	-1	-1	0
may	PMC3820476	20753	20756	O	-1	-1	0
suggest	PMC3820476	20757	20764	O	-1	-1	0
improved	PMC3820476	20765	20773	O	-1	-1	0
management	PMC3820476	20774	20784	O	-1	-1	0
of	PMC3820476	20785	20787	O	-1	-1	0
breast	PMC3820476	20788	20794	O	-1	-1	0
cancer	PMC3820476	20795	20801	O	-1	-1	0
patients	PMC3820476	20802	20810	O	-1	-1	0
with	PMC3820476	20811	20815	O	-1	-1	0
comorbidity	PMC3820476	20816	20827	O	-1	-1	0
over	PMC3820476	20828	20832	O	-1	-1	0
time	PMC3820476	20833	20837	O	-1	-1	0
.	PMC3820476	20837	20838	O	-1	-1	0


	PMC3820476	20838	20840	O	-1	-1	0

Acknowledgments	PMC3820476	20840	20855	O	-1	-1	0

Cancer	PMC3820476	20856	20862	O	-1	-1	0
analyses	PMC3820476	20863	20871	O	-1	-1	0
in	PMC3820476	20872	20874	O	-1	-1	0
the	PMC3820476	20875	20878	O	-1	-1	0
Central	PMC3820476	20879	20886	O	-1	-1	0
Denmark	PMC3820476	20887	20894	O	-1	-1	0
Region	PMC3820476	20895	20901	O	-1	-1	0
were	PMC3820476	20902	20906	O	-1	-1	0
conducted	PMC3820476	20907	20916	O	-1	-1	0
as	PMC3820476	20917	20919	O	-1	-1	0
part	PMC3820476	20920	20924	O	-1	-1	0
of	PMC3820476	20925	20927	O	-1	-1	0
the	PMC3820476	20928	20931	O	-1	-1	0
Aarhus	PMC3820476	20932	20938	O	-1	-1	0
University	PMC3820476	20939	20949	O	-1	-1	0
Disease	PMC3820476	20950	20957	O	-1	-1	0
Epidemiology	PMC3820476	20958	20970	O	-1	-1	0
and	PMC3820476	20971	20974	O	-1	-1	0
Outcomes	PMC3820476	20975	20983	O	-1	-1	0
(	PMC3820476	20984	20985	O	-1	-1	0
AUDEO	PMC3820476	20985	20990	O	-1	-1	0
)	PMC3820476	20990	20991	O	-1	-1	0
Project	PMC3820476	20992	20999	O	-1	-1	0
at	PMC3820476	21000	21002	O	-1	-1	0
the	PMC3820476	21003	21006	O	-1	-1	0
Department	PMC3820476	21007	21017	O	-1	-1	0
of	PMC3820476	21018	21020	O	-1	-1	0
Clinical	PMC3820476	21021	21029	O	-1	-1	0
Epidemiology	PMC3820476	21030	21042	O	-1	-1	0
,	PMC3820476	21042	21043	O	-1	-1	0
Aarhus	PMC3820476	21044	21050	O	-1	-1	0
University	PMC3820476	21051	21061	O	-1	-1	0
Hospital	PMC3820476	21062	21070	O	-1	-1	0
.	PMC3820476	21070	21071	O	-1	-1	0


	PMC3820476	21071	21073	O	-1	-1	0

Disclosure	PMC3820476	21073	21083	O	-1	-1	0

The	PMC3820476	21084	21087	O	-1	-1	0
authors	PMC3820476	21088	21095	O	-1	-1	0
report	PMC3820476	21096	21102	O	-1	-1	0
no	PMC3820476	21103	21105	O	-1	-1	0
conflicts	PMC3820476	21106	21115	O	-1	-1	0
of	PMC3820476	21116	21118	O	-1	-1	0
interest	PMC3820476	21119	21127	O	-1	-1	0
in	PMC3820476	21128	21130	O	-1	-1	0
this	PMC3820476	21131	21135	O	-1	-1	0
work	PMC3820476	21136	21140	O	-1	-1	0
.	PMC3820476	21140	21141	O	-1	-1	0


	PMC3820476	21141	21143	O	-1	-1	0

References	PMC3820476	21143	21153	O	-1	-1	0


	PMC3820476	21153	21155	O	-1	-1	0
1	PMC3820476	21155	21156	O	-1	-1	0
.	PMC3820476	21156	21157	O	-1	-1	0

Organisation	PMC3820476	21158	21170	O	-1	-1	0
for	PMC3820476	21171	21174	O	-1	-1	0
Economic	PMC3820476	21175	21183	O	-1	-1	0
Co	PMC3820476	21184	21186	O	-1	-1	0
-	PMC3820476	21186	21187	O	-1	-1	0
operation	PMC3820476	21187	21196	O	-1	-1	0
and	PMC3820476	21197	21200	O	-1	-1	0
Development	PMC3820476	21201	21212	O	-1	-1	0
.	PMC3820476	21212	21213	O	-1	-1	0

Health	PMC3820476	21214	21220	O	-1	-1	0
at	PMC3820476	21221	21223	O	-1	-1	0
a	PMC3820476	21224	21225	O	-1	-1	0
Glance	PMC3820476	21226	21232	O	-1	-1	0
:	PMC3820476	21232	21233	O	-1	-1	0
Europe	PMC3820476	21234	21240	O	-1	-1	0
2012	PMC3820476	21241	21245	O	-1	-1	0
.	PMC3820476	21245	21246	O	-1	-1	0

Available	PMC3820476	21247	21256	O	-1	-1	0
from	PMC3820476	21257	21261	O	-1	-1	0
:	PMC3820476	21261	21262	O	-1	-1	0
http://dx.doi	PMC3820476	21263	21276	O	-1	-1	0
.	PMC3820476	21276	21277	O	-1	-1	0

org/10.1787/9789264183896-en	PMC3820476	21278	21306	O	-1	-1	0
.	PMC3820476	21306	21307	O	-1	-1	0

Accessed	PMC3820476	21308	21316	O	-1	-1	0
July	PMC3820476	21317	21321	O	-1	-1	0
12	PMC3820476	21322	21324	O	-1	-1	0
,	PMC3820476	21324	21325	O	-1	-1	0
2013	PMC3820476	21326	21330	O	-1	-1	0
.	PMC3820476	21330	21331	O	-1	-1	0

2	PMC3820476	21332	21333	O	-1	-1	0
.	PMC3820476	21333	21334	O	-1	-1	0

Engholm	PMC3820476	21335	21342	O	-1	-1	0
G	PMC3820476	21343	21344	O	-1	-1	0
,	PMC3820476	21344	21345	O	-1	-1	0
Ferlay	PMC3820476	21346	21352	O	-1	-1	0
J	PMC3820476	21353	21354	O	-1	-1	0
,	PMC3820476	21354	21355	O	-1	-1	0
Christensen	PMC3820476	21356	21367	O	-1	-1	0
N	PMC3820476	21368	21369	O	-1	-1	0
,	PMC3820476	21369	21370	O	-1	-1	0
et	PMC3820476	21371	21373	O	-1	-1	0
al	PMC3820476	21374	21376	O	-1	-1	0
.	PMC3820476	21376	21377	O	-1	-1	0

NORDCAN	PMC3820476	21378	21385	O	-1	-1	0
–	PMC3820476	21386	21387	O	-1	-1	0
a	PMC3820476	21388	21389	O	-1	-1	0
Nordic	PMC3820476	21390	21396	O	-1	-1	0
tool	PMC3820476	21397	21401	O	-1	-1	0
for	PMC3820476	21402	21405	O	-1	-1	0
cancer	PMC3820476	21406	21412	O	-1	-1	0
information	PMC3820476	21413	21424	O	-1	-1	0
,	PMC3820476	21424	21425	O	-1	-1	0
planning	PMC3820476	21426	21434	O	-1	-1	0
,	PMC3820476	21434	21435	O	-1	-1	0
quality	PMC3820476	21436	21443	O	-1	-1	0
control	PMC3820476	21444	21451	O	-1	-1	0
and	PMC3820476	21452	21455	O	-1	-1	0
research	PMC3820476	21456	21464	O	-1	-1	0
.	PMC3820476	21464	21465	O	-1	-1	0

Acta	PMC3820476	21466	21470	O	-1	-1	0
Oncol	PMC3820476	21471	21476	O	-1	-1	0
.	PMC3820476	21476	21477	O	-1	-1	0

2010;49(5):725–736	PMC3820476	21478	21496	O	-1	-1	0
.	PMC3820476	21496	21497	O	-1	-1	0

3	PMC3820476	21498	21499	O	-1	-1	0
.	PMC3820476	21499	21500	O	-1	-1	0

Extermann	PMC3820476	21501	21510	O	-1	-1	0
M.	PMC3820476	21511	21513	O	-1	-1	0
Measurement	PMC3820476	21514	21525	O	-1	-1	0
and	PMC3820476	21526	21529	O	-1	-1	0
impact	PMC3820476	21530	21536	O	-1	-1	0
of	PMC3820476	21537	21539	O	-1	-1	0
comorbidity	PMC3820476	21540	21551	O	-1	-1	0
in	PMC3820476	21552	21554	O	-1	-1	0
older	PMC3820476	21555	21560	O	-1	-1	0
cancer	PMC3820476	21561	21567	O	-1	-1	0
patients	PMC3820476	21568	21576	O	-1	-1	0
.	PMC3820476	21576	21577	O	-1	-1	0

Crit	PMC3820476	21578	21582	O	-1	-1	0
Rev	PMC3820476	21583	21586	O	-1	-1	0
Oncol	PMC3820476	21587	21592	O	-1	-1	0
Hematol	PMC3820476	21593	21600	O	-1	-1	0
.	PMC3820476	21600	21601	O	-1	-1	0

2000;35(3):181–200	PMC3820476	21602	21620	O	-1	-1	0
.	PMC3820476	21620	21621	O	-1	-1	0

4	PMC3820476	21622	21623	O	-1	-1	0
.	PMC3820476	21623	21624	O	-1	-1	0

Ogle	PMC3820476	21625	21629	O	-1	-1	0
KS	PMC3820476	21630	21632	O	-1	-1	0
,	PMC3820476	21632	21633	O	-1	-1	0
Swanson	PMC3820476	21634	21641	O	-1	-1	0
GM	PMC3820476	21642	21644	O	-1	-1	0
,	PMC3820476	21644	21645	O	-1	-1	0
Woods	PMC3820476	21646	21651	O	-1	-1	0
N	PMC3820476	21652	21653	O	-1	-1	0
,	PMC3820476	21653	21654	O	-1	-1	0
Azzouz	PMC3820476	21655	21661	O	-1	-1	0
F.	PMC3820476	21662	21664	O	-1	-1	0
Cancer	PMC3820476	21665	21671	O	-1	-1	0
and	PMC3820476	21672	21675	O	-1	-1	0
comorbidity	PMC3820476	21676	21687	O	-1	-1	0
:	PMC3820476	21687	21688	O	-1	-1	0
redefining	PMC3820476	21689	21699	O	-1	-1	0
chronic	PMC3820476	21700	21707	O	-1	-1	0
diseases	PMC3820476	21708	21716	O	-1	-1	0
.	PMC3820476	21716	21717	O	-1	-1	0

Cancer	PMC3820476	21718	21724	O	-1	-1	0
.	PMC3820476	21724	21725	O	-1	-1	0

2000;88(3):653–663	PMC3820476	21726	21744	O	-1	-1	0
.	PMC3820476	21744	21745	O	-1	-1	0

5	PMC3820476	21746	21747	O	-1	-1	0
.	PMC3820476	21747	21748	O	-1	-1	0

Cronin	PMC3820476	21749	21755	O	-1	-1	0
-	PMC3820476	21755	21756	O	-1	-1	0
Fenton	PMC3820476	21756	21762	O	-1	-1	0
DP	PMC3820476	21763	21765	O	-1	-1	0
,	PMC3820476	21765	21766	O	-1	-1	0
Nørgaard	PMC3820476	21767	21775	O	-1	-1	0
M	PMC3820476	21776	21777	O	-1	-1	0
,	PMC3820476	21777	21778	O	-1	-1	0
Jacobsen	PMC3820476	21779	21787	O	-1	-1	0
J	PMC3820476	21788	21789	O	-1	-1	0
,	PMC3820476	21789	21790	O	-1	-1	0
et	PMC3820476	21791	21793	O	-1	-1	0
al	PMC3820476	21794	21796	O	-1	-1	0
.	PMC3820476	21796	21797	O	-1	-1	0
Comorbidity	PMC3820476	21798	21809	O	-1	-1	0
and	PMC3820476	21810	21813	O	-1	-1	0
survival	PMC3820476	21814	21822	O	-1	-1	0
of	PMC3820476	21823	21825	O	-1	-1	0
Danish	PMC3820476	21826	21832	O	-1	-1	0
breast	PMC3820476	21833	21839	O	-1	-1	0
cancer	PMC3820476	21840	21846	O	-1	-1	0
patients	PMC3820476	21847	21855	O	-1	-1	0
from	PMC3820476	21856	21860	O	-1	-1	0
1995	PMC3820476	21861	21865	O	-1	-1	0
to	PMC3820476	21866	21868	O	-1	-1	0
2005	PMC3820476	21869	21873	O	-1	-1	0
.	PMC3820476	21873	21874	O	-1	-1	0

Br	PMC3820476	21875	21877	O	-1	-1	0
J	PMC3820476	21878	21879	O	-1	-1	0
Cancer	PMC3820476	21880	21886	O	-1	-1	0
.	PMC3820476	21886	21887	O	-1	-1	0

2007;96(9):1462–1468	PMC3820476	21888	21908	O	-1	-1	0
.	PMC3820476	21908	21909	O	-1	-1	0

6	PMC3820476	21910	21911	O	-1	-1	0
.	PMC3820476	21911	21912	O	-1	-1	0

Patnaik	PMC3820476	21913	21920	O	-1	-1	0
JL	PMC3820476	21921	21923	O	-1	-1	0
,	PMC3820476	21923	21924	O	-1	-1	0
Byers	PMC3820476	21925	21930	O	-1	-1	0
T	PMC3820476	21931	21932	O	-1	-1	0
,	PMC3820476	21932	21933	O	-1	-1	0
Diguiseppi	PMC3820476	21934	21944	O	-1	-1	0
C	PMC3820476	21945	21946	O	-1	-1	0
,	PMC3820476	21946	21947	O	-1	-1	0
Denberg	PMC3820476	21948	21955	O	-1	-1	0
TD	PMC3820476	21956	21958	O	-1	-1	0
,	PMC3820476	21958	21959	O	-1	-1	0
Dabelea	PMC3820476	21960	21967	O	-1	-1	0
D.	PMC3820476	21968	21970	O	-1	-1	0

The	PMC3820476	21971	21974	O	-1	-1	0
influence	PMC3820476	21975	21984	O	-1	-1	0
of	PMC3820476	21985	21987	O	-1	-1	0
comorbidities	PMC3820476	21988	22001	O	-1	-1	0
on	PMC3820476	22002	22004	O	-1	-1	0
overall	PMC3820476	22005	22012	O	-1	-1	0
survival	PMC3820476	22013	22021	O	-1	-1	0
among	PMC3820476	22022	22027	O	-1	-1	0
older	PMC3820476	22028	22033	O	-1	-1	0
women	PMC3820476	22034	22039	O	-1	-1	0
diagnosed	PMC3820476	22040	22049	O	-1	-1	0
with	PMC3820476	22050	22054	O	-1	-1	0
breast	PMC3820476	22055	22061	O	-1	-1	0
cancer	PMC3820476	22062	22068	O	-1	-1	0
.	PMC3820476	22068	22069	O	-1	-1	0

J	PMC3820476	22070	22071	O	-1	-1	0
Natl	PMC3820476	22072	22076	O	-1	-1	0
Cancer	PMC3820476	22077	22083	O	-1	-1	0
Inst	PMC3820476	22084	22088	O	-1	-1	0
.	PMC3820476	22088	22089	O	-1	-1	0

2011;103(14):1101–1111	PMC3820476	22090	22112	O	-1	-1	0
.	PMC3820476	22112	22113	O	-1	-1	0

7	PMC3820476	22114	22115	O	-1	-1	0
.	PMC3820476	22115	22116	O	-1	-1	0

Ring	PMC3820476	22117	22121	O	-1	-1	0
A	PMC3820476	22122	22123	O	-1	-1	0
,	PMC3820476	22123	22124	O	-1	-1	0
Sestak	PMC3820476	22125	22131	O	-1	-1	0
I	PMC3820476	22132	22133	O	-1	-1	0
,	PMC3820476	22133	22134	O	-1	-1	0
Baum	PMC3820476	22135	22139	O	-1	-1	0
M	PMC3820476	22140	22141	O	-1	-1	0
,	PMC3820476	22141	22142	O	-1	-1	0
et	PMC3820476	22143	22145	O	-1	-1	0
al	PMC3820476	22146	22148	O	-1	-1	0
.	PMC3820476	22148	22149	O	-1	-1	0

Influence	PMC3820476	22150	22159	O	-1	-1	0
of	PMC3820476	22160	22162	O	-1	-1	0
comorbidities	PMC3820476	22163	22176	O	-1	-1	0
and	PMC3820476	22177	22180	O	-1	-1	0
age	PMC3820476	22181	22184	O	-1	-1	0
on	PMC3820476	22185	22187	O	-1	-1	0
risk	PMC3820476	22188	22192	O	-1	-1	0
of	PMC3820476	22193	22195	O	-1	-1	0
death	PMC3820476	22196	22201	O	-1	-1	0
without	PMC3820476	22202	22209	O	-1	-1	0
recurrence	PMC3820476	22210	22220	O	-1	-1	0
:	PMC3820476	22220	22221	O	-1	-1	0
a	PMC3820476	22222	22223	O	-1	-1	0
retrospective	PMC3820476	22224	22237	O	-1	-1	0
analysis	PMC3820476	22238	22246	O	-1	-1	0
of	PMC3820476	22247	22249	O	-1	-1	0
the	PMC3820476	22250	22253	O	-1	-1	0
Arimidex	PMC3820476	22254	22262	O	-1	-1	0
,	PMC3820476	22262	22263	O	-1	-1	0

Tamoxifen	PMC3820476	22264	22273	O	-1	-1	0
Alone	PMC3820476	22274	22279	O	-1	-1	0
or	PMC3820476	22280	22282	O	-1	-1	0
in	PMC3820476	22283	22285	O	-1	-1	0
Combination	PMC3820476	22286	22297	O	-1	-1	0
trial	PMC3820476	22298	22303	O	-1	-1	0
.	PMC3820476	22303	22304	O	-1	-1	0

J	PMC3820476	22305	22306	O	-1	-1	0
Clin	PMC3820476	22307	22311	O	-1	-1	0
Oncol	PMC3820476	22312	22317	O	-1	-1	0
.	PMC3820476	22317	22318	O	-1	-1	0

2011;29(32	PMC3820476	22319	22329	O	-1	-1	0
)	PMC3820476	22329	22330	O	-1	-1	0

:	PMC3820476	22330	22331	O	-1	-1	0

4266–4272	PMC3820476	22332	22341	O	-1	-1	0
.	PMC3820476	22341	22342	O	-1	-1	0


	PMC3820476	22342	22344	O	-1	-1	0

44	PMC3820476	22344	22346	O	-1	-1	0


	PMC3820476	22346	22348	O	-1	-1	0
submit	PMC3820476	22348	22354	O	-1	-1	0
your	PMC3820476	22355	22359	O	-1	-1	0
manuscript	PMC3820476	22360	22370	O	-1	-1	0
|	PMC3820476	22371	22372	O	-1	-1	0

www.dovepress.com	PMC3820476	22373	22390	O	-1	-1	0


	PMC3820476	22390	22392	O	-1	-1	0

Dovepress	PMC3820476	22392	22401	O	-1	-1	0


	PMC3820476	22401	22403	O	-1	-1	0

Dovepress	PMC3820476	22403	22412	O	-1	-1	0
8	PMC3820476	22413	22414	O	-1	-1	0
.	PMC3820476	22414	22415	O	-1	-1	0

Riihimaki	PMC3820476	22416	22425	O	-1	-1	0
M	PMC3820476	22426	22427	O	-1	-1	0
,	PMC3820476	22427	22428	O	-1	-1	0
Thomsen	PMC3820476	22429	22436	O	-1	-1	0
H	PMC3820476	22437	22438	O	-1	-1	0
,	PMC3820476	22438	22439	O	-1	-1	0
Brandt	PMC3820476	22440	22446	O	-1	-1	0
A	PMC3820476	22447	22448	O	-1	-1	0
,	PMC3820476	22448	22449	O	-1	-1	0
Sundquist	PMC3820476	22450	22459	O	-1	-1	0
J	PMC3820476	22460	22461	O	-1	-1	0
,	PMC3820476	22461	22462	O	-1	-1	0
Hemminki	PMC3820476	22463	22471	O	-1	-1	0
K.	PMC3820476	22472	22474	O	-1	-1	0
Death	PMC3820476	22475	22480	O	-1	-1	0
causes	PMC3820476	22481	22487	O	-1	-1	0
in	PMC3820476	22488	22490	O	-1	-1	0
breast	PMC3820476	22491	22497	O	-1	-1	0
cancer	PMC3820476	22498	22504	O	-1	-1	0
patients	PMC3820476	22505	22513	O	-1	-1	0
.	PMC3820476	22513	22514	O	-1	-1	0

Ann	PMC3820476	22515	22518	O	-1	-1	0
Oncol	PMC3820476	22519	22524	O	-1	-1	0
.	PMC3820476	22524	22525	O	-1	-1	0

2012;23(3):604–610	PMC3820476	22526	22544	O	-1	-1	0
.	PMC3820476	22544	22545	O	-1	-1	0

9	PMC3820476	22546	22547	O	-1	-1	0
.	PMC3820476	22547	22548	O	-1	-1	0

Bush	PMC3820476	22549	22553	O	-1	-1	0
D	PMC3820476	22554	22555	O	-1	-1	0
,	PMC3820476	22555	22556	O	-1	-1	0
Smith	PMC3820476	22557	22562	O	-1	-1	0
B	PMC3820476	22563	22564	O	-1	-1	0
,	PMC3820476	22564	22565	O	-1	-1	0
Younger	PMC3820476	22566	22573	O	-1	-1	0
J	PMC3820476	22574	22575	O	-1	-1	0
,	PMC3820476	22575	22576	O	-1	-1	0
Michaelson	PMC3820476	22577	22587	O	-1	-1	0
JS	PMC3820476	22588	22590	O	-1	-1	0
.	PMC3820476	22590	22591	O	-1	-1	0

The	PMC3820476	22592	22595	O	-1	-1	0
non	PMC3820476	22596	22599	O	-1	-1	0
-	PMC3820476	22599	22600	O	-1	-1	0
breast	PMC3820476	22600	22606	O	-1	-1	0
-	PMC3820476	22606	22607	O	-1	-1	0
cancer	PMC3820476	22607	22613	O	-1	-1	0
death	PMC3820476	22614	22619	O	-1	-1	0
rate	PMC3820476	22620	22624	O	-1	-1	0
among	PMC3820476	22625	22630	O	-1	-1	0
breast	PMC3820476	22631	22637	O	-1	-1	0
cancer	PMC3820476	22638	22644	O	-1	-1	0
patients	PMC3820476	22645	22653	O	-1	-1	0
.	PMC3820476	22653	22654	O	-1	-1	0

Breast	PMC3820476	22655	22661	O	-1	-1	0
Cancer	PMC3820476	22662	22668	O	-1	-1	0
Res	PMC3820476	22669	22672	O	-1	-1	0
Treat	PMC3820476	22673	22678	O	-1	-1	0
.	PMC3820476	22678	22679	O	-1	-1	0

2011;127(1):243–249	PMC3820476	22680	22699	O	-1	-1	0
.	PMC3820476	22699	22700	O	-1	-1	0

10	PMC3820476	22701	22703	O	-1	-1	0
.	PMC3820476	22703	22704	O	-1	-1	0

Schonberg	PMC3820476	22705	22714	O	-1	-1	0
MA	PMC3820476	22715	22717	O	-1	-1	0
,	PMC3820476	22717	22718	O	-1	-1	0
Marcantonio	PMC3820476	22719	22730	O	-1	-1	0
ER	PMC3820476	22731	22733	O	-1	-1	0
,	PMC3820476	22733	22734	O	-1	-1	0
Li	PMC3820476	22735	22737	O	-1	-1	0
D	PMC3820476	22738	22739	O	-1	-1	0
,	PMC3820476	22739	22740	O	-1	-1	0
Silliman	PMC3820476	22741	22749	O	-1	-1	0
RA	PMC3820476	22750	22752	O	-1	-1	0
,	PMC3820476	22752	22753	O	-1	-1	0
Ngo	PMC3820476	22754	22757	O	-1	-1	0
L	PMC3820476	22758	22759	O	-1	-1	0
,	PMC3820476	22759	22760	O	-1	-1	0
McCarthy	PMC3820476	22761	22769	O	-1	-1	0
EP	PMC3820476	22770	22772	O	-1	-1	0
.	PMC3820476	22772	22773	O	-1	-1	0

Breast	PMC3820476	22774	22780	O	-1	-1	0
cancer	PMC3820476	22781	22787	O	-1	-1	0
among	PMC3820476	22788	22793	O	-1	-1	0
the	PMC3820476	22794	22797	O	-1	-1	0
oldest	PMC3820476	22798	22804	O	-1	-1	0
old	PMC3820476	22805	22808	O	-1	-1	0
:	PMC3820476	22808	22809	O	-1	-1	0

tumor	PMC3820476	22810	22815	O	-1	-1	0
characteristics	PMC3820476	22816	22831	O	-1	-1	0
,	PMC3820476	22831	22832	O	-1	-1	0
treatment	PMC3820476	22833	22842	O	-1	-1	0
choices	PMC3820476	22843	22850	O	-1	-1	0
,	PMC3820476	22850	22851	O	-1	-1	0
and	PMC3820476	22852	22855	O	-1	-1	0
survival	PMC3820476	22856	22864	O	-1	-1	0
.	PMC3820476	22864	22865	O	-1	-1	0

J	PMC3820476	22866	22867	O	-1	-1	0
Clin	PMC3820476	22868	22872	O	-1	-1	0
Oncol	PMC3820476	22873	22878	O	-1	-1	0
.	PMC3820476	22878	22879	O	-1	-1	0

2010;28(12):2038–2045	PMC3820476	22880	22901	O	-1	-1	0
.	PMC3820476	22901	22902	O	-1	-1	0

11	PMC3820476	22903	22905	O	-1	-1	0
.	PMC3820476	22905	22906	O	-1	-1	0

Janssen	PMC3820476	22907	22914	O	-1	-1	0
-	PMC3820476	22914	22915	O	-1	-1	0
Heijnen	PMC3820476	22915	22922	O	-1	-1	0
ML	PMC3820476	22923	22925	O	-1	-1	0
,	PMC3820476	22925	22926	O	-1	-1	0
Houterman	PMC3820476	22927	22936	O	-1	-1	0
S	PMC3820476	22937	22938	O	-1	-1	0
,	PMC3820476	22938	22939	O	-1	-1	0
Lemmens	PMC3820476	22940	22947	O	-1	-1	0
VE	PMC3820476	22948	22950	O	-1	-1	0
,	PMC3820476	22950	22951	O	-1	-1	0
Louwman	PMC3820476	22952	22959	O	-1	-1	0
MW	PMC3820476	22960	22962	O	-1	-1	0
,	PMC3820476	22962	22963	O	-1	-1	0
Maas	PMC3820476	22964	22968	O	-1	-1	0
HA	PMC3820476	22969	22971	O	-1	-1	0
,	PMC3820476	22971	22972	O	-1	-1	0
Coebergh	PMC3820476	22973	22981	O	-1	-1	0
JW	PMC3820476	22982	22984	O	-1	-1	0
.	PMC3820476	22984	22985	O	-1	-1	0

Prognostic	PMC3820476	22986	22996	O	-1	-1	0
impact	PMC3820476	22997	23003	O	-1	-1	0
of	PMC3820476	23004	23006	O	-1	-1	0
increasing	PMC3820476	23007	23017	O	-1	-1	0
age	PMC3820476	23018	23021	O	-1	-1	0
and	PMC3820476	23022	23025	O	-1	-1	0
comorbidity	PMC3820476	23026	23037	O	-1	-1	0
in	PMC3820476	23038	23040	O	-1	-1	0
cancer	PMC3820476	23041	23047	O	-1	-1	0
patients	PMC3820476	23048	23056	O	-1	-1	0
:	PMC3820476	23056	23057	O	-1	-1	0
a	PMC3820476	23058	23059	O	-1	-1	0
population	PMC3820476	23060	23070	O	-1	-1	0
-	PMC3820476	23070	23071	O	-1	-1	0
based	PMC3820476	23071	23076	O	-1	-1	0
approach	PMC3820476	23077	23085	O	-1	-1	0
.	PMC3820476	23085	23086	O	-1	-1	0

Crit	PMC3820476	23087	23091	O	-1	-1	0
Rev	PMC3820476	23092	23095	O	-1	-1	0

Oncol	PMC3820476	23096	23101	O	-1	-1	0
Hematol	PMC3820476	23102	23109	O	-1	-1	0
.	PMC3820476	23109	23110	O	-1	-1	0

2005;55(3):231–240	PMC3820476	23111	23129	O	-1	-1	0
.	PMC3820476	23129	23130	O	-1	-1	0

12	PMC3820476	23131	23133	O	-1	-1	0
.	PMC3820476	23133	23134	O	-1	-1	0

Jørgensen	PMC3820476	23135	23144	O	-1	-1	0
TL	PMC3820476	23145	23147	O	-1	-1	0
,	PMC3820476	23147	23148	O	-1	-1	0
Hallas	PMC3820476	23149	23155	O	-1	-1	0
J	PMC3820476	23156	23157	O	-1	-1	0
,	PMC3820476	23157	23158	O	-1	-1	0
Friis	PMC3820476	23159	23164	O	-1	-1	0
S	PMC3820476	23165	23166	O	-1	-1	0
,	PMC3820476	23166	23167	O	-1	-1	0
Herrstedt	PMC3820476	23168	23177	O	-1	-1	0
J.	PMC3820476	23178	23180	O	-1	-1	0
Comorbidity	PMC3820476	23181	23192	O	-1	-1	0
in	PMC3820476	23193	23195	O	-1	-1	0
elderly	PMC3820476	23196	23203	O	-1	-1	0
cancer	PMC3820476	23204	23210	O	-1	-1	0
patients	PMC3820476	23211	23219	O	-1	-1	0
in	PMC3820476	23220	23222	O	-1	-1	0
relation	PMC3820476	23223	23231	O	-1	-1	0
to	PMC3820476	23232	23234	O	-1	-1	0
overall	PMC3820476	23235	23242	O	-1	-1	0
and	PMC3820476	23243	23246	O	-1	-1	0
cancer	PMC3820476	23247	23253	O	-1	-1	0
-	PMC3820476	23253	23254	O	-1	-1	0
specific	PMC3820476	23254	23262	O	-1	-1	0
mortality	PMC3820476	23263	23272	O	-1	-1	0
.	PMC3820476	23272	23273	O	-1	-1	0

Br	PMC3820476	23274	23276	O	-1	-1	0

J	PMC3820476	23277	23278	O	-1	-1	0
Cancer	PMC3820476	23279	23285	O	-1	-1	0
.	PMC3820476	23285	23286	O	-1	-1	0

2012;106(7):1353–1360	PMC3820476	23287	23308	O	-1	-1	0
.	PMC3820476	23308	23309	O	-1	-1	0

13	PMC3820476	23310	23312	O	-1	-1	0
.	PMC3820476	23312	23313	O	-1	-1	0

Lietzen	PMC3820476	23314	23321	O	-1	-1	0
LW	PMC3820476	23322	23324	O	-1	-1	0
,	PMC3820476	23324	23325	O	-1	-1	0
Sørensen	PMC3820476	23326	23334	O	-1	-1	0
GV	PMC3820476	23335	23337	O	-1	-1	0
,	PMC3820476	23337	23338	O	-1	-1	0
Ording	PMC3820476	23339	23345	O	-1	-1	0
AG	PMC3820476	23346	23348	O	-1	-1	0
,	PMC3820476	23348	23349	O	-1	-1	0
et	PMC3820476	23350	23352	O	-1	-1	0
al	PMC3820476	23353	23355	O	-1	-1	0
.	PMC3820476	23355	23356	O	-1	-1	0

Survival	PMC3820476	23357	23365	O	-1	-1	0
of	PMC3820476	23366	23368	O	-1	-1	0
women	PMC3820476	23369	23374	O	-1	-1	0
with	PMC3820476	23375	23379	O	-1	-1	0
breast	PMC3820476	23380	23386	O	-1	-1	0
cancer	PMC3820476	23387	23393	O	-1	-1	0
in	PMC3820476	23394	23396	O	-1	-1	0
central	PMC3820476	23397	23404	O	-1	-1	0
and	PMC3820476	23405	23408	O	-1	-1	0
northern	PMC3820476	23409	23417	O	-1	-1	0
Denmark	PMC3820476	23418	23425	O	-1	-1	0
,	PMC3820476	23425	23426	O	-1	-1	0
1998–2009	PMC3820476	23427	23436	O	-1	-1	0
.	PMC3820476	23436	23437	O	-1	-1	0

Clin	PMC3820476	23438	23442	O	-1	-1	0
Epidemiol	PMC3820476	23443	23452	O	-1	-1	0
.	PMC3820476	23452	23453	O	-1	-1	0

2011;3	PMC3820476	23454	23460	O	-1	-1	0

Suppl	PMC3820476	23461	23466	O	-1	-1	0
1:35–40	PMC3820476	23467	23474	O	-1	-1	0
.	PMC3820476	23474	23475	O	-1	-1	0

14	PMC3820476	23476	23478	O	-1	-1	0
.	PMC3820476	23478	23479	O	-1	-1	0

Land	PMC3820476	23480	23484	O	-1	-1	0
LH	PMC3820476	23485	23487	O	-1	-1	0
,	PMC3820476	23487	23488	O	-1	-1	0
Dalton	PMC3820476	23489	23495	O	-1	-1	0
SO	PMC3820476	23496	23498	O	-1	-1	0
,	PMC3820476	23498	23499	O	-1	-1	0
Jensen	PMC3820476	23500	23506	O	-1	-1	0
MB	PMC3820476	23507	23509	O	-1	-1	0
,	PMC3820476	23509	23510	O	-1	-1	0
Ewertz	PMC3820476	23511	23517	O	-1	-1	0
M.	PMC3820476	23518	23520	O	-1	-1	0
Impact	PMC3820476	23521	23527	O	-1	-1	0
of	PMC3820476	23528	23530	O	-1	-1	0
comorbidity	PMC3820476	23531	23542	O	-1	-1	0
on	PMC3820476	23543	23545	O	-1	-1	0
mortality	PMC3820476	23546	23555	O	-1	-1	0
:	PMC3820476	23555	23556	O	-1	-1	0
a	PMC3820476	23557	23558	O	-1	-1	0
cohort	PMC3820476	23559	23565	O	-1	-1	0
study	PMC3820476	23566	23571	O	-1	-1	0
of	PMC3820476	23572	23574	O	-1	-1	0
62,591	PMC3820476	23575	23581	O	-1	-1	0
Danish	PMC3820476	23582	23588	O	-1	-1	0
women	PMC3820476	23589	23594	O	-1	-1	0
diagnosed	PMC3820476	23595	23604	O	-1	-1	0
with	PMC3820476	23605	23609	O	-1	-1	0
early	PMC3820476	23610	23615	O	-1	-1	0
breast	PMC3820476	23616	23622	O	-1	-1	0
cancer	PMC3820476	23623	23629	O	-1	-1	0
,	PMC3820476	23629	23630	O	-1	-1	0
1990–2008	PMC3820476	23631	23640	O	-1	-1	0
.	PMC3820476	23640	23641	O	-1	-1	0

Breast	PMC3820476	23642	23648	O	-1	-1	0
Cancer	PMC3820476	23649	23655	O	-1	-1	0
Res	PMC3820476	23656	23659	O	-1	-1	0
Treat	PMC3820476	23660	23665	O	-1	-1	0
.	PMC3820476	23665	23666	O	-1	-1	0

2012;131(3	PMC3820476	23667	23677	O	-1	-1	0
)	PMC3820476	23677	23678	O	-1	-1	0
:	PMC3820476	23678	23679	O	-1	-1	0

1013–1020	PMC3820476	23680	23689	O	-1	-1	0
.	PMC3820476	23689	23690	O	-1	-1	0

15	PMC3820476	23691	23693	O	-1	-1	0
.	PMC3820476	23693	23694	O	-1	-1	0

Charlson	PMC3820476	23695	23703	O	-1	-1	0
ME	PMC3820476	23704	23706	O	-1	-1	0
,	PMC3820476	23706	23707	O	-1	-1	0
Pompei	PMC3820476	23708	23714	O	-1	-1	0
P	PMC3820476	23715	23716	O	-1	-1	0
,	PMC3820476	23716	23717	O	-1	-1	0
Ales	PMC3820476	23718	23722	O	-1	-1	0
KL	PMC3820476	23723	23725	O	-1	-1	0
,	PMC3820476	23725	23726	O	-1	-1	0
MacKenzie	PMC3820476	23727	23736	O	-1	-1	0
CR	PMC3820476	23737	23739	O	-1	-1	0
.	PMC3820476	23739	23740	O	-1	-1	0

A	PMC3820476	23741	23742	O	-1	-1	0
new	PMC3820476	23743	23746	O	-1	-1	0
method	PMC3820476	23747	23753	O	-1	-1	0
of	PMC3820476	23754	23756	O	-1	-1	0
classifying	PMC3820476	23757	23768	O	-1	-1	0
prognostic	PMC3820476	23769	23779	O	-1	-1	0
comorbidity	PMC3820476	23780	23791	O	-1	-1	0
in	PMC3820476	23792	23794	O	-1	-1	0
longitudinal	PMC3820476	23795	23807	O	-1	-1	0
studies	PMC3820476	23808	23815	O	-1	-1	0
:	PMC3820476	23815	23816	O	-1	-1	0
development	PMC3820476	23817	23828	O	-1	-1	0
and	PMC3820476	23829	23832	O	-1	-1	0
validation	PMC3820476	23833	23843	O	-1	-1	0
.	PMC3820476	23843	23844	O	-1	-1	0

J	PMC3820476	23845	23846	O	-1	-1	0
Chronic	PMC3820476	23847	23854	O	-1	-1	0
Dis	PMC3820476	23855	23858	O	-1	-1	0
.	PMC3820476	23858	23859	O	-1	-1	0

1987;40(5):373–383	PMC3820476	23860	23878	O	-1	-1	0
.	PMC3820476	23878	23879	O	-1	-1	0

16	PMC3820476	23880	23882	O	-1	-1	0
.	PMC3820476	23882	23883	O	-1	-1	0

Pedersen	PMC3820476	23884	23892	O	-1	-1	0
CB	PMC3820476	23893	23895	O	-1	-1	0
.	PMC3820476	23895	23896	O	-1	-1	0

The	PMC3820476	23897	23900	O	-1	-1	0
Danish	PMC3820476	23901	23907	O	-1	-1	0
Civil	PMC3820476	23908	23913	O	-1	-1	0
Registration	PMC3820476	23914	23926	O	-1	-1	0
System	PMC3820476	23927	23933	O	-1	-1	0
.	PMC3820476	23933	23934	O	-1	-1	0

Scand	PMC3820476	23935	23940	O	-1	-1	0
J	PMC3820476	23941	23942	O	-1	-1	0
Public	PMC3820476	23943	23949	O	-1	-1	0
Health	PMC3820476	23950	23956	O	-1	-1	0
.	PMC3820476	23956	23957	O	-1	-1	0

2011;39(Suppl	PMC3820476	23958	23971	O	-1	-1	0
7):22–25	PMC3820476	23972	23980	O	-1	-1	0
.	PMC3820476	23980	23981	O	-1	-1	0

17	PMC3820476	23982	23984	O	-1	-1	0
.	PMC3820476	23984	23985	O	-1	-1	0

Lynge	PMC3820476	23986	23991	O	-1	-1	0
E	PMC3820476	23992	23993	O	-1	-1	0
,	PMC3820476	23993	23994	O	-1	-1	0
Sandegaard	PMC3820476	23995	24005	O	-1	-1	0
JL	PMC3820476	24006	24008	O	-1	-1	0
,	PMC3820476	24008	24009	O	-1	-1	0
Rebolj	PMC3820476	24010	24016	O	-1	-1	0
M.	PMC3820476	24017	24019	O	-1	-1	0

The	PMC3820476	24020	24023	O	-1	-1	0
Danish	PMC3820476	24024	24030	O	-1	-1	0
National	PMC3820476	24031	24039	O	-1	-1	0
Patient	PMC3820476	24040	24047	O	-1	-1	0
Register	PMC3820476	24048	24056	O	-1	-1	0
.	PMC3820476	24056	24057	O	-1	-1	0

Scand	PMC3820476	24058	24063	O	-1	-1	0
J	PMC3820476	24064	24065	O	-1	-1	0
Public	PMC3820476	24066	24072	O	-1	-1	0
Health	PMC3820476	24073	24079	O	-1	-1	0
.	PMC3820476	24079	24080	O	-1	-1	0

2011;39(Suppl	PMC3820476	24081	24094	O	-1	-1	0
7):30–33	PMC3820476	24095	24103	O	-1	-1	0
.	PMC3820476	24103	24104	O	-1	-1	0

18	PMC3820476	24105	24107	O	-1	-1	0
.	PMC3820476	24107	24108	O	-1	-1	0

Klabunde	PMC3820476	24109	24117	O	-1	-1	0
CN	PMC3820476	24118	24120	O	-1	-1	0
,	PMC3820476	24120	24121	O	-1	-1	0
Legler	PMC3820476	24122	24128	O	-1	-1	0
JM	PMC3820476	24129	24131	O	-1	-1	0
,	PMC3820476	24131	24132	O	-1	-1	0
Warren	PMC3820476	24133	24139	O	-1	-1	0
JL	PMC3820476	24140	24142	O	-1	-1	0
,	PMC3820476	24142	24143	O	-1	-1	0
Baldwin	PMC3820476	24144	24151	O	-1	-1	0
LM	PMC3820476	24152	24154	O	-1	-1	0
,	PMC3820476	24154	24155	O	-1	-1	0

Schrag	PMC3820476	24156	24162	O	-1	-1	0
D.	PMC3820476	24163	24165	O	-1	-1	0
A	PMC3820476	24166	24167	O	-1	-1	0
refined	PMC3820476	24168	24175	O	-1	-1	0
comorbidity	PMC3820476	24176	24187	O	-1	-1	0
measurement	PMC3820476	24188	24199	O	-1	-1	0
algorithm	PMC3820476	24200	24209	O	-1	-1	0
for	PMC3820476	24210	24213	O	-1	-1	0
claims	PMC3820476	24214	24220	O	-1	-1	0
-	PMC3820476	24220	24221	O	-1	-1	0
based	PMC3820476	24221	24226	O	-1	-1	0
studies	PMC3820476	24227	24234	O	-1	-1	0
of	PMC3820476	24235	24237	O	-1	-1	0
breast	PMC3820476	24238	24244	O	-1	-1	0
,	PMC3820476	24244	24245	O	-1	-1	0
prostate	PMC3820476	24246	24254	O	-1	-1	0
,	PMC3820476	24254	24255	O	-1	-1	0
colorectal	PMC3820476	24256	24266	O	-1	-1	0
,	PMC3820476	24266	24267	O	-1	-1	0
and	PMC3820476	24268	24271	O	-1	-1	0
lung	PMC3820476	24272	24276	O	-1	-1	0
cancer	PMC3820476	24277	24283	O	-1	-1	0
patients	PMC3820476	24284	24292	O	-1	-1	0
.	PMC3820476	24292	24293	O	-1	-1	0

Ann	PMC3820476	24294	24297	O	-1	-1	0
Epidemiol	PMC3820476	24298	24307	O	-1	-1	0
.	PMC3820476	24307	24308	O	-1	-1	0
2007;17(8):584–590	PMC3820476	24309	24327	O	-1	-1	0
.	PMC3820476	24327	24328	O	-1	-1	0

19	PMC3820476	24329	24331	O	-1	-1	0
.	PMC3820476	24331	24332	O	-1	-1	0

Brenner	PMC3820476	24333	24340	O	-1	-1	0
H	PMC3820476	24341	24342	O	-1	-1	0
,	PMC3820476	24342	24343	O	-1	-1	0
Rachet	PMC3820476	24344	24350	O	-1	-1	0
B.	PMC3820476	24351	24353	O	-1	-1	0
Hybrid	PMC3820476	24354	24360	O	-1	-1	0
analysis	PMC3820476	24361	24369	O	-1	-1	0
for	PMC3820476	24370	24373	O	-1	-1	0
up	PMC3820476	24374	24376	O	-1	-1	0
-	PMC3820476	24376	24377	O	-1	-1	0
to	PMC3820476	24377	24379	O	-1	-1	0
-	PMC3820476	24379	24380	O	-1	-1	0
date	PMC3820476	24380	24384	O	-1	-1	0
long	PMC3820476	24385	24389	O	-1	-1	0
-	PMC3820476	24389	24390	O	-1	-1	0
term	PMC3820476	24390	24394	O	-1	-1	0
survival	PMC3820476	24395	24403	O	-1	-1	0
rates	PMC3820476	24404	24409	O	-1	-1	0
in	PMC3820476	24410	24412	O	-1	-1	0
cancer	PMC3820476	24413	24419	O	-1	-1	0
registries	PMC3820476	24420	24430	O	-1	-1	0
with	PMC3820476	24431	24435	O	-1	-1	0
delayed	PMC3820476	24436	24443	O	-1	-1	0
recording	PMC3820476	24444	24453	O	-1	-1	0
of	PMC3820476	24454	24456	O	-1	-1	0
incident	PMC3820476	24457	24465	O	-1	-1	0
cases	PMC3820476	24466	24471	O	-1	-1	0
.	PMC3820476	24471	24472	O	-1	-1	0

Eur	PMC3820476	24473	24476	O	-1	-1	0

J	PMC3820476	24477	24478	O	-1	-1	0
Cancer	PMC3820476	24479	24485	O	-1	-1	0
.	PMC3820476	24485	24486	O	-1	-1	0

2004;40(16):2494–2501	PMC3820476	24487	24508	O	-1	-1	0
.	PMC3820476	24508	24509	O	-1	-1	0

20	PMC3820476	24510	24512	O	-1	-1	0
.	PMC3820476	24512	24513	O	-1	-1	0

[	PMC3820476	24514	24515	O	-1	-1	0
Short	PMC3820476	24515	24520	O	-1	-1	0
and	PMC3820476	24521	24524	O	-1	-1	0
long	PMC3820476	24525	24529	O	-1	-1	0
term	PMC3820476	24530	24534	O	-1	-1	0
survival	PMC3820476	24535	24543	O	-1	-1	0
after	PMC3820476	24544	24549	O	-1	-1	0
hospitalization	PMC3820476	24550	24565	O	-1	-1	0
for	PMC3820476	24566	24569	O	-1	-1	0
selected	PMC3820476	24570	24578	O	-1	-1	0
cancer	PMC3820476	24579	24585	O	-1	-1	0
diseases	PMC3820476	24586	24594	O	-1	-1	0
in	PMC3820476	24595	24597	O	-1	-1	0
North	PMC3820476	24598	24603	O	-1	-1	0
Jutland	PMC3820476	24604	24611	O	-1	-1	0
County	PMC3820476	24612	24618	O	-1	-1	0
,	PMC3820476	24618	24619	O	-1	-1	0
Viborg	PMC3820476	24620	24626	O	-1	-1	0
County	PMC3820476	24627	24633	O	-1	-1	0
and	PMC3820476	24634	24637	O	-1	-1	0
Aarhus	PMC3820476	24638	24644	O	-1	-1	0
County	PMC3820476	24645	24651	O	-1	-1	0
.	PMC3820476	24651	24652	O	-1	-1	0
]	PMC3820476	24652	24653	O	-1	-1	0

Kortog	PMC3820476	24654	24660	O	-1	-1	0
Langtidsoverlevelse	PMC3820476	24661	24680	O	-1	-1	0
Efter	PMC3820476	24681	24686	O	-1	-1	0
Indlæggelse	PMC3820476	24687	24698	O	-1	-1	0
for	PMC3820476	24699	24702	O	-1	-1	0
Udvalgte	PMC3820476	24703	24711	O	-1	-1	0
Kræftsygdomme	PMC3820476	24712	24725	O	-1	-1	0

i	PMC3820476	24726	24727	O	-1	-1	0

Nordjyllands	PMC3820476	24728	24740	O	-1	-1	0
,	PMC3820476	24740	24741	O	-1	-1	0
Viborg	PMC3820476	24742	24748	O	-1	-1	0
og	PMC3820476	24749	24751	O	-1	-1	0
Århus	PMC3820476	24752	24757	O	-1	-1	0
Amter	PMC3820476	24758	24763	O	-1	-1	0
1985−2003	PMC3820476	24764	24773	O	-1	-1	0
.	PMC3820476	24773	24774	O	-1	-1	0
­Department	PMC3820476	24775	24786	O	-1	-1	0
of	PMC3820476	24787	24789	O	-1	-1	0
Clinical	PMC3820476	24790	24798	O	-1	-1	0
Epidemiology	PMC3820476	24799	24811	O	-1	-1	0
,	PMC3820476	24811	24812	O	-1	-1	0
Aarhus	PMC3820476	24813	24819	O	-1	-1	0
University	PMC3820476	24820	24830	O	-1	-1	0
Hospital	PMC3820476	24831	24839	O	-1	-1	0
;	PMC3820476	24839	24840	O	-1	-1	0
2004	PMC3820476	24841	24845	O	-1	-1	0
.	PMC3820476	24845	24846	O	-1	-1	0
­Available	PMC3820476	24847	24857	O	-1	-1	0

from	PMC3820476	24858	24862	O	-1	-1	0
:	PMC3820476	24862	24863	O	-1	-1	0
http://	PMC3820476	24864	24871	O	-1	-1	0
kea.au.dk/files/28.pdf	PMC3820476	24872	24894	O	-1	-1	0
.	PMC3820476	24894	24895	O	-1	-1	0

Accessed	PMC3820476	24896	24904	O	-1	-1	0
January	PMC3820476	24905	24912	O	-1	-1	0
21	PMC3820476	24913	24915	O	-1	-1	0
,	PMC3820476	24915	24916	O	-1	-1	0
2013	PMC3820476	24917	24921	O	-1	-1	0
.	PMC3820476	24921	24922	O	-1	-1	0

Danish	PMC3820476	24923	24929	O	-1	-1	0
.	PMC3820476	24929	24930	O	-1	-1	0

21	PMC3820476	24931	24933	O	-1	-1	0
.	PMC3820476	24933	24934	O	-1	-1	0

Thygesen	PMC3820476	24935	24943	O	-1	-1	0
SK	PMC3820476	24944	24946	O	-1	-1	0
,	PMC3820476	24946	24947	O	-1	-1	0
Christiansen	PMC3820476	24948	24960	O	-1	-1	0
CF	PMC3820476	24961	24963	O	-1	-1	0
,	PMC3820476	24963	24964	O	-1	-1	0
Christensen	PMC3820476	24965	24976	O	-1	-1	0
S	PMC3820476	24977	24978	O	-1	-1	0
,	PMC3820476	24978	24979	O	-1	-1	0
Lash	PMC3820476	24980	24984	O	-1	-1	0
TL	PMC3820476	24985	24987	O	-1	-1	0
,	PMC3820476	24987	24988	O	-1	-1	0
Sørensen	PMC3820476	24989	24997	O	-1	-1	0
HT	PMC3820476	24998	25000	O	-1	-1	0
.	PMC3820476	25000	25001	O	-1	-1	0

The	PMC3820476	25002	25005	O	-1	-1	0
predictive	PMC3820476	25006	25016	O	-1	-1	0
value	PMC3820476	25017	25022	O	-1	-1	0
of	PMC3820476	25023	25025	O	-1	-1	0
ICD-10	PMC3820476	25026	25032	O	-1	-1	0
diagnostic	PMC3820476	25033	25043	O	-1	-1	0
coding	PMC3820476	25044	25050	O	-1	-1	0
used	PMC3820476	25051	25055	O	-1	-1	0
to	PMC3820476	25056	25058	O	-1	-1	0
assess	PMC3820476	25059	25065	O	-1	-1	0
Charlson	PMC3820476	25066	25074	O	-1	-1	0
comorbidity	PMC3820476	25075	25086	O	-1	-1	0
index	PMC3820476	25087	25092	O	-1	-1	0
conditions	PMC3820476	25093	25103	O	-1	-1	0
in	PMC3820476	25104	25106	O	-1	-1	0
the	PMC3820476	25107	25110	O	-1	-1	0
population	PMC3820476	25111	25121	O	-1	-1	0
-	PMC3820476	25121	25122	O	-1	-1	0
based	PMC3820476	25122	25127	O	-1	-1	0
Danish	PMC3820476	25128	25134	O	-1	-1	0
National	PMC3820476	25135	25143	O	-1	-1	0
Registry	PMC3820476	25144	25152	O	-1	-1	0
of	PMC3820476	25153	25155	O	-1	-1	0
Patients	PMC3820476	25156	25164	O	-1	-1	0
.	PMC3820476	25164	25165	O	-1	-1	0

BMC	PMC3820476	25166	25169	O	-1	-1	0
Med	PMC3820476	25170	25173	O	-1	-1	0
Res	PMC3820476	25174	25177	O	-1	-1	0
Methodol	PMC3820476	25178	25186	O	-1	-1	0
.	PMC3820476	25186	25187	O	-1	-1	0

2011;11:83	PMC3820476	25188	25198	O	-1	-1	0
.	PMC3820476	25198	25199	O	-1	-1	0

22	PMC3820476	25200	25202	O	-1	-1	0
.	PMC3820476	25202	25203	O	-1	-1	0

Gonzalez	PMC3820476	25204	25212	O	-1	-1	0
EC	PMC3820476	25213	25215	O	-1	-1	0
,	PMC3820476	25215	25216	O	-1	-1	0
Ferrante	PMC3820476	25217	25225	O	-1	-1	0
JM	PMC3820476	25226	25228	O	-1	-1	0
,	PMC3820476	25228	25229	O	-1	-1	0
Van	PMC3820476	25230	25233	O	-1	-1	0
Durme	PMC3820476	25234	25239	O	-1	-1	0
DJ	PMC3820476	25240	25242	O	-1	-1	0
,	PMC3820476	25242	25243	O	-1	-1	0
Pal	PMC3820476	25244	25247	O	-1	-1	0
N	PMC3820476	25248	25249	O	-1	-1	0
,	PMC3820476	25249	25250	O	-1	-1	0
Roetzheim	PMC3820476	25251	25260	O	-1	-1	0
RG	PMC3820476	25261	25263	O	-1	-1	0
.	PMC3820476	25263	25264	O	-1	-1	0

Comorbid	PMC3820476	25265	25273	O	-1	-1	0
illness	PMC3820476	25274	25281	O	-1	-1	0
and	PMC3820476	25282	25285	O	-1	-1	0
the	PMC3820476	25286	25289	O	-1	-1	0
early	PMC3820476	25290	25295	O	-1	-1	0
detection	PMC3820476	25296	25305	O	-1	-1	0
of	PMC3820476	25306	25308	O	-1	-1	0
cancer	PMC3820476	25309	25315	O	-1	-1	0
.	PMC3820476	25315	25316	O	-1	-1	0

South	PMC3820476	25317	25322	O	-1	-1	0
Med	PMC3820476	25323	25326	O	-1	-1	0
J.	PMC3820476	25327	25329	O	-1	-1	0
2001;94(9):913–920	PMC3820476	25330	25348	O	-1	-1	0
.	PMC3820476	25348	25349	O	-1	-1	0

23	PMC3820476	25350	25352	O	-1	-1	0
.	PMC3820476	25352	25353	O	-1	-1	0

Yasmeen	PMC3820476	25354	25361	O	-1	-1	0
S	PMC3820476	25362	25363	O	-1	-1	0
,	PMC3820476	25363	25364	O	-1	-1	0
Xing	PMC3820476	25365	25369	O	-1	-1	0
G	PMC3820476	25370	25371	O	-1	-1	0
,	PMC3820476	25371	25372	O	-1	-1	0
Morris	PMC3820476	25373	25379	O	-1	-1	0
C	PMC3820476	25380	25381	O	-1	-1	0
,	PMC3820476	25381	25382	O	-1	-1	0
Chlebowski	PMC3820476	25383	25393	O	-1	-1	0
RT	PMC3820476	25394	25396	O	-1	-1	0
,	PMC3820476	25396	25397	O	-1	-1	0
Romano	PMC3820476	25398	25404	O	-1	-1	0
PS	PMC3820476	25405	25407	O	-1	-1	0
.	PMC3820476	25407	25408	O	-1	-1	0

Comorbidities	PMC3820476	25409	25422	O	-1	-1	0
and	PMC3820476	25423	25426	O	-1	-1	0
mammography	PMC3820476	25427	25438	O	-1	-1	0
use	PMC3820476	25439	25442	O	-1	-1	0
interact	PMC3820476	25443	25451	O	-1	-1	0
to	PMC3820476	25452	25454	O	-1	-1	0
explain	PMC3820476	25455	25462	O	-1	-1	0
racial	PMC3820476	25463	25469	O	-1	-1	0
/	PMC3820476	25469	25470	O	-1	-1	0
ethnic	PMC3820476	25470	25476	O	-1	-1	0
disparities	PMC3820476	25477	25488	O	-1	-1	0
in	PMC3820476	25489	25491	O	-1	-1	0
breast	PMC3820476	25492	25498	O	-1	-1	0
cancer	PMC3820476	25499	25505	O	-1	-1	0
stage	PMC3820476	25506	25511	O	-1	-1	0
at	PMC3820476	25512	25514	O	-1	-1	0
diagnosis	PMC3820476	25515	25524	O	-1	-1	0
.	PMC3820476	25524	25525	O	-1	-1	0

Cancer	PMC3820476	25526	25532	O	-1	-1	0
.	PMC3820476	25532	25533	O	-1	-1	0

2011;117(14):3252–3261	PMC3820476	25534	25556	O	-1	-1	0
.	PMC3820476	25556	25557	O	-1	-1	0
24	PMC3820476	25558	25560	O	-1	-1	0
.	PMC3820476	25560	25561	O	-1	-1	0

Yancik	PMC3820476	25562	25568	O	-1	-1	0
R	PMC3820476	25569	25570	O	-1	-1	0
,	PMC3820476	25570	25571	O	-1	-1	0
Wesley	PMC3820476	25572	25578	O	-1	-1	0
MN	PMC3820476	25579	25581	O	-1	-1	0
,	PMC3820476	25581	25582	O	-1	-1	0
Ries	PMC3820476	25583	25587	O	-1	-1	0
LA	PMC3820476	25588	25590	O	-1	-1	0
,	PMC3820476	25590	25591	O	-1	-1	0
Havlik	PMC3820476	25592	25598	O	-1	-1	0
RJ	PMC3820476	25599	25601	O	-1	-1	0
,	PMC3820476	25601	25602	O	-1	-1	0
Edwards	PMC3820476	25603	25610	O	-1	-1	0
BK	PMC3820476	25611	25613	O	-1	-1	0
,	PMC3820476	25613	25614	O	-1	-1	0
Yates	PMC3820476	25615	25620	O	-1	-1	0
JW	PMC3820476	25621	25623	O	-1	-1	0
.	PMC3820476	25623	25624	O	-1	-1	0
Effect	PMC3820476	25625	25631	O	-1	-1	0
of	PMC3820476	25632	25634	O	-1	-1	0
age	PMC3820476	25635	25638	O	-1	-1	0
and	PMC3820476	25639	25642	O	-1	-1	0
comorbidity	PMC3820476	25643	25654	O	-1	-1	0
in	PMC3820476	25655	25657	O	-1	-1	0
postmenopausal	PMC3820476	25658	25672	O	-1	-1	0
breast	PMC3820476	25673	25679	O	-1	-1	0
cancer	PMC3820476	25680	25686	O	-1	-1	0
patients	PMC3820476	25687	25695	O	-1	-1	0
aged	PMC3820476	25696	25700	O	-1	-1	0
55	PMC3820476	25701	25703	O	-1	-1	0
years	PMC3820476	25704	25709	O	-1	-1	0
and	PMC3820476	25710	25713	O	-1	-1	0
older	PMC3820476	25714	25719	O	-1	-1	0
.	PMC3820476	25719	25720	O	-1	-1	0

JAMA	PMC3820476	25721	25725	O	-1	-1	0
.	PMC3820476	25725	25726	O	-1	-1	0

2001;285(7):885–892	PMC3820476	25727	25746	O	-1	-1	0
.	PMC3820476	25746	25747	O	-1	-1	0

25	PMC3820476	25748	25750	O	-1	-1	0
.	PMC3820476	25750	25751	O	-1	-1	0

Berglund	PMC3820476	25752	25760	O	-1	-1	0
A	PMC3820476	25761	25762	O	-1	-1	0
,	PMC3820476	25762	25763	O	-1	-1	0
Wigertz	PMC3820476	25764	25771	O	-1	-1	0
A	PMC3820476	25772	25773	O	-1	-1	0
,	PMC3820476	25773	25774	O	-1	-1	0
Adolfsson	PMC3820476	25775	25784	O	-1	-1	0
J	PMC3820476	25785	25786	O	-1	-1	0
,	PMC3820476	25786	25787	O	-1	-1	0
et	PMC3820476	25788	25790	O	-1	-1	0
al	PMC3820476	25791	25793	O	-1	-1	0
.	PMC3820476	25793	25794	O	-1	-1	0

Impact	PMC3820476	25795	25801	O	-1	-1	0
of	PMC3820476	25802	25804	O	-1	-1	0
comorbidity	PMC3820476	25805	25816	O	-1	-1	0
on	PMC3820476	25817	25819	O	-1	-1	0
management	PMC3820476	25820	25830	O	-1	-1	0
and	PMC3820476	25831	25834	O	-1	-1	0
mortality	PMC3820476	25835	25844	O	-1	-1	0
in	PMC3820476	25845	25847	O	-1	-1	0
women	PMC3820476	25848	25853	O	-1	-1	0
diagnosed	PMC3820476	25854	25863	O	-1	-1	0
with	PMC3820476	25864	25868	O	-1	-1	0
breast	PMC3820476	25869	25875	O	-1	-1	0
cancer	PMC3820476	25876	25882	O	-1	-1	0
.	PMC3820476	25882	25883	O	-1	-1	0

Breast	PMC3820476	25884	25890	O	-1	-1	0
Cancer	PMC3820476	25891	25897	O	-1	-1	0
Res	PMC3820476	25898	25901	O	-1	-1	0
Treat	PMC3820476	25902	25907	O	-1	-1	0
.	PMC3820476	25907	25908	O	-1	-1	0

2012;135(1):281–289	PMC3820476	25909	25928	O	-1	-1	0
.	PMC3820476	25928	25929	O	-1	-1	0

26	PMC3820476	25930	25932	O	-1	-1	0
.	PMC3820476	25932	25933	O	-1	-1	0

Hancke	PMC3820476	25934	25940	O	-1	-1	0
K	PMC3820476	25941	25942	O	-1	-1	0
,	PMC3820476	25942	25943	O	-1	-1	0
Denkinger	PMC3820476	25944	25953	O	-1	-1	0
MD	PMC3820476	25954	25956	O	-1	-1	0
,	PMC3820476	25956	25957	O	-1	-1	0
König	PMC3820476	25958	25963	O	-1	-1	0
J	PMC3820476	25964	25965	O	-1	-1	0
,	PMC3820476	25965	25966	O	-1	-1	0
et	PMC3820476	25967	25969	O	-1	-1	0
al	PMC3820476	25970	25972	O	-1	-1	0
.	PMC3820476	25972	25973	O	-1	-1	0

Standard	PMC3820476	25974	25982	O	-1	-1	0
treatment	PMC3820476	25983	25992	O	-1	-1	0
of	PMC3820476	25993	25995	O	-1	-1	0
female	PMC3820476	25996	26002	O	-1	-1	0
patients	PMC3820476	26003	26011	O	-1	-1	0
with	PMC3820476	26012	26016	O	-1	-1	0
breast	PMC3820476	26017	26023	O	-1	-1	0
cancer	PMC3820476	26024	26030	O	-1	-1	0
decreases	PMC3820476	26031	26040	O	-1	-1	0
substantially	PMC3820476	26041	26054	O	-1	-1	0
for	PMC3820476	26055	26058	O	-1	-1	0
women	PMC3820476	26059	26064	O	-1	-1	0

aged	PMC3820476	26065	26069	O	-1	-1	0
70	PMC3820476	26070	26072	O	-1	-1	0
years	PMC3820476	26073	26078	O	-1	-1	0
and	PMC3820476	26079	26082	O	-1	-1	0
older	PMC3820476	26083	26088	O	-1	-1	0
:	PMC3820476	26088	26089	O	-1	-1	0

a	PMC3820476	26090	26091	O	-1	-1	0
German	PMC3820476	26092	26098	O	-1	-1	0
clinical	PMC3820476	26099	26107	O	-1	-1	0
cohort	PMC3820476	26108	26114	O	-1	-1	0
study	PMC3820476	26115	26120	O	-1	-1	0
.	PMC3820476	26120	26121	O	-1	-1	0

Ann	PMC3820476	26122	26125	O	-1	-1	0
Oncol	PMC3820476	26126	26131	O	-1	-1	0
.	PMC3820476	26131	26132	O	-1	-1	0

2010;21(4):748–753	PMC3820476	26133	26151	O	-1	-1	0
.	PMC3820476	26151	26152	O	-1	-1	0


	PMC3820476	26152	26154	O	-1	-1	0

Clinical	PMC3820476	26154	26162	O	-1	-1	0
Epidemiology	PMC3820476	26163	26175	O	-1	-1	0
2013:5	PMC3820476	26176	26182	O	-1	-1	0

(	PMC3820476	26183	26184	O	-1	-1	0
Suppl	PMC3820476	26184	26189	O	-1	-1	0
1	PMC3820476	26190	26191	O	-1	-1	0
)	PMC3820476	26191	26192	O	-1	-1	0


	PMC3820476	26192	26194	O	-1	-1	0

Dovepress	PMC3820476	26194	26203	O	-1	-1	0


	PMC3820476	26203	26205	O	-1	-1	0
Comorbidity	PMC3820476	26205	26216	O	-1	-1	0
and	PMC3820476	26217	26220	O	-1	-1	0
survival	PMC3820476	26221	26229	O	-1	-1	0
of	PMC3820476	26230	26232	O	-1	-1	0
Danish	PMC3820476	26233	26239	O	-1	-1	0
breast	PMC3820476	26240	26246	O	-1	-1	0
cancer	PMC3820476	26247	26253	O	-1	-1	0
patients	PMC3820476	26254	26262	O	-1	-1	0


	PMC3820476	26262	26264	O	-1	-1	0

Supplementary	PMC3820476	26264	26277	O	-1	-1	0
tables	PMC3820476	26278	26284	O	-1	-1	0

Table	PMC3820476	26285	26290	O	-1	-1	0
S1	PMC3820476	26291	26293	O	-1	-1	0
Specification	PMC3820476	26294	26307	O	-1	-1	0
of	PMC3820476	26308	26310	O	-1	-1	0
Charlson	PMC3820476	26311	26319	O	-1	-1	0
diseases	PMC3820476	26320	26328	O	-1	-1	0
,	PMC3820476	26328	26329	O	-1	-1	0
International	PMC3820476	26330	26343	O	-1	-1	0
Classification	PMC3820476	26344	26358	O	-1	-1	0
of	PMC3820476	26359	26361	O	-1	-1	0
Diseases	PMC3820476	26362	26370	O	-1	-1	0
(	PMC3820476	26371	26372	O	-1	-1	0
ICD)-8	PMC3820476	26372	26378	O	-1	-1	0
and	PMC3820476	26379	26382	O	-1	-1	0
ICD-10	PMC3820476	26383	26389	O	-1	-1	0
codes	PMC3820476	26390	26395	O	-1	-1	0
,	PMC3820476	26395	26396	O	-1	-1	0
and	PMC3820476	26397	26400	O	-1	-1	0
the	PMC3820476	26401	26404	O	-1	-1	0
Charlson	PMC3820476	26405	26413	O	-1	-1	0
weight	PMC3820476	26414	26420	O	-1	-1	0

Charlson	PMC3820476	26421	26429	O	-1	-1	0
comorbidity	PMC3820476	26430	26441	O	-1	-1	0

index	PMC3820476	26442	26447	O	-1	-1	0
variable	PMC3820476	26448	26456	O	-1	-1	0


	PMC3820476	26456	26458	O	-1	-1	0

ICD-8	PMC3820476	26458	26463	O	-1	-1	0


	PMC3820476	26463	26465	O	-1	-1	0
ICD-10	PMC3820476	26465	26471	O	-1	-1	0


	PMC3820476	26471	26473	O	-1	-1	0

Charlson	PMC3820476	26473	26481	O	-1	-1	0

weight	PMC3820476	26482	26488	O	-1	-1	0


	PMC3820476	26488	26490	O	-1	-1	0

Myocardial	PMC3820476	26490	26500	O	-1	-1	0
infarction	PMC3820476	26501	26511	O	-1	-1	0

Congestive	PMC3820476	26512	26522	O	-1	-1	0
heart	PMC3820476	26523	26528	O	-1	-1	0
failure	PMC3820476	26529	26536	O	-1	-1	0


	PMC3820476	26536	26538	O	-1	-1	0
I21	PMC3820476	26538	26541	O	-1	-1	0
,	PMC3820476	26541	26542	O	-1	-1	0
I22	PMC3820476	26543	26546	O	-1	-1	0
,	PMC3820476	26546	26547	O	-1	-1	0
I23	PMC3820476	26548	26551	O	-1	-1	0

I50	PMC3820476	26552	26555	O	-1	-1	0
,	PMC3820476	26555	26556	O	-1	-1	0
I11.0	PMC3820476	26557	26562	O	-1	-1	0
,	PMC3820476	26562	26563	O	-1	-1	0
I13.0	PMC3820476	26564	26569	O	-1	-1	0
,	PMC3820476	26569	26570	O	-1	-1	0

I13.2	PMC3820476	26571	26576	O	-1	-1	0


	PMC3820476	26576	26578	O	-1	-1	0

1	PMC3820476	26578	26579	O	-1	-1	0

1	PMC3820476	26580	26581	O	-1	-1	0


	PMC3820476	26581	26583	O	-1	-1	0

Peripheral	PMC3820476	26583	26593	O	-1	-1	0
vascular	PMC3820476	26594	26602	O	-1	-1	0
disease	PMC3820476	26603	26610	O	-1	-1	0

Cerebrovascular	PMC3820476	26611	26626	O	-1	-1	0
disease	PMC3820476	26627	26634	O	-1	-1	0

Dementia	PMC3820476	26635	26643	O	-1	-1	0

Chronic	PMC3820476	26644	26651	O	-1	-1	0
pulmonary	PMC3820476	26652	26661	O	-1	-1	0
disease	PMC3820476	26662	26669	O	-1	-1	0


	PMC3820476	26669	26671	O	-1	-1	0
410	PMC3820476	26671	26674	O	-1	-1	0
427.09	PMC3820476	26675	26681	O	-1	-1	0
,	PMC3820476	26681	26682	O	-1	-1	0
427.10	PMC3820476	26683	26689	O	-1	-1	0
,	PMC3820476	26689	26690	O	-1	-1	0
427.11	PMC3820476	26691	26697	O	-1	-1	0
,	PMC3820476	26697	26698	O	-1	-1	0
427.19	PMC3820476	26699	26705	O	-1	-1	0
,	PMC3820476	26705	26706	O	-1	-1	0
428.99	PMC3820476	26707	26713	O	-1	-1	0
,	PMC3820476	26713	26714	O	-1	-1	0
782.49	PMC3820476	26715	26721	O	-1	-1	0

440	PMC3820476	26722	26725	O	-1	-1	0
,	PMC3820476	26725	26726	O	-1	-1	0
441	PMC3820476	26727	26730	O	-1	-1	0
,	PMC3820476	26730	26731	O	-1	-1	0
442	PMC3820476	26732	26735	O	-1	-1	0
,	PMC3820476	26735	26736	O	-1	-1	0
443	PMC3820476	26737	26740	O	-1	-1	0
,	PMC3820476	26740	26741	O	-1	-1	0
444	PMC3820476	26742	26745	O	-1	-1	0
,	PMC3820476	26745	26746	O	-1	-1	0
445	PMC3820476	26747	26750	O	-1	-1	0

430–438	PMC3820476	26751	26758	O	-1	-1	0

290.09–290.19	PMC3820476	26759	26772	O	-1	-1	0
,	PMC3820476	26772	26773	O	-1	-1	0
293.09	PMC3820476	26774	26780	O	-1	-1	0
490–493	PMC3820476	26781	26788	O	-1	-1	0
,	PMC3820476	26788	26789	O	-1	-1	0
515–518	PMC3820476	26790	26797	O	-1	-1	0


	PMC3820476	26797	26799	O	-1	-1	0
1	PMC3820476	26799	26800	O	-1	-1	0

1	PMC3820476	26801	26802	O	-1	-1	0

1	PMC3820476	26803	26804	O	-1	-1	0

1	PMC3820476	26805	26806	O	-1	-1	0


	PMC3820476	26806	26808	O	-1	-1	0

Connective	PMC3820476	26808	26818	O	-1	-1	0
tissue	PMC3820476	26819	26825	O	-1	-1	0
disease	PMC3820476	26826	26833	O	-1	-1	0


	PMC3820476	26833	26835	O	-1	-1	0
712	PMC3820476	26835	26838	O	-1	-1	0
,	PMC3820476	26838	26839	O	-1	-1	0
716	PMC3820476	26840	26843	O	-1	-1	0
,	PMC3820476	26843	26844	O	-1	-1	0
734	PMC3820476	26845	26848	O	-1	-1	0
,	PMC3820476	26848	26849	O	-1	-1	0
446	PMC3820476	26850	26853	O	-1	-1	0
,	PMC3820476	26853	26854	O	-1	-1	0
135.99	PMC3820476	26855	26861	O	-1	-1	0


	PMC3820476	26861	26863	O	-1	-1	0

Ulcer	PMC3820476	26863	26868	O	-1	-1	0
disease	PMC3820476	26869	26876	O	-1	-1	0

Mild	PMC3820476	26877	26881	O	-1	-1	0
liver	PMC3820476	26882	26887	O	-1	-1	0
disease	PMC3820476	26888	26895	O	-1	-1	0


	PMC3820476	26895	26897	O	-1	-1	0
530.91	PMC3820476	26897	26903	O	-1	-1	0
,	PMC3820476	26903	26904	O	-1	-1	0
530.98	PMC3820476	26905	26911	O	-1	-1	0
,	PMC3820476	26911	26912	O	-1	-1	0
531–534	PMC3820476	26913	26920	O	-1	-1	0
571	PMC3820476	26921	26924	O	-1	-1	0
,	PMC3820476	26924	26925	O	-1	-1	0
573.01	PMC3820476	26926	26932	O	-1	-1	0
,	PMC3820476	26932	26933	O	-1	-1	0
573.04	PMC3820476	26934	26940	O	-1	-1	0


	PMC3820476	26940	26942	O	-1	-1	0

Diabetes	PMC3820476	26942	26950	O	-1	-1	0
type	PMC3820476	26951	26955	O	-1	-1	0
1	PMC3820476	26956	26957	O	-1	-1	0

Diabetes	PMC3820476	26958	26966	O	-1	-1	0
type	PMC3820476	26967	26971	O	-1	-1	0
2	PMC3820476	26972	26973	O	-1	-1	0

Hemiplegia	PMC3820476	26974	26984	O	-1	-1	0
Moderate	PMC3820476	26985	26993	O	-1	-1	0
-	PMC3820476	26993	26994	O	-1	-1	0
to	PMC3820476	26994	26996	O	-1	-1	0
-	PMC3820476	26996	26997	O	-1	-1	0
severe	PMC3820476	26997	27003	O	-1	-1	0
renal	PMC3820476	27004	27009	O	-1	-1	0
disease	PMC3820476	27010	27017	O	-1	-1	0


	PMC3820476	27017	27019	O	-1	-1	0
249.00	PMC3820476	27019	27025	O	-1	-1	0
,	PMC3820476	27025	27026	O	-1	-1	0
249.06	PMC3820476	27027	27033	O	-1	-1	0
,	PMC3820476	27033	27034	O	-1	-1	0
249.07	PMC3820476	27035	27041	O	-1	-1	0
,	PMC3820476	27041	27042	O	-1	-1	0
249.09	PMC3820476	27043	27049	O	-1	-1	0
250.00	PMC3820476	27050	27056	O	-1	-1	0
,	PMC3820476	27056	27057	O	-1	-1	0
250.06	PMC3820476	27058	27064	O	-1	-1	0
,	PMC3820476	27064	27065	O	-1	-1	0
250.07	PMC3820476	27066	27072	O	-1	-1	0
,	PMC3820476	27072	27073	O	-1	-1	0
250.09	PMC3820476	27074	27080	O	-1	-1	0

344	PMC3820476	27081	27084	O	-1	-1	0

403	PMC3820476	27085	27088	O	-1	-1	0
,	PMC3820476	27088	27089	O	-1	-1	0
404	PMC3820476	27090	27093	O	-1	-1	0
,	PMC3820476	27093	27094	O	-1	-1	0
580–583	PMC3820476	27095	27102	O	-1	-1	0
,	PMC3820476	27102	27103	O	-1	-1	0
584	PMC3820476	27104	27107	O	-1	-1	0
,	PMC3820476	27107	27108	O	-1	-1	0
590.09	PMC3820476	27109	27115	O	-1	-1	0
,	PMC3820476	27115	27116	O	-1	-1	0
593.19	PMC3820476	27117	27123	O	-1	-1	0
,	PMC3820476	27123	27124	O	-1	-1	0
753.10–753.19	PMC3820476	27125	27138	O	-1	-1	0
,	PMC3820476	27138	27139	O	-1	-1	0
792	PMC3820476	27140	27143	O	-1	-1	0


	PMC3820476	27143	27145	O	-1	-1	0
I70	PMC3820476	27145	27148	O	-1	-1	0
,	PMC3820476	27148	27149	O	-1	-1	0
I71	PMC3820476	27150	27153	O	-1	-1	0
,	PMC3820476	27153	27154	O	-1	-1	0
I72	PMC3820476	27155	27158	O	-1	-1	0
,	PMC3820476	27158	27159	O	-1	-1	0
I73	PMC3820476	27160	27163	O	-1	-1	0
,	PMC3820476	27163	27164	O	-1	-1	0
I74	PMC3820476	27165	27168	O	-1	-1	0
,	PMC3820476	27168	27169	O	-1	-1	0
I77	PMC3820476	27170	27173	O	-1	-1	0

I60–I69	PMC3820476	27174	27181	O	-1	-1	0
,	PMC3820476	27181	27182	O	-1	-1	0
G45	PMC3820476	27183	27186	O	-1	-1	0
,	PMC3820476	27186	27187	O	-1	-1	0
G46	PMC3820476	27188	27191	O	-1	-1	0

F00–F03	PMC3820476	27192	27199	O	-1	-1	0
,	PMC3820476	27199	27200	O	-1	-1	0
F05.1	PMC3820476	27201	27206	O	-1	-1	0
,	PMC3820476	27206	27207	O	-1	-1	0
G30	PMC3820476	27208	27211	O	-1	-1	0

J40–J47	PMC3820476	27212	27219	O	-1	-1	0
,	PMC3820476	27219	27220	O	-1	-1	0
J60–J67	PMC3820476	27221	27228	O	-1	-1	0
,	PMC3820476	27228	27229	O	-1	-1	0
J68.4	PMC3820476	27230	27235	O	-1	-1	0
,	PMC3820476	27235	27236	O	-1	-1	0
J70.1	PMC3820476	27237	27242	O	-1	-1	0
,	PMC3820476	27242	27243	O	-1	-1	0
J70.3	PMC3820476	27244	27249	O	-1	-1	0
,	PMC3820476	27249	27250	O	-1	-1	0

J84.1	PMC3820476	27251	27256	O	-1	-1	0
,	PMC3820476	27256	27257	O	-1	-1	0
J92.0	PMC3820476	27258	27263	O	-1	-1	0
,	PMC3820476	27263	27264	O	-1	-1	0
J96.1	PMC3820476	27265	27270	O	-1	-1	0
,	PMC3820476	27270	27271	O	-1	-1	0
J98.2	PMC3820476	27272	27277	O	-1	-1	0
,	PMC3820476	27277	27278	O	-1	-1	0
J98.3	PMC3820476	27279	27284	O	-1	-1	0

M05	PMC3820476	27285	27288	O	-1	-1	0
,	PMC3820476	27288	27289	O	-1	-1	0
M06	PMC3820476	27290	27293	O	-1	-1	0
,	PMC3820476	27293	27294	O	-1	-1	0
M08	PMC3820476	27295	27298	O	-1	-1	0
,	PMC3820476	27298	27299	O	-1	-1	0
M09	PMC3820476	27300	27303	O	-1	-1	0
,	PMC3820476	27303	27304	O	-1	-1	0
M30	PMC3820476	27305	27308	O	-1	-1	0
,	PMC3820476	27308	27309	O	-1	-1	0
M31	PMC3820476	27310	27313	O	-1	-1	0
,	PMC3820476	27313	27314	O	-1	-1	0

M32	PMC3820476	27315	27318	O	-1	-1	0
,	PMC3820476	27318	27319	O	-1	-1	0
M33	PMC3820476	27320	27323	O	-1	-1	0
,	PMC3820476	27323	27324	O	-1	-1	0
M34	PMC3820476	27325	27328	O	-1	-1	0
,	PMC3820476	27328	27329	O	-1	-1	0
M35	PMC3820476	27330	27333	O	-1	-1	0
,	PMC3820476	27333	27334	O	-1	-1	0
M36	PMC3820476	27335	27338	O	-1	-1	0
,	PMC3820476	27338	27339	O	-1	-1	0
D86	PMC3820476	27340	27343	O	-1	-1	0
K22.1	PMC3820476	27344	27349	O	-1	-1	0
,	PMC3820476	27349	27350	O	-1	-1	0

K25–K28	PMC3820476	27351	27358	O	-1	-1	0

B18	PMC3820476	27359	27362	O	-1	-1	0
,	PMC3820476	27362	27363	O	-1	-1	0
K70.0-K70.3	PMC3820476	27364	27375	O	-1	-1	0
,	PMC3820476	27375	27376	O	-1	-1	0
K70.9	PMC3820476	27377	27382	O	-1	-1	0
,	PMC3820476	27382	27383	O	-1	-1	0
K71	PMC3820476	27384	27387	O	-1	-1	0
,	PMC3820476	27387	27388	O	-1	-1	0
K73	PMC3820476	27389	27392	O	-1	-1	0
,	PMC3820476	27392	27393	O	-1	-1	0
K74	PMC3820476	27394	27397	O	-1	-1	0

,	PMC3820476	27397	27398	O	-1	-1	0
K76.0	PMC3820476	27399	27404	O	-1	-1	0
E10.0	PMC3820476	27405	27410	O	-1	-1	0
,	PMC3820476	27410	27411	O	-1	-1	0
E10.1	PMC3820476	27412	27417	O	-1	-1	0
,	PMC3820476	27417	27418	O	-1	-1	0
E10.9	PMC3820476	27419	27424	O	-1	-1	0

E11.0	PMC3820476	27425	27430	O	-1	-1	0
,	PMC3820476	27430	27431	O	-1	-1	0
E11.1	PMC3820476	27432	27437	O	-1	-1	0
,	PMC3820476	27437	27438	O	-1	-1	0
E11.9	PMC3820476	27439	27444	O	-1	-1	0

G81	PMC3820476	27445	27448	O	-1	-1	0
,	PMC3820476	27448	27449	O	-1	-1	0
G82	PMC3820476	27450	27453	O	-1	-1	0

I12	PMC3820476	27454	27457	O	-1	-1	0
,	PMC3820476	27457	27458	O	-1	-1	0
I13	PMC3820476	27459	27462	O	-1	-1	0
,	PMC3820476	27462	27463	O	-1	-1	0
N00–N05	PMC3820476	27464	27471	O	-1	-1	0
,	PMC3820476	27471	27472	O	-1	-1	0
N07	PMC3820476	27473	27476	O	-1	-1	0
,	PMC3820476	27476	27477	O	-1	-1	0
N11	PMC3820476	27478	27481	O	-1	-1	0
,	PMC3820476	27481	27482	O	-1	-1	0
N14	PMC3820476	27483	27486	O	-1	-1	0
,	PMC3820476	27486	27487	O	-1	-1	0

N17–N19	PMC3820476	27488	27495	O	-1	-1	0
,	PMC3820476	27495	27496	O	-1	-1	0

Q61	PMC3820476	27497	27500	O	-1	-1	0


	PMC3820476	27500	27502	O	-1	-1	0
249.01–249.05	PMC3820476	27502	27515	O	-1	-1	0
,	PMC3820476	27515	27516	O	-1	-1	0
249.08	PMC3820476	27517	27523	O	-1	-1	0

250.01–250.05	PMC3820476	27524	27537	O	-1	-1	0
,	PMC3820476	27537	27538	O	-1	-1	0
250.08	PMC3820476	27539	27545	O	-1	-1	0
140–194	PMC3820476	27546	27553	O	-1	-1	0

204–207	PMC3820476	27554	27561	O	-1	-1	0
200–203	PMC3820476	27562	27569	O	-1	-1	0
,	PMC3820476	27569	27570	O	-1	-1	0
275.59	PMC3820476	27571	27577	O	-1	-1	0
070.00	PMC3820476	27578	27584	O	-1	-1	0
,	PMC3820476	27584	27585	O	-1	-1	0
070.02	PMC3820476	27586	27592	O	-1	-1	0
,	PMC3820476	27592	27593	O	-1	-1	0
070.04	PMC3820476	27594	27600	O	-1	-1	0
,	PMC3820476	27600	27601	O	-1	-1	0
070.06	PMC3820476	27602	27608	O	-1	-1	0
,	PMC3820476	27608	27609	O	-1	-1	0

070.08	PMC3820476	27610	27616	O	-1	-1	0
,	PMC3820476	27616	27617	O	-1	-1	0
573.00	PMC3820476	27618	27624	O	-1	-1	0
,	PMC3820476	27624	27625	O	-1	-1	0
456.00–456.09	PMC3820476	27626	27639	O	-1	-1	0

195–198	PMC3820476	27640	27647	O	-1	-1	0
,	PMC3820476	27647	27648	O	-1	-1	0
199	PMC3820476	27649	27652	O	-1	-1	0

079.83	PMC3820476	27653	27659	O	-1	-1	0


	PMC3820476	27659	27661	O	-1	-1	0

E10.2–E10.8	PMC3820476	27661	27672	O	-1	-1	0

E11.2–E11.8	PMC3820476	27673	27684	O	-1	-1	0

C00–C75	PMC3820476	27685	27692	O	-1	-1	0

C91–C95	PMC3820476	27693	27700	O	-1	-1	0

C81–C85	PMC3820476	27701	27708	O	-1	-1	0
,	PMC3820476	27708	27709	O	-1	-1	0
C88	PMC3820476	27710	27713	O	-1	-1	0
,	PMC3820476	27713	27714	O	-1	-1	0
C90	PMC3820476	27715	27718	O	-1	-1	0
,	PMC3820476	27718	27719	O	-1	-1	0
C96	PMC3820476	27720	27723	O	-1	-1	0
B15.0	PMC3820476	27724	27729	O	-1	-1	0
,	PMC3820476	27729	27730	O	-1	-1	0
B16.0	PMC3820476	27731	27736	O	-1	-1	0
,	PMC3820476	27736	27737	O	-1	-1	0
B16.2	PMC3820476	27738	27743	O	-1	-1	0
,	PMC3820476	27743	27744	O	-1	-1	0
B19.0	PMC3820476	27745	27750	O	-1	-1	0
,	PMC3820476	27750	27751	O	-1	-1	0
K70.4	PMC3820476	27752	27757	O	-1	-1	0
,	PMC3820476	27757	27758	O	-1	-1	0
K72	PMC3820476	27759	27762	O	-1	-1	0
,	PMC3820476	27762	27763	O	-1	-1	0
K76.6	PMC3820476	27764	27769	O	-1	-1	0
,	PMC3820476	27769	27770	O	-1	-1	0

I85	PMC3820476	27771	27774	O	-1	-1	0
C76–C80	PMC3820476	27775	27782	O	-1	-1	0

B21–B24	PMC3820476	27783	27790	O	-1	-1	0


	PMC3820476	27790	27792	O	-1	-1	0

Diabetes	PMC3820476	27792	27800	O	-1	-1	0
with	PMC3820476	27801	27805	O	-1	-1	0
end	PMC3820476	27806	27809	O	-1	-1	0
organ	PMC3820476	27810	27815	O	-1	-1	0
damage	PMC3820476	27816	27822	O	-1	-1	0

Type	PMC3820476	27823	27827	O	-1	-1	0
1	PMC3820476	27828	27829	O	-1	-1	0

Type	PMC3820476	27830	27834	O	-1	-1	0
2	PMC3820476	27835	27836	O	-1	-1	0

Any	PMC3820476	27837	27840	O	-1	-1	0
tumor	PMC3820476	27841	27846	O	-1	-1	0

Leukemia	PMC3820476	27847	27855	O	-1	-1	0

Lymphoma	PMC3820476	27856	27864	O	-1	-1	0

Moderate	PMC3820476	27865	27873	O	-1	-1	0
-	PMC3820476	27873	27874	O	-1	-1	0
to	PMC3820476	27874	27876	O	-1	-1	0
-	PMC3820476	27876	27877	O	-1	-1	0
severe	PMC3820476	27877	27883	O	-1	-1	0
liver	PMC3820476	27884	27889	O	-1	-1	0
disease	PMC3820476	27890	27897	O	-1	-1	0


	PMC3820476	27897	27899	O	-1	-1	0
1	PMC3820476	27899	27900	O	-1	-1	0

1	PMC3820476	27901	27902	O	-1	-1	0

1	PMC3820476	27903	27904	O	-1	-1	0

1	PMC3820476	27905	27906	O	-1	-1	0

2	PMC3820476	27907	27908	O	-1	-1	0

2	PMC3820476	27909	27910	O	-1	-1	0

2	PMC3820476	27911	27912	O	-1	-1	0


	PMC3820476	27912	27914	O	-1	-1	0

Metastatic	PMC3820476	27914	27924	O	-1	-1	0
solid	PMC3820476	27925	27930	O	-1	-1	0
tumor	PMC3820476	27931	27936	O	-1	-1	0

AIDS	PMC3820476	27937	27941	O	-1	-1	0


	PMC3820476	27941	27943	O	-1	-1	0

2	PMC3820476	27943	27944	O	-1	-1	0

2	PMC3820476	27945	27946	O	-1	-1	0

2	PMC3820476	27947	27948	O	-1	-1	0

3	PMC3820476	27949	27950	O	-1	-1	0
6	PMC3820476	27951	27952	O	-1	-1	0

6	PMC3820476	27953	27954	O	-1	-1	0


	PMC3820476	27954	27956	O	-1	-1	0

Table	PMC3820476	27956	27961	O	-1	-1	0
S2	PMC3820476	27962	27964	O	-1	-1	0
Distribution	PMC3820476	27965	27977	O	-1	-1	0
of	PMC3820476	27978	27980	O	-1	-1	0
breast	PMC3820476	27981	27987	O	-1	-1	0
cancer	PMC3820476	27988	27994	O	-1	-1	0
patients	PMC3820476	27995	28003	O	-1	-1	0
diagnosed	PMC3820476	28004	28013	O	-1	-1	0
between	PMC3820476	28014	28021	O	-1	-1	0
2000	PMC3820476	28022	28026	O	-1	-1	0
and	PMC3820476	28027	28030	O	-1	-1	0
2011	PMC3820476	28031	28035	O	-1	-1	0
by	PMC3820476	28036	28038	O	-1	-1	0
individual	PMC3820476	28039	28049	O	-1	-1	0
Charlson	PMC3820476	28050	28058	O	-1	-1	0
disease	PMC3820476	28059	28066	O	-1	-1	0
in	PMC3820476	28067	28069	O	-1	-1	0
four	PMC3820476	28070	28074	O	-1	-1	0
calendar	PMC3820476	28075	28083	O	-1	-1	0

time	PMC3820476	28084	28088	O	-1	-1	0
periods	PMC3820476	28089	28096	O	-1	-1	0


	PMC3820476	28096	28098	O	-1	-1	0

Myocardial	PMC3820476	28098	28108	O	-1	-1	0
infarction	PMC3820476	28109	28119	O	-1	-1	0

Congestive	PMC3820476	28120	28130	O	-1	-1	0
heart	PMC3820476	28131	28136	O	-1	-1	0
failure	PMC3820476	28137	28144	O	-1	-1	0

Peripheral	PMC3820476	28145	28155	O	-1	-1	0
vascular	PMC3820476	28156	28164	O	-1	-1	0
disease	PMC3820476	28165	28172	O	-1	-1	0

Cerebrovascular	PMC3820476	28173	28188	O	-1	-1	0
disease	PMC3820476	28189	28196	O	-1	-1	0

Dementia	PMC3820476	28197	28205	O	-1	-1	0

Chronic	PMC3820476	28206	28213	O	-1	-1	0
pulmonary	PMC3820476	28214	28223	O	-1	-1	0
disease	PMC3820476	28224	28231	O	-1	-1	0

Connective	PMC3820476	28232	28242	O	-1	-1	0
tissue	PMC3820476	28243	28249	O	-1	-1	0
disease	PMC3820476	28250	28257	O	-1	-1	0

Ulcer	PMC3820476	28258	28263	O	-1	-1	0
disease	PMC3820476	28264	28271	O	-1	-1	0

Mild	PMC3820476	28272	28276	O	-1	-1	0
liver	PMC3820476	28277	28282	O	-1	-1	0
disease	PMC3820476	28283	28290	O	-1	-1	0

Diabetes	PMC3820476	28291	28299	O	-1	-1	0

I	PMC3820476	28300	28301	O	-1	-1	0
and	PMC3820476	28302	28305	O	-1	-1	0
II	PMC3820476	28306	28308	O	-1	-1	0
Hemiplegia	PMC3820476	28309	28319	O	-1	-1	0

Moderate	PMC3820476	28320	28328	O	-1	-1	0
to	PMC3820476	28329	28331	O	-1	-1	0
severe	PMC3820476	28332	28338	O	-1	-1	0
renal	PMC3820476	28339	28344	O	-1	-1	0
disease	PMC3820476	28345	28352	O	-1	-1	0

Diabetes	PMC3820476	28353	28361	O	-1	-1	0
with	PMC3820476	28362	28366	O	-1	-1	0
end	PMC3820476	28367	28370	O	-1	-1	0
organ	PMC3820476	28371	28376	O	-1	-1	0
damage	PMC3820476	28377	28383	O	-1	-1	0

Any	PMC3820476	28384	28387	O	-1	-1	0
tumor	PMC3820476	28388	28393	O	-1	-1	0

Leukemia	PMC3820476	28394	28402	O	-1	-1	0

Lymphoma	PMC3820476	28403	28411	O	-1	-1	0

Moderate	PMC3820476	28412	28420	O	-1	-1	0
-	PMC3820476	28420	28421	O	-1	-1	0
to	PMC3820476	28421	28423	O	-1	-1	0
-	PMC3820476	28423	28424	O	-1	-1	0
severe	PMC3820476	28424	28430	O	-1	-1	0
liver	PMC3820476	28431	28436	O	-1	-1	0
disease	PMC3820476	28437	28444	O	-1	-1	0

Metastatic	PMC3820476	28445	28455	O	-1	-1	0
solid	PMC3820476	28456	28461	O	-1	-1	0
tumor	PMC3820476	28462	28467	O	-1	-1	0

AIDS	PMC3820476	28468	28472	O	-1	-1	0

Total	PMC3820476	28473	28478	O	-1	-1	0


	PMC3820476	28478	28480	O	-1	-1	0

Clinical	PMC3820476	28480	28488	O	-1	-1	0
Epidemiology	PMC3820476	28489	28501	O	-1	-1	0
2013:5	PMC3820476	28502	28508	O	-1	-1	0

(	PMC3820476	28509	28510	O	-1	-1	0
Suppl	PMC3820476	28510	28515	O	-1	-1	0
1	PMC3820476	28516	28517	O	-1	-1	0
)	PMC3820476	28517	28518	O	-1	-1	0


	PMC3820476	28518	28520	O	-1	-1	0

Calendar	PMC3820476	28520	28528	O	-1	-1	0
time	PMC3820476	28529	28533	O	-1	-1	0
period	PMC3820476	28534	28540	O	-1	-1	0

2000–2002	PMC3820476	28541	28550	O	-1	-1	0

2003–2005	PMC3820476	28551	28560	O	-1	-1	0

N	PMC3820476	28561	28562	O	-1	-1	0

%	PMC3820476	28563	28564	O	-1	-1	0

N	PMC3820476	28565	28566	O	-1	-1	0

%	PMC3820476	28567	28568	O	-1	-1	0


	PMC3820476	28568	28570	O	-1	-1	0

2006–2008	PMC3820476	28570	28579	O	-1	-1	0

N	PMC3820476	28580	28581	O	-1	-1	0

%	PMC3820476	28582	28583	O	-1	-1	0


	PMC3820476	28583	28585	O	-1	-1	0

2009–2011	PMC3820476	28585	28594	O	-1	-1	0

N	PMC3820476	28595	28596	O	-1	-1	0

%	PMC3820476	28597	28598	O	-1	-1	0


	PMC3820476	28598	28600	O	-1	-1	0

N	PMC3820476	28600	28601	O	-1	-1	0


	PMC3820476	28601	28603	O	-1	-1	0

%	PMC3820476	28603	28604	O	-1	-1	0


	PMC3820476	28604	28606	O	-1	-1	0
28	PMC3820476	28606	28608	O	-1	-1	0

43	PMC3820476	28609	28611	O	-1	-1	0

52	PMC3820476	28612	28614	O	-1	-1	0

79	PMC3820476	28615	28617	O	-1	-1	0

6	PMC3820476	28618	28619	O	-1	-1	0

91	PMC3820476	28620	28622	O	-1	-1	0

52	PMC3820476	28623	28625	O	-1	-1	0

39	PMC3820476	28626	28628	O	-1	-1	0

8	PMC3820476	28629	28630	O	-1	-1	0

37	PMC3820476	28631	28633	O	-1	-1	0

7	PMC3820476	28634	28635	O	-1	-1	0

6	PMC3820476	28636	28637	O	-1	-1	0

21	PMC3820476	28638	28640	O	-1	-1	0

80	PMC3820476	28641	28643	O	-1	-1	0

2	PMC3820476	28644	28645	O	-1	-1	0

6	PMC3820476	28646	28647	O	-1	-1	0

3	PMC3820476	28648	28649	O	-1	-1	0

7	PMC3820476	28650	28651	O	-1	-1	0
0	PMC3820476	28652	28653	O	-1	-1	0

1,980	PMC3820476	28654	28659	O	-1	-1	0


	PMC3820476	28659	28661	O	-1	-1	0

38	PMC3820476	28661	28663	O	-1	-1	0

49	PMC3820476	28664	28666	O	-1	-1	0

47	PMC3820476	28667	28669	O	-1	-1	0

102	PMC3820476	28670	28673	O	-1	-1	0

14	PMC3820476	28674	28676	O	-1	-1	0

134	PMC3820476	28677	28680	O	-1	-1	0

58	PMC3820476	28681	28683	O	-1	-1	0

54	PMC3820476	28684	28686	O	-1	-1	0

18	PMC3820476	28687	28689	O	-1	-1	0
49	PMC3820476	28690	28692	O	-1	-1	0

4	PMC3820476	28693	28694	O	-1	-1	0

27	PMC3820476	28695	28697	O	-1	-1	0

40	PMC3820476	28698	28700	O	-1	-1	0

90	PMC3820476	28701	28703	O	-1	-1	0

0	PMC3820476	28704	28705	O	-1	-1	0

12	PMC3820476	28706	28708	O	-1	-1	0

5	PMC3820476	28709	28710	O	-1	-1	0

22	PMC3820476	28711	28713	O	-1	-1	0
0	PMC3820476	28714	28715	O	-1	-1	0

2,410	PMC3820476	28716	28721	O	-1	-1	0


	PMC3820476	28721	28723	O	-1	-1	0

32	PMC3820476	28723	28725	O	-1	-1	0

47	PMC3820476	28726	28728	O	-1	-1	0

69	PMC3820476	28729	28731	O	-1	-1	0

116	PMC3820476	28732	28735	O	-1	-1	0

16	PMC3820476	28736	28738	O	-1	-1	0

145	PMC3820476	28739	28742	O	-1	-1	0

75	PMC3820476	28743	28745	O	-1	-1	0

49	PMC3820476	28746	28748	O	-1	-1	0

23	PMC3820476	28749	28751	O	-1	-1	0

73	PMC3820476	28752	28754	O	-1	-1	0

4	PMC3820476	28755	28756	O	-1	-1	0

23	PMC3820476	28757	28759	O	-1	-1	0

38	PMC3820476	28760	28762	O	-1	-1	0

130	PMC3820476	28763	28766	O	-1	-1	0

4	PMC3820476	28767	28768	O	-1	-1	0

9	PMC3820476	28769	28770	O	-1	-1	0

3	PMC3820476	28771	28772	O	-1	-1	0

22	PMC3820476	28773	28775	O	-1	-1	0
0	PMC3820476	28776	28777	O	-1	-1	0

2,945	PMC3820476	28778	28783	O	-1	-1	0


	PMC3820476	28783	28785	O	-1	-1	0

134	PMC3820476	28785	28788	O	-1	-1	0

196	PMC3820476	28789	28792	O	-1	-1	0

222	PMC3820476	28793	28796	O	-1	-1	0

388	PMC3820476	28797	28800	O	-1	-1	0

45	PMC3820476	28801	28803	O	-1	-1	0

475	PMC3820476	28804	28807	O	-1	-1	0

222	PMC3820476	28808	28811	O	-1	-1	0

178	PMC3820476	28812	28815	O	-1	-1	0

53	PMC3820476	28816	28818	O	-1	-1	0

199	PMC3820476	28819	28822	O	-1	-1	0

20	PMC3820476	28823	28825	O	-1	-1	0

71	PMC3820476	28826	28828	O	-1	-1	0

140	PMC3820476	28829	28832	O	-1	-1	0

362	PMC3820476	28833	28836	O	-1	-1	0

7	PMC3820476	28837	28838	O	-1	-1	0

30	PMC3820476	28839	28841	O	-1	-1	0

14	PMC3820476	28842	28844	O	-1	-1	0

67	PMC3820476	28845	28847	O	-1	-1	0

0	PMC3820476	28848	28849	O	-1	-1	0

9,329	PMC3820476	28850	28855	O	-1	-1	0


	PMC3820476	28855	28857	O	-1	-1	0

1.4	PMC3820476	28857	28860	O	-1	-1	0

2.1	PMC3820476	28861	28864	O	-1	-1	0

2.4	PMC3820476	28865	28868	O	-1	-1	0

4.2	PMC3820476	28869	28872	O	-1	-1	0

0.5	PMC3820476	28873	28876	O	-1	-1	0

5.1	PMC3820476	28877	28880	O	-1	-1	0

2.4	PMC3820476	28881	28884	O	-1	-1	0

1.9	PMC3820476	28885	28888	O	-1	-1	0
0.6	PMC3820476	28889	28892	O	-1	-1	0

2.1	PMC3820476	28893	28896	O	-1	-1	0

0.2	PMC3820476	28897	28900	O	-1	-1	0

0.8	PMC3820476	28901	28904	O	-1	-1	0

1.5	PMC3820476	28905	28908	O	-1	-1	0

3.9	PMC3820476	28909	28912	O	-1	-1	0
0.1	PMC3820476	28913	28916	O	-1	-1	0

0.3	PMC3820476	28917	28920	O	-1	-1	0

0.2	PMC3820476	28921	28924	O	-1	-1	0
0.7	PMC3820476	28925	28928	O	-1	-1	0


	PMC3820476	28928	28930	O	-1	-1	0

1.4	PMC3820476	28930	28933	O	-1	-1	0

2.2	PMC3820476	28934	28937	O	-1	-1	0

2.6	PMC3820476	28938	28941	O	-1	-1	0

4.0	PMC3820476	28942	28945	O	-1	-1	0

0.3	PMC3820476	28946	28949	O	-1	-1	0

4.6	PMC3820476	28950	28953	O	-1	-1	0

2.6	PMC3820476	28954	28957	O	-1	-1	0

2.0	PMC3820476	28958	28961	O	-1	-1	0
0.4	PMC3820476	28962	28965	O	-1	-1	0

1.9	PMC3820476	28966	28969	O	-1	-1	0

0.4	PMC3820476	28970	28973	O	-1	-1	0
0.3	PMC3820476	28974	28977	O	-1	-1	0
1.1	PMC3820476	28978	28981	O	-1	-1	0

4.0	PMC3820476	28982	28985	O	-1	-1	0
0.1	PMC3820476	28986	28989	O	-1	-1	0

0.3	PMC3820476	28990	28993	O	-1	-1	0

0.2	PMC3820476	28994	28997	O	-1	-1	0

0.4	PMC3820476	28998	29001	O	-1	-1	0

0	PMC3820476	29002	29003	O	-1	-1	0

100	PMC3820476	29004	29007	O	-1	-1	0


	PMC3820476	29007	29009	O	-1	-1	0

36	PMC3820476	29009	29011	O	-1	-1	0

57	PMC3820476	29012	29014	O	-1	-1	0

54	PMC3820476	29015	29017	O	-1	-1	0

91	PMC3820476	29018	29020	O	-1	-1	0

9	PMC3820476	29021	29022	O	-1	-1	0

105	PMC3820476	29023	29026	O	-1	-1	0

37	PMC3820476	29027	29029	O	-1	-1	0

36	PMC3820476	29030	29032	O	-1	-1	0

4	PMC3820476	29033	29034	O	-1	-1	0

40	PMC3820476	29035	29037	O	-1	-1	0

5	PMC3820476	29038	29039	O	-1	-1	0

15	PMC3820476	29040	29042	O	-1	-1	0

41	PMC3820476	29043	29045	O	-1	-1	0

62	PMC3820476	29046	29048	O	-1	-1	0

1	PMC3820476	29049	29050	O	-1	-1	0

3	PMC3820476	29051	29052	O	-1	-1	0

3	PMC3820476	29053	29054	O	-1	-1	0

16	PMC3820476	29055	29057	O	-1	-1	0

0	PMC3820476	29058	29059	O	-1	-1	0

1,994	PMC3820476	29060	29065	O	-1	-1	0


	PMC3820476	29065	29067	O	-1	-1	0
1.8	PMC3820476	29067	29070	O	-1	-1	0

2.9	PMC3820476	29071	29074	O	-1	-1	0

2.7	PMC3820476	29075	29078	O	-1	-1	0

4.6	PMC3820476	29079	29082	O	-1	-1	0
0.5	PMC3820476	29083	29086	O	-1	-1	0

5.3	PMC3820476	29087	29090	O	-1	-1	0

1.9	PMC3820476	29091	29094	O	-1	-1	0

1.8	PMC3820476	29095	29098	O	-1	-1	0

0.2	PMC3820476	29099	29102	O	-1	-1	0

2.0	PMC3820476	29103	29106	O	-1	-1	0

0.3	PMC3820476	29107	29110	O	-1	-1	0
0.8	PMC3820476	29111	29114	O	-1	-1	0
2.1	PMC3820476	29115	29118	O	-1	-1	0

3.1	PMC3820476	29119	29122	O	-1	-1	0

0.1	PMC3820476	29123	29126	O	-1	-1	0

0.2	PMC3820476	29127	29130	O	-1	-1	0

0.2	PMC3820476	29131	29134	O	-1	-1	0

0.8	PMC3820476	29135	29138	O	-1	-1	0
0	PMC3820476	29139	29140	O	-1	-1	0

100	PMC3820476	29141	29144	O	-1	-1	0


	PMC3820476	29144	29146	O	-1	-1	0

All	PMC3820476	29146	29149	O	-1	-1	0


	PMC3820476	29149	29151	O	-1	-1	0
1.6	PMC3820476	29151	29154	O	-1	-1	0

2.0	PMC3820476	29155	29158	O	-1	-1	0

2.0	PMC3820476	29159	29162	O	-1	-1	0

4.2	PMC3820476	29163	29166	O	-1	-1	0

0.6	PMC3820476	29167	29170	O	-1	-1	0

5.6	PMC3820476	29171	29174	O	-1	-1	0

2.4	PMC3820476	29175	29178	O	-1	-1	0

2.2	PMC3820476	29179	29182	O	-1	-1	0

0.7	PMC3820476	29183	29186	O	-1	-1	0

2.0	PMC3820476	29187	29190	O	-1	-1	0

0.2	PMC3820476	29191	29194	O	-1	-1	0

1.1	PMC3820476	29195	29198	O	-1	-1	0

1.7	PMC3820476	29199	29202	O	-1	-1	0
3.7	PMC3820476	29203	29206	O	-1	-1	0

0	PMC3820476	29207	29208	O	-1	-1	0

0.5	PMC3820476	29209	29212	O	-1	-1	0

0.2	PMC3820476	29213	29216	O	-1	-1	0

0.9	PMC3820476	29217	29220	O	-1	-1	0

0	PMC3820476	29221	29222	O	-1	-1	0

100	PMC3820476	29223	29226	O	-1	-1	0


	PMC3820476	29226	29228	O	-1	-1	0

1.1	PMC3820476	29228	29231	O	-1	-1	0

1.6	PMC3820476	29232	29235	O	-1	-1	0

2.3	PMC3820476	29236	29239	O	-1	-1	0

3.9	PMC3820476	29240	29243	O	-1	-1	0

0.5	PMC3820476	29244	29247	O	-1	-1	0

4.9	PMC3820476	29248	29251	O	-1	-1	0

2.5	PMC3820476	29252	29255	O	-1	-1	0

1.7	PMC3820476	29256	29259	O	-1	-1	0

0.8	PMC3820476	29260	29263	O	-1	-1	0

2.5	PMC3820476	29264	29267	O	-1	-1	0

0.1	PMC3820476	29268	29271	O	-1	-1	0

0.8	PMC3820476	29272	29275	O	-1	-1	0

1.3	PMC3820476	29276	29279	O	-1	-1	0

4.4	PMC3820476	29280	29283	O	-1	-1	0
0.1	PMC3820476	29284	29287	O	-1	-1	0

0.3	PMC3820476	29288	29291	O	-1	-1	0

0.1	PMC3820476	29292	29295	O	-1	-1	0

0.7	PMC3820476	29296	29299	O	-1	-1	0

0	PMC3820476	29300	29301	O	-1	-1	0

100	PMC3820476	29302	29305	O	-1	-1	0


	PMC3820476	29305	29307	O	-1	-1	0
submit	PMC3820476	29307	29313	O	-1	-1	0
your	PMC3820476	29314	29318	O	-1	-1	0
manuscript	PMC3820476	29319	29329	O	-1	-1	0

|	PMC3820476	29330	29331	O	-1	-1	0

www.dovepress.com	PMC3820476	29332	29349	O	-1	-1	0


	PMC3820476	29349	29351	O	-1	-1	0

Dovepress	PMC3820476	29351	29360	O	-1	-1	0


	PMC3820476	29360	29362	O	-1	-1	0
100	PMC3820476	29362	29365	O	-1	-1	0


	PMC3820476	29365	29367	O	-1	-1	0
45	PMC3820476	29367	29369	O	-1	-1	0


	PMC3820476	29369	29371	O	-1	-1	0

Ording	PMC3820476	29371	29377	O	-1	-1	0
et	PMC3820476	29378	29380	O	-1	-1	0
al	PMC3820476	29381	29383	O	-1	-1	0


	PMC3820476	29383	29385	O	-1	-1	0

Clinical	PMC3820476	29385	29393	O	-1	-1	0
Epidemiology	PMC3820476	29394	29406	O	-1	-1	0


	PMC3820476	29406	29408	O	-1	-1	0

Publish	PMC3820476	29408	29415	O	-1	-1	0
your	PMC3820476	29416	29420	O	-1	-1	0
work	PMC3820476	29421	29425	O	-1	-1	0
in	PMC3820476	29426	29428	O	-1	-1	0
this	PMC3820476	29429	29433	O	-1	-1	0
journal	PMC3820476	29434	29441	O	-1	-1	0

Clinical	PMC3820476	29442	29450	O	-1	-1	0
Epidemiology	PMC3820476	29451	29463	O	-1	-1	0
is	PMC3820476	29464	29466	O	-1	-1	0
an	PMC3820476	29467	29469	O	-1	-1	0
international	PMC3820476	29470	29483	O	-1	-1	0
,	PMC3820476	29483	29484	O	-1	-1	0
peer	PMC3820476	29485	29489	O	-1	-1	0
-	PMC3820476	29489	29490	O	-1	-1	0
reviewed	PMC3820476	29490	29498	O	-1	-1	0
,	PMC3820476	29498	29499	O	-1	-1	0
open	PMC3820476	29500	29504	O	-1	-1	0
access	PMC3820476	29505	29511	O	-1	-1	0
journal	PMC3820476	29512	29519	O	-1	-1	0
focusing	PMC3820476	29520	29528	O	-1	-1	0
on	PMC3820476	29529	29531	O	-1	-1	0
disease	PMC3820476	29532	29539	O	-1	-1	0
and	PMC3820476	29540	29543	O	-1	-1	0
drug	PMC3820476	29544	29548	O	-1	-1	0
epidemiology	PMC3820476	29549	29561	O	-1	-1	0
,	PMC3820476	29561	29562	O	-1	-1	0
identification	PMC3820476	29563	29577	O	-1	-1	0
of	PMC3820476	29578	29580	O	-1	-1	0
risk	PMC3820476	29581	29585	O	-1	-1	0
factors	PMC3820476	29586	29593	O	-1	-1	0
and	PMC3820476	29594	29597	O	-1	-1	0
screening	PMC3820476	29598	29607	O	-1	-1	0
procedures	PMC3820476	29608	29618	O	-1	-1	0
to	PMC3820476	29619	29621	O	-1	-1	0
develop	PMC3820476	29622	29629	O	-1	-1	0
optimal	PMC3820476	29630	29637	O	-1	-1	0
preventative	PMC3820476	29638	29650	O	-1	-1	0
initiatives	PMC3820476	29651	29662	O	-1	-1	0
and	PMC3820476	29663	29666	O	-1	-1	0
programs	PMC3820476	29667	29675	O	-1	-1	0
.	PMC3820476	29675	29676	O	-1	-1	0

Specific	PMC3820476	29677	29685	O	-1	-1	0
topics	PMC3820476	29686	29692	O	-1	-1	0
include	PMC3820476	29693	29700	O	-1	-1	0
:	PMC3820476	29700	29701	O	-1	-1	0
diagnosis	PMC3820476	29702	29711	O	-1	-1	0
,	PMC3820476	29711	29712	O	-1	-1	0
prognosis	PMC3820476	29713	29722	O	-1	-1	0
,	PMC3820476	29722	29723	O	-1	-1	0
treatment	PMC3820476	29724	29733	O	-1	-1	0
,	PMC3820476	29733	29734	O	-1	-1	0
screening	PMC3820476	29735	29744	O	-1	-1	0
,	PMC3820476	29744	29745	O	-1	-1	0
prevention	PMC3820476	29746	29756	O	-1	-1	0
,	PMC3820476	29756	29757	O	-1	-1	0
risk	PMC3820476	29758	29762	O	-1	-1	0
factor	PMC3820476	29763	29769	O	-1	-1	0
modification	PMC3820476	29770	29782	O	-1	-1	0
,	PMC3820476	29782	29783	O	-1	-1	0
systematic	PMC3820476	29784	29794	O	-1	-1	0


	PMC3820476	29794	29796	O	-1	-1	0

Dovepress	PMC3820476	29796	29805	O	-1	-1	0


	PMC3820476	29805	29807	O	-1	-1	0

Dovepress	PMC3820476	29807	29816	O	-1	-1	0
reviews	PMC3820476	29817	29824	O	-1	-1	0
,	PMC3820476	29824	29825	O	-1	-1	0
risk	PMC3820476	29826	29830	O	-1	-1	0
&	PMC3820476	29831	29832	O	-1	-1	0
safety	PMC3820476	29833	29839	O	-1	-1	0
of	PMC3820476	29840	29842	O	-1	-1	0
medical	PMC3820476	29843	29850	O	-1	-1	0
interventions	PMC3820476	29851	29864	O	-1	-1	0
,	PMC3820476	29864	29865	O	-1	-1	0
epidemiology	PMC3820476	29866	29878	O	-1	-1	0
&	PMC3820476	29879	29880	O	-1	-1	0
biostatical	PMC3820476	29881	29892	O	-1	-1	0
methods	PMC3820476	29893	29900	O	-1	-1	0
,	PMC3820476	29900	29901	O	-1	-1	0
evaluation	PMC3820476	29902	29912	O	-1	-1	0
of	PMC3820476	29913	29915	O	-1	-1	0
guidelines	PMC3820476	29916	29926	O	-1	-1	0
,	PMC3820476	29926	29927	O	-1	-1	0
translational	PMC3820476	29928	29941	O	-1	-1	0
medicine	PMC3820476	29942	29950	O	-1	-1	0
,	PMC3820476	29950	29951	O	-1	-1	0
health	PMC3820476	29952	29958	O	-1	-1	0
policies	PMC3820476	29959	29967	O	-1	-1	0
&	PMC3820476	29968	29969	O	-1	-1	0
economic	PMC3820476	29970	29978	O	-1	-1	0
evaluations	PMC3820476	29979	29990	O	-1	-1	0
.	PMC3820476	29990	29991	O	-1	-1	0

The	PMC3820476	29992	29995	O	-1	-1	0
manuscript	PMC3820476	29996	30006	O	-1	-1	0
management	PMC3820476	30007	30017	O	-1	-1	0
system	PMC3820476	30018	30024	O	-1	-1	0
is	PMC3820476	30025	30027	O	-1	-1	0
completely	PMC3820476	30028	30038	O	-1	-1	0
online	PMC3820476	30039	30045	O	-1	-1	0
and	PMC3820476	30046	30049	O	-1	-1	0
includes	PMC3820476	30050	30058	O	-1	-1	0
a	PMC3820476	30059	30060	O	-1	-1	0
very	PMC3820476	30061	30065	O	-1	-1	0
quick	PMC3820476	30066	30071	O	-1	-1	0
and	PMC3820476	30072	30075	O	-1	-1	0
fair	PMC3820476	30076	30080	O	-1	-1	0
peer	PMC3820476	30081	30085	O	-1	-1	0
-	PMC3820476	30085	30086	O	-1	-1	0
review	PMC3820476	30086	30092	O	-1	-1	0
system	PMC3820476	30093	30099	O	-1	-1	0
,	PMC3820476	30099	30100	O	-1	-1	0
which	PMC3820476	30101	30106	O	-1	-1	0
is	PMC3820476	30107	30109	O	-1	-1	0
all	PMC3820476	30110	30113	O	-1	-1	0
easy	PMC3820476	30114	30118	O	-1	-1	0
to	PMC3820476	30119	30121	O	-1	-1	0
use	PMC3820476	30122	30125	O	-1	-1	0
.	PMC3820476	30125	30126	O	-1	-1	0


	PMC3820476	30126	30128	O	-1	-1	0

Submit	PMC3820476	30128	30134	O	-1	-1	0
your	PMC3820476	30135	30139	O	-1	-1	0
manuscript	PMC3820476	30140	30150	O	-1	-1	0
here	PMC3820476	30151	30155	O	-1	-1	0
:	PMC3820476	30155	30156	O	-1	-1	0

http://www.dovepress.com/clinical-epidemiology-journal	PMC3820476	30157	30211	O	-1	-1	0


	PMC3820476	30211	30213	O	-1	-1	0
46	PMC3820476	30213	30215	O	-1	-1	0


	PMC3820476	30215	30217	O	-1	-1	0

submit	PMC3820476	30217	30223	O	-1	-1	0
your	PMC3820476	30224	30228	O	-1	-1	0
manuscript	PMC3820476	30229	30239	O	-1	-1	0

|	PMC3820476	30240	30241	O	-1	-1	0

www.dovepress.com	PMC3820476	30242	30259	O	-1	-1	0


	PMC3820476	30259	30261	O	-1	-1	0

Dovepress	PMC3820476	30261	30270	O	-1	-1	0


	PMC3820476	30270	30272	O	-1	-1	0

Clinical	PMC3820476	30272	30280	O	-1	-1	0
Epidemiology	PMC3820476	30281	30293	O	-1	-1	0
2013:5	PMC3820476	30294	30300	O	-1	-1	0

(	PMC3820476	30301	30302	O	-1	-1	0
Suppl	PMC3820476	30302	30307	O	-1	-1	0
1	PMC3820476	30308	30309	O	-1	-1	0
)	PMC3820476	30309	30310	O	-1	-1	0


	PMC3820476	30310	30312	O	-1	-1	0

